Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,37784,-0.249518241919932,0.00684995406804244,-0.262944151893296,-0.236092331946569,4.85801059988992e-277
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37791,-0.13016264854021,0.00363997987115204,-0.137297009087668,-0.123028287992752,1.63451469382525e-267
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40174,0.0968868526582337,0.00273606569703075,0.0915241638920534,0.102249541424414,2.47271499684043e-264
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40095,0.087044867644885,0.00272803244817722,0.0816979240464577,0.0923918112433124,1.70525164534623e-216
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,40057,-0.109774744549624,0.00352725655604017,-0.116688167399462,-0.102861321699785,2.33525123700557e-206
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,40095,-0.113735457225825,0.00368531258388588,-0.120958669890241,-0.106512244561409,4.51330331727719e-203
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37697,-0.140229556986071,0.00476563856222979,-0.149570208568042,-0.130888905404101,2.09901437061075e-184
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,39746,-0.313135277493755,0.0109273888895201,-0.334552959717214,-0.291717595270295,5.80508832263812e-176
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,40233,-0.321925882296465,0.0116121110765053,-0.344685620006416,-0.299166144586515,3.23976968279525e-165
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40186,0.0658951608239074,0.00241859668414673,0.0611547113229798,0.070635610324835,9.42326682332329e-160
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39991,-0.0699990688763234,0.00258036658481368,-0.0750565873825583,-0.0649415503700886,2.22240244798709e-158
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40262,0.278245238412002,0.0103469042982322,0.257965305987467,0.298525170836537,8.60286121434027e-156
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,40095,-0.0998430873089323,0.00373222856570336,-0.107158255297711,-0.0925279193201538,3.40841791706097e-154
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,37808,0.149206238664167,0.00582694949961274,0.137785417644926,0.160627059683408,3.2279558184773e-141
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,40178,-0.0772307198523197,0.00302459362426059,-0.0831589233558704,-0.0713025163487689,6.02154291199343e-141
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40258,0.139103862445468,0.00562196322549862,0.128084814523491,0.150122910367446,1.21812668680546e-132
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39889,0.115712721978004,0.00472736400915837,0.106447088520054,0.124978355435954,7.61363070682889e-130
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,40100,-0.114555863508351,0.00473395616033998,-0.123834417582617,-0.105277309434084,4.89566135249693e-127
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,40213,-0.249653794435741,0.010342065141316,-0.269924242112721,-0.229383346758762,1.87428043921321e-126
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,37470,-0.0611315347551986,0.00254296383817391,-0.0661157438780195,-0.0561473256323778,5.57937090229321e-125
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,40065,-0.192754038546234,0.00814648096530346,-0.208721141238229,-0.176786935854239,1.24472503286757e-121
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37587,-0.0541776437538821,0.0022900500323209,-0.0586661418172311,-0.0496891456905331,3.29936700794457e-121
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,37782,0.0500428506670296,0.0021273609152246,0.0458732232731894,0.0542124780608698,6.40648635507555e-120
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,40248,-0.137237464700022,0.00588418183153568,-0.148770461089832,-0.125704468310212,2.55826786543433e-118
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,37791,0.124554412897255,0.00534384354682513,0.114080479545477,0.135028346249032,8.18543609933081e-118
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,40185,0.0580097858146283,0.00249648435841357,0.0531166764721377,0.0629028951571189,1.83228635733001e-117
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,37782,0.0989629776578,0.00431743483303577,0.0905008053850499,0.10742514993055,4.46825704916985e-114
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,40115,-0.154313268347271,0.0067555777978966,-0.167554200831148,-0.141072335863394,1.24226414571746e-113
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FURIN,Furin,40174,-0.0679478510199866,0.0029795793358435,-0.0737878265182399,-0.0621078755217333,2.82571104790889e-113
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,37362,-0.189598666915443,0.00840729479842342,-0.206076964720353,-0.173120369110533,1.7364197691391e-110
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,40248,0.0688727248651252,0.00306697849111832,0.0628614470225333,0.0748840027077171,5.81852710614971e-110
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,40122,-0.100982637174695,0.00460405700095031,-0.110006588896558,-0.0919586854528323,4.72090014385216e-105
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,40133,-0.0348688805230667,0.00159953964100028,-0.0380039782194272,-0.0317337828267062,8.14935897685285e-104
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40297,0.0652466175750688,0.00307519028141899,0.0592192446234875,0.07127399052665,1.55260770707191e-98
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,40139,0.0378727787557042,0.00178699814866379,0.0343702623843231,0.0413752951270852,2.60717228285674e-98
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40164,0.0638856580826234,0.00302589771177081,0.0579548985675526,0.0698164175976942,1.3652056863292e-97
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,40164,-0.0635985765058803,0.00302686351241412,-0.069531228990212,-0.0576659240215487,1.09873633882042e-96
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,40095,0.0498005468670131,0.00238857860569421,0.0451189327998525,0.0544821609341738,3.03207340571636e-95
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AFM,Afamin,37808,-0.0343611321310566,0.00165508189020026,-0.0376050926358491,-0.0311171716262641,2.98253443451062e-94
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,40126,-0.1099191972687,0.00530183383724258,-0.120310791589696,-0.099527602947705,3.24344284050444e-94
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37470,0.054690789805778,0.00271184909476016,0.0493755655800481,0.0600060140315079,4.32508343460857e-89
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39810,-0.120038794538957,0.00597977633528672,-0.131759156156119,-0.108318432921795,1.6911625338098e-88
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,40137,-0.0533259636576469,0.00266460976189072,-0.0585485987909527,-0.0481033285243411,5.34346198307521e-88
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,40222,0.0608198182923935,0.00304792940370947,0.054845876661123,0.0667937599236641,1.64391934473053e-87
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,40233,0.0387149865685359,0.0019417454033034,0.0349091655780613,0.0425208075590106,2.25228834462075e-87
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37171,-0.0564567005113898,0.00284787059931314,-0.0620385268860435,-0.050874874136736,3.66149690449981e-86
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,37782,0.093318700240052,0.00479093309715093,0.0839284713696362,0.102708929110468,2.41191810712184e-83
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,40126,0.079166028278641,0.00407253046152587,0.0711838685740503,0.0871481879832317,3.43638476468907e-83
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40185,-0.0793066628726425,0.00410283743542296,-0.0873482242460715,-0.0712651014992135,2.71441722505767e-82
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,40181,-0.0983389862136236,0.00521686998281388,-0.108564051379939,-0.0881139210473084,2.13813681949605e-78
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,40248,-0.0562697208076068,0.00301880355221895,-0.062186575769956,-0.0503528658452577,1.01648255108431e-76
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,37667,-0.0424164551102831,0.00227330829523912,-0.0468721393689518,-0.0379607708516144,1.03937384874527e-76
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40164,0.0625010940231577,0.00335386687694652,0.0559275149443425,0.0690746731019728,1.10884575999191e-76
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,40274,-0.088101724726266,0.00473599582413964,-0.0973842765415797,-0.0788191729109523,1.99861379175438e-76
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,37441,-0.0598981180924291,0.0032267748993121,-0.0662225968950808,-0.0535736392897774,6.14591554951059e-76
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,40115,0.0887251447540889,0.00481802293487255,0.0792818198017387,0.0981684697064391,6.11839499387105e-75
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,40297,-0.0864841233536585,0.00470673341552405,-0.0957093208480857,-0.0772589258592314,1.25031403595311e-74
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,40186,0.0718818254070409,0.00395530275697012,0.0641294320033794,0.0796342188107023,4.66938467312075e-73
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40095,0.0437122782730458,0.00241005753577867,0.0389885655029196,0.048435991043172,8.97605540231097e-73
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,40095,0.0599316255808618,0.00334496030616762,0.0533755033807733,0.0664877477809503,4.45718059957445e-71
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,40105,0.0724063047817401,0.00406175268104115,0.0644452695268994,0.0803673400365807,2.1880662749587e-70
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40213,-0.066732809793954,0.00374792640106027,-0.0740787455400321,-0.0593868740478759,3.13296105195052e-70
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40133,0.0469859965878875,0.00265509856937945,0.0417820033919038,0.0521899897838713,2.10775019711648e-69
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,39815,-0.12078197856407,0.00684421452155,-0.134196639026308,-0.107367318101832,5.11559959997219e-69
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,37777,-0.0429407864245347,0.00243382493415071,-0.0477110832954701,-0.0381704895535993,6.93876402684871e-69
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,37756,-0.0719773426524046,0.00410610153977253,-0.0800253016703587,-0.0639293836344504,4.96511773275607e-68
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40126,0.0415700002531733,0.00240130959597193,0.0368634334450683,0.0462765670612783,1.60322451615649e-66
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37470,-0.0581690201084232,0.00336007447753127,-0.0647547660843845,-0.0515832741324619,2.1185652475861e-66
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,37782,-0.0398792832032182,0.00231517350128627,-0.0444170232657393,-0.0353415431406971,8.84307168499344e-66
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,37784,-0.139646112944287,0.00814297097036883,-0.155606336046209,-0.123685889842364,3.18134148331641e-65
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,40095,-0.0861280224096931,0.00504078519370997,-0.0960079613893646,-0.0762480834300215,7.28285152990594e-65
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,40229,-0.0305174501247002,0.00178720047218067,-0.0340203630501744,-0.0270145371992261,8.61687497882085e-65
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,39014,-0.0608451096359865,0.00357150740884731,-0.0678452641573273,-0.0538449551146458,1.86075762462251e-64
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37782,-0.0334846965654178,0.00198072649459936,-0.0373669204948325,-0.029602472636003,1.88304468708085e-63
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40065,-0.0627512693764854,0.00371484019263135,-0.0700323561540428,-0.0554701825989279,1.88353035993347e-63
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39991,-0.0479954233469335,0.00285921339919617,-0.053599481609358,-0.042391365084509,1.09717138666576e-62
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,40121,-0.0775090224210153,0.00470934267123043,-0.086739334056627,-0.0682787107854037,2.33641965751919e-60
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40297,-0.0574093769461625,0.00348853515159465,-0.064246905843288,-0.050571848049037,2.38204965235615e-60
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37784,-0.0413932522624508,0.00252277964110982,-0.0463379003590261,-0.0364486041658756,6.4950341866281e-60
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40065,-0.11602856694642,0.0070783832678635,-0.129902198151432,-0.102154935741407,6.90434902656938e-60
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40140,0.0464415289581957,0.00284106183000994,0.0408730477713762,0.0520100101450152,1.43022001116356e-59
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,40095,-0.0509258428248818,0.00312224377781806,-0.0570454406294052,-0.0448062450203584,2.55821413623006e-59
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,40297,0.039770378993153,0.00247219280371421,0.0349248810978732,0.0446158768884329,9.01201541018125e-58
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37618,-0.038917728877648,0.0024219192819469,-0.0436646906702639,-0.0341707670850321,1.48357441955534e-57
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39810,-0.120299437712224,0.00753215408075934,-0.135062459710512,-0.105536415713936,5.80710253583571e-57
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,40100,-0.117780442166709,0.00740841887678823,-0.132300943165214,-0.103259941168204,1.80474975920156e-56
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,40095,-0.0335478476271368,0.00211427779847389,-0.0376918321121456,-0.029403863142128,2.9320352725157e-56
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40297,0.0343785538346935,0.00216814967312597,0.0301289804753666,0.0386281271940205,3.44577414684023e-56
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40251,-0.0296859175036253,0.00187453431710753,-0.033360004765156,-0.0260118302420945,4.70812249671761e-56
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37631,-0.0463962705217975,0.0029378070619815,-0.0521543723632812,-0.0406381686803137,1.12854639378439e-55
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39746,-0.105918552543874,0.00677415609232676,-0.119195898484835,-0.0926412066029139,1.1024387435975e-54
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40297,0.0441596299468684,0.00282877753516338,0.0386152259779482,0.0497040339157886,1.56449156786898e-54
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40077,-0.0769807193260066,0.00493307518932686,-0.0866495466970872,-0.0673118919549259,1.7343884043388e-54
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,39729,-0.0830915469482578,0.00532778973887082,-0.0935340148364446,-0.072649079060071,2.03995974988131e-54
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37737,-0.104553756735313,0.00672382901364958,-0.117732461602066,-0.0913750518685598,4.78061980361029e-54
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,40040,-0.107290319514875,0.00694542099989664,-0.120903344674672,-0.0936772943550775,1.9475145846646e-53
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,40264,0.0743888953295421,0.00485064273261272,0.0648816355736212,0.083896155085463,1.05433074648454e-52
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40065,-0.143453360225996,0.00938976592716538,-0.161857301443241,-0.125049419008752,2.57580026029891e-52
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,37470,-0.0569383652964036,0.00372975315059535,-0.0642486814715705,-0.0496280491212367,3.64431424509258e-52
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39746,-0.0799626341311048,0.00525076439332043,-0.0902541323420129,-0.0696711359201968,5.48219701756643e-52
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,37430,-0.0705131354471516,0.00463309284814622,-0.0795939974295181,-0.061432273464785,7.36071876421615e-52
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40248,-0.0503882954121407,0.00331344870478065,-0.0568826548735108,-0.0438939359507706,7.37831375973513e-52
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,40106,-0.0423403027131566,0.00278528319136616,-0.0477994577682343,-0.0368811476580789,8.10891437118724e-52
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40100,-0.0369810824022811,0.00246676061322448,-0.0418159332042011,-0.0321462316003611,1.86197029049288e-50
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,40100,-0.134197527191973,0.00903697377381908,-0.151909995788658,-0.116485058595288,1.51639750968901e-49
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40174,-0.0458321451499106,0.00308777887775229,-0.0518841917503051,-0.0397800985495161,1.6686428364583e-49
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40126,-0.0396066650144068,0.00267403721450732,-0.0448477779548411,-0.0343655520739725,2.65724787789261e-49
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40207,-0.0407755489399178,0.00276168485779302,-0.0461884512611921,-0.0353626466186435,5.25638407173381e-49
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,40065,-0.0731305300457456,0.00496850919269181,-0.0828688080634216,-0.0633922520280697,1.03507884655458e-48
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40233,-0.0682390197613655,0.00467165583369214,-0.0773954651954021,-0.0590825743273289,5.2119058530347e-48
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40174,0.0318119326799998,0.00218339378406516,0.0275324808632321,0.0360913844967675,8.93410078806718e-48
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40040,-0.0333217161461583,0.00229712561135045,-0.0378240823444052,-0.0288193499479114,2.26450327142616e-47
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,40133,-0.0436618349348534,0.00301546033047216,-0.0495721371825788,-0.0377515326871279,3.30028404891521e-47
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,40095,0.0376167221773929,0.00260601600772782,0.0325089308022464,0.0427245135525394,6.27909737418676e-47
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40065,0.0307340857016996,0.00213208899631301,0.0265551912689261,0.0349129801344731,8.31708174007487e-47
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,40095,0.0376740100655783,0.00263058047701454,0.0325180723306297,0.0428299478005268,3.14570489241066e-46
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,37696,-0.14154587075674,0.00988620050195766,-0.160922823740577,-0.122168917772903,3.75812679003082e-46
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37715,-0.106566205869735,0.00744967879836026,-0.121167576314521,-0.0919648354249486,4.4944890158681e-46
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,40194,-0.0609962936405533,0.00427184954179225,-0.0693691187424661,-0.0526234685386405,5.75649130816475e-46
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39810,-0.062710313770962,0.00439432361102567,-0.0713231880485723,-0.0540974394933517,6.54460657578039e-46
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,39810,0.0302313522645911,0.00211846581465267,0.0260791592678718,0.0343835452613103,6.57763112489183e-46
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,40251,-0.062548922441547,0.00439086887740199,-0.0711550254412549,-0.0539428194418391,9.21691839737711e-46
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,37579,-0.030404035931977,0.00214501622207819,-0.0346082677272502,-0.0261998041367037,2.85138798789012e-45
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,37808,-0.0254704341615234,0.00179892866102548,-0.0289963343371333,-0.0219445339859135,3.5027963468089e-45
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,40274,-0.0432342501438599,0.00306607593977261,-0.0492437589858142,-0.0372247413019056,7.01604410981947e-45
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,37151,0.0559938488265904,0.00397371505740469,0.0482053673140772,0.0637823303391035,9.36479460126849e-45
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,40130,0.0463317440098881,0.00332272405216785,0.0398192048676391,0.052844283152137,6.26911677213103e-44
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,37808,-0.0272198690276416,0.00195204916295584,-0.031045885387035,-0.0233938526682481,6.92270300262258e-44
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37697,-0.0636079382602578,0.00456984237447922,-0.0725648293142371,-0.0546510472062786,9.85802218824661e-44
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,37696,-0.0850331780884631,0.00611968011765654,-0.09702775111907,-0.0730386050578563,1.37274412060159e-43
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,39727,-0.0622249220276089,0.00449849252334362,-0.0710419673733624,-0.0534078766818554,2.96254419435888e-43
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,40160,-0.0792808499558014,0.00573825254981168,-0.0905278249534323,-0.0680338749581705,3.63986408767643e-43
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39661,-0.0228595432436771,0.00165909752165767,-0.0261113743861261,-0.0196077121012281,6.23395241215659e-43
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,37791,0.0466353074636823,0.0033897782728636,0.0399913420488696,0.053279272878495,8.97601603224783e-43
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,40153,-0.0396202822413356,0.00289056892429234,-0.0452857973329486,-0.0339547671497226,1.62540977265101e-42
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LEP,Leptin,40126,-0.0776369942292584,0.00570400357083198,-0.0888168412280891,-0.0664571472304277,5.96787540243116e-42
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39746,-0.0980146581703916,0.00721235673281988,-0.112150877366719,-0.0838784389740646,8.04890633626054e-42
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40164,0.0337421259702264,0.00248428044632796,0.0288729362954236,0.0386113156450292,8.78446722123485e-42
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40186,0.0250368829692358,0.00184821772858526,0.0214143762212087,0.0286593897172629,1.42130677436768e-41
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,39991,-0.0495428104927388,0.00365800502511405,-0.0567125003419623,-0.0423731206435152,1.48641804690588e-41
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40297,-0.0806650728957481,0.00604885710292466,-0.0925208328174805,-0.0688093129740158,2.37149322993224e-40
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40079,-0.0242987718452551,0.00182227219891694,-0.0278704253551323,-0.0207271183353779,2.4283185365074e-40
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40121,0.0404088409785359,0.00303124591317639,0.0344675989887102,0.0463500829683616,2.54211152363163e-40
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,40065,-0.0975182859986262,0.00731880843832411,-0.111863150537742,-0.083173421459511,2.77320966888083e-40
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39815,-0.0660570755431729,0.00498157627124085,-0.075820965034805,-0.0562931860515408,6.51928438115503e-40
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,37376,-0.093450892660543,0.00706023399643137,-0.107288951293549,-0.0796128340275375,9.8282369625683e-40
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,39991,0.039582103199488,0.00300635498378137,0.0336896474312765,0.0454745589676995,2.23318769657992e-39
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,40126,-0.0754054089321407,0.00573457914136532,-0.0866451840492167,-0.0641656338150646,2.77432824350199e-39
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,40065,-0.0629399781953815,0.00480800581333467,-0.0723636695895175,-0.0535162868012456,5.97097835896349e-39
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39834,-0.0496019648514609,0.00379235931250954,-0.0570349891039796,-0.0421689405989422,6.95814076197684e-39
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,40248,-0.052728601080009,0.00404806709576289,-0.0606628125877043,-0.0447943895723137,1.3825976330018e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37756,-0.0669209500889266,0.00513773364119849,-0.0769909080256756,-0.0568509921521776,1.50997578847947e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39821,-0.0866601753919789,0.00666554583060679,-0.0997246452199682,-0.0735957055639896,1.92061378864287e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37808,-0.0203954994346189,0.00157200118468857,-0.0234766217566085,-0.0173143771126293,2.91700776109566e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40143,0.0399193382111116,0.00308309339772332,0.0338764751515739,0.0459622012706493,3.79066513644096e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40065,-0.0782312542913601,0.0060647262345985,-0.0901181177111731,-0.066344390871547,7.08325483981285e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40274,0.0298629512593581,0.00231554053583804,0.0253244918091155,0.0344014107096007,7.28439184393462e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,40097,-0.0342715353356755,0.00265778605949414,-0.039480796012284,-0.029062274659067,7.50919226576395e-38
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,40074,-0.105071190325932,0.00818054404913928,-0.121105056662245,-0.089037323989619,1.43923207147871e-37
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,40216,-0.0671763100086632,0.00526266466279135,-0.0774911327477343,-0.0568614872695922,3.94199462845046e-37
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40233,-0.10953609931491,0.0086242271967407,-0.126439584620522,-0.0926326140092986,8.83929607270771e-37
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40065,-0.0999704184707732,0.00787282527892333,-0.115401156017463,-0.0845396809240835,9.20004079852094e-37
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,40233,-0.0418299462219299,0.00329532434237154,-0.0482887819329781,-0.0353711105108817,9.687904039482e-37
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,40065,-0.0781632141021437,0.00616122380065207,-0.0902392127514218,-0.0660872154528657,1.06865556244956e-36
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39904,-0.168164350379167,0.013271456715701,-0.194176405541941,-0.142152295216393,1.30006007013874e-36
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37430,0.0719726634047853,0.00570802395813788,0.060784936446835,0.0831603903627355,3.07055146492432e-36
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,39914,-0.0407099857925143,0.00323224865467252,-0.0470451931556725,-0.0343747784293562,3.38949617473941e-36
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,37430,-0.0614860925004869,0.00488394102274868,-0.0710586169050744,-0.0519135680958995,3.92444426711831e-36
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40233,0.0509019198756388,0.00405781567814125,0.042948601146482,0.0588552386047957,6.34905246211404e-36
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,37430,-0.0726231637773582,0.00578787884673539,-0.0839674063169596,-0.0612789212377569,6.63142248562192e-36
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,37808,-0.0231525981085279,0.00185183404836699,-0.0267821928433272,-0.0195230033737286,1.14514790406611e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,39991,0.0317799386583787,0.00254929521447839,0.026783320038001,0.0367765572787563,1.68812911613855e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37784,-0.0623001587052337,0.00499929171599944,-0.0720987704685926,-0.0525015469418748,1.90031036771047e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37430,-0.0639572903809221,0.00513195112484243,-0.0740159145856133,-0.053898666176231,1.90553332739199e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39991,-0.0575890010686696,0.00463001343795236,-0.0666638274070562,-0.048514174730283,2.38859663456598e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,39991,-0.0992211953707564,0.00798797225323008,-0.114877620987087,-0.0835647697544254,2.94362253547373e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,40133,0.029630812727251,0.00240381240791725,0.0249193404077332,0.0343422850467688,9.43616431537092e-35
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,37782,-0.079969327921459,0.00649675750693574,-0.0927029726350531,-0.067235683207865,1.24740715330047e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,37723,0.021024126861811,0.00170807324817345,0.017676303295391,0.0243719504282309,1.25645361585609e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,40126,0.0571882942427138,0.00467232525334049,0.0480305367461664,0.0663460517392611,2.73198820668562e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40174,-0.0999545005735467,0.00817302605337735,-0.115973631638166,-0.083935369508927,3.08269741493684e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,40095,-0.0260232719584566,0.00212904188284473,-0.0301961940488323,-0.021850349868081,3.35542477588117e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37737,0.0399019244617562,0.0032783876313137,0.0334762847043813,0.046327564219131,6.70419020412689e-34
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40126,-0.094609970928633,0.00779799755149914,-0.109894046129571,-0.0793258957276947,1.00509394811138e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40174,0.0461990128655436,0.00381911573019685,0.0387135460343578,0.0536844796967294,1.54774043462886e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37737,-0.0936418844229278,0.00773943195102207,-0.108811171046931,-0.0784725977989246,1.59785630215226e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40126,0.0430036205743555,0.00355782148356019,0.0360302904665775,0.0499769506821334,1.74201251708944e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,40297,-0.0610053711793839,0.00505128770038681,-0.0709058950721421,-0.0511048472866258,1.95494708421932e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,40072,-0.0574580364136657,0.00478693905889467,-0.0668404369690992,-0.0480756358582322,4.783986509305e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,40097,0.188345311019209,0.0156922397258131,0.157588521156616,0.219102100881803,4.81798279289568e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,40174,0.0443325801706002,0.00369793296129311,0.0370846315664657,0.0515805287747347,5.68575560984242e-33
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40065,-0.082693799750715,0.00692760374428546,-0.0962719030895145,-0.0691156964119155,1.05528527177516e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40065,-0.104207908600321,0.00873154080394803,-0.121321728576059,-0.0870940886245826,1.08332491469982e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40194,-0.0770335826112453,0.00648920953668074,-0.0897524333031395,-0.064314731919351,2.30058712503682e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,40274,-0.0319896895975581,0.0026971388774517,-0.0372760817973634,-0.0267032973977527,2.59877945653062e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40233,-0.0697902743876725,0.00588840799688895,-0.0813315540615749,-0.0582489947137702,2.87460189496525e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40126,-0.0446844588960839,0.00377217997215873,-0.052077931641515,-0.0372909861506528,3.10559315129066e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,40071,0.0330968675155005,0.00279440472894275,0.0276198342467727,0.0385739007842283,3.17643457810156e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40065,-0.0467267109640511,0.00394519303753805,-0.0544592893176257,-0.0389941326104765,3.17746449379863e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,40274,-0.0825843876692427,0.00697374336336179,-0.0962529246614318,-0.0689158506770536,3.23120058308599e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,40174,-0.0424621641885479,0.00358778591427731,-0.0494942245805315,-0.0354301037965644,3.51634322572804e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,37102,-0.0245597771267212,0.0020760161074042,-0.0286287686972334,-0.0204907855562089,4.02154376536635e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,37544,-0.0299486265466971,0.00253385292188279,-0.0349149782735873,-0.0249822748198068,4.51020888160509e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40164,0.0471108888981129,0.00398858785407033,0.039293256704135,0.0549285210920907,4.65647552656833e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,37362,-0.0458735820507501,0.00388496298143001,-0.0534881094943529,-0.0382590546071473,5.18610531232276e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40100,-0.100721913394736,0.00854128630589081,-0.117462834554282,-0.0839809922351898,5.83624155538395e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37784,-0.0631129274043898,0.00535157827757659,-0.0736020208284399,-0.0526238339803397,6.08862911218576e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40065,0.0435478180257272,0.00369898854750447,0.0362978004726184,0.0507978355788359,7.34239242383026e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40100,0.0408655726510489,0.00347444865044442,0.0340556532961778,0.0476754920059199,8.36471791246148e-32
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37784,-0.0836832725115356,0.00712524986470229,-0.0976487622463521,-0.0697177827767191,1.07829019984806e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,40100,-0.076064773785493,0.00651525641152872,-0.0888346763520893,-0.0632948712188967,2.31134323833126e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,40100,-0.086126285485758,0.00739747789025076,-0.10062534215065,-0.0716272288208665,3.36316143328074e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37791,-0.0321816335021527,0.00277106757183828,-0.0376129259429557,-0.0267503410613496,4.9656187156701e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40065,0.0436705667359324,0.00377018161929082,0.0362810107621224,0.0510601227097424,6.71066960512579e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,37791,-0.116509164869651,0.0100578215484961,-0.136222495104703,-0.0967958346345984,6.98547882621623e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37763,0.050337182254921,0.00434997000730471,0.0418112410406037,0.0588631234692382,8.03776233414339e-31
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37696,-0.0973556033476596,0.00843278319661215,-0.113883858413019,-0.0808273482822998,1.0984872341226e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,40243,0.0344790354472497,0.0029878263802912,0.0286228957418789,0.0403351751526204,1.10297621339908e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,40121,0.0396200052778884,0.00343694379285617,0.0328835954438903,0.0463564151118865,1.27155134659406e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,40177,-0.0689370715454276,0.00600281907031083,-0.0807025969232368,-0.0571715461676184,2.0960268697152e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,37784,0.0281803197670966,0.00245552378292919,0.0233674931525554,0.0329931463816378,2.40939709999636e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37784,0.0339917726745889,0.00296228710812044,0.0281856899426728,0.039797855406505,2.4498985968907e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39810,-0.0557784722820639,0.00488157285714314,-0.0653463550820645,-0.0462105894820633,4.08747146354574e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40174,-0.0219027856474828,0.00192321819996078,-0.0256722933194059,-0.0181332779755597,6.24303238935631e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,40297,-0.058424943535501,0.00513224680535638,-0.0684841472739995,-0.0483657397970025,6.57379085909319e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37697,-0.0692458832895148,0.0060957313439436,-0.0811935167236443,-0.0572982498553853,9.11047486769401e-30
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39746,-0.062889170131481,0.00554604201289733,-0.0737594124767597,-0.0520189277862022,1.09901036096389e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,40065,-0.115589927405819,0.010198119615971,-0.135578241853122,-0.0956016129585158,1.15707507683708e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37697,-0.0392370313211917,0.00346242045946209,-0.0460233754217374,-0.032450687220646,1.24355255203202e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,40297,-0.0508152970837958,0.00449069291457143,-0.0596170551963558,-0.0420135389712358,1.4250290006832e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,40100,-0.082919237553882,0.00732832936524897,-0.09728276310977,-0.068555711997994,1.44273030498463e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,40097,-0.029353910603142,0.00259683737231569,-0.0344437118528808,-0.0242641093534033,1.63705739907065e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39923,-0.0466901978650261,0.00413136357083593,-0.0547876704638645,-0.0385927252661877,1.68537561656504e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39832,0.0303891932112715,0.00269311463643729,0.0251106885238544,0.0356676978986886,2.05358179213434e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,40186,-0.0412422063591528,0.00367203964231376,-0.0484394040580878,-0.0340450086602179,3.69063429957694e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37725,-0.1091158425335,0.00973986581149648,-0.128205979524033,-0.0900257055429664,5.31724518851187e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,37791,0.0402383593819917,0.0035943986856512,0.0331933379581154,0.0472833808058681,5.82398936710758e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37791,0.0330667125562733,0.00295467407271986,0.0272755513737424,0.0388578737388042,6.05069703929147e-29
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,40100,-0.0918134577902018,0.00824878997118815,-0.107981086133731,-0.075645829446673,1.14158554685713e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,37403,-0.083085896163491,0.00748045640116873,-0.0977475907097817,-0.0684242016172003,1.55940108563853e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40121,0.0380342556107266,0.00342731684530814,0.0313167145939226,0.0447517966275305,1.6496447274088e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40100,-0.105201805515,0.00950610684935785,-0.123833774939741,-0.0865698360902583,2.3171345280214e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40095,-0.0227256778557221,0.00205541463597881,-0.0267542905422406,-0.0186970651692037,2.59608399194945e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,40100,-0.0427027036137211,0.00386764228623965,-0.0502832824947508,-0.0351221247326914,3.08011086898125e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40248,-0.0343135944595995,0.00312137170866698,-0.0404314830085868,-0.0281957059106123,5.21062761881354e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,40248,0.0337961704466548,0.00307523974695063,0.0277687005426316,0.0398236403506781,5.40593303863585e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,40174,-0.081375068832581,0.00741177442443489,-0.0959021467044734,-0.0668479909606886,6.08087620588438e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40024,0.0606174455783924,0.0055309702525914,0.0497767438833133,0.0714581472734716,7.55053301123647e-28
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37470,-0.0813228687661768,0.00747299340404693,-0.0959699358381088,-0.0666758016942448,1.83912857894112e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,40164,-0.0489644803522417,0.00450160851270329,-0.0577876330371401,-0.0401413276673432,1.85646759676731e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,40100,-0.0917153114634961,0.00843783351623057,-0.108253465155308,-0.0751771577716842,2.01781349833274e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40065,-0.0661099945052164,0.00611104298981641,-0.0780876387652566,-0.0541323502451762,3.52717661252836e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,39955,-0.077883660072546,0.00720093519393574,-0.09199749305266,-0.0637698270924319,3.62371925425567e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,40095,0.0235943464942506,0.00218308602865767,0.0193154978780816,0.0278731951104196,3.94250911634561e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40145,0.0297013812620998,0.00274829015537252,0.0243147325575697,0.0350880299666299,3.96426220359195e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37696,0.028329802676335,0.00262130177998809,0.0231920511875584,0.0334675541651117,4.11402603027697e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40160,0.0441034908784156,0.00408684697503635,0.0360932708073444,0.0521137109494869,4.69416937589959e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40261,-0.0367414083305686,0.0034058765944406,-0.0434169264556722,-0.030065890205465,4.89028130463609e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,37430,-0.0591840336988575,0.00549058808018284,-0.0699455863360159,-0.0484224810616992,5.6156911464728e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39991,-0.0556850370287595,0.00516794921741419,-0.0658142174948913,-0.0455558565626277,5.62220498203044e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNST,Consortin,40126,-0.104322682582434,0.00968557426597451,-0.123306408143744,-0.0853389570211243,5.86787344647448e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39621,-0.0856267416932177,0.00798037723591266,-0.101268281075607,-0.0699852023108289,9.21452351079318e-27
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40066,-0.0466947422724726,0.00435739220519326,-0.0552352309946514,-0.0381542535502938,1.05791266317664e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39967,-0.0853686197759121,0.00798052063311169,-0.101010440216811,-0.0697267993350132,1.29988095100254e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40152,-0.0222338103176123,0.00207947746124034,-0.0263095861416433,-0.0181580344935812,1.36950201448536e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,37678,-0.0343964718089475,0.00321644046667487,-0.0407006951236303,-0.0280922484942648,1.39503299528028e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,40274,-0.03121759519359,0.00292069780192768,-0.0369421628853682,-0.0254930275018117,1.42123667993e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40065,0.0253634869184205,0.00237637723040615,0.0207057875468245,0.0300211862900166,1.67729450366342e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,40100,0.024911518076105,0.00233795992693243,0.0203291166193174,0.0294939195328925,2.03043722313101e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39746,-0.104115760705905,0.00977705726640199,-0.123278792948053,-0.0849527284637576,2.18084285282392e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37376,-0.113899269890423,0.0106959671723835,-0.134863365548295,-0.0929351742325513,2.27154687572689e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37791,0.0202285203123976,0.00190260011685451,0.0164994240833628,0.0239576165414325,2.69419445956441e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40114,-0.0471874990438027,0.0044416973312257,-0.055893225813005,-0.0384817722746003,2.83919095726675e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40065,-0.116523467170177,0.0109954906797955,-0.138074628902576,-0.0949723054377777,3.75975631437596e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37784,-0.0621764556830485,0.00586654138232539,-0.0736748767924063,-0.0506780345736907,3.84781806481855e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39810,-0.0874521140282519,0.00826790423665396,-0.103657206332094,-0.0712470217244101,4.66783829408033e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40075,-0.0179965750315522,0.00170214334507771,-0.0213327759879045,-0.0146603740751999,4.8740870274021e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,40297,-0.0422917802899304,0.00400173813307958,-0.0501351870307664,-0.0344483735490944,5.09957148030434e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37362,-0.0646387394508951,0.00611593160002333,-0.0766259653869408,-0.0526515135148493,5.30327847546667e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37362,-0.0703590873935203,0.00666512192465717,-0.0834227263658484,-0.0572954484211922,6.05848899879534e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39991,-0.0700390999058389,0.00664105736474196,-0.0830555723407331,-0.0570226274709446,6.45878436106047e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,40274,-0.0421720673589387,0.00400715263632596,-0.0500260865261376,-0.0343180481917398,8.13315759083231e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40297,-0.0463406973569324,0.0044074857951664,-0.0549793695154585,-0.0377020251984062,9.04492667280341e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,40233,0.0283949453460719,0.00270107604759658,0.0231008362927826,0.0336890543993612,9.20901558179166e-26
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37768,0.0693297733126938,0.0066027022810654,0.0563884768418056,0.082271069783582,1.08590977395059e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40100,-0.0577302670751428,0.00550351203020753,-0.0685171506543495,-0.046943383495936,1.17177865491198e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37696,-0.0990335684723302,0.00943896636591324,-0.11753394254952,-0.0805331943951402,1.18528850949612e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40095,0.0380364076768163,0.00363695036264687,0.0309079849660284,0.0451648303876041,1.62904106952277e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37784,0.0306766650499808,0.00293619525725928,0.0249217223457526,0.036431607754209,1.88120581878099e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,40164,0.0284654438566857,0.00273585444700309,0.0231031691405597,0.0338277185728118,2.85435258019964e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37717,-0.0782319848429643,0.00752066702148907,-0.0929724922050829,-0.0634914774808457,3.02744900451491e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,40274,-0.0704066053478917,0.00678099071587607,-0.0836973471510088,-0.0571158635447746,3.57187236459632e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,40095,-0.0415648155548172,0.00400583701643717,-0.049416256107034,-0.0337133750026003,3.84483588315855e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37403,-0.0784258193695132,0.00756282113412749,-0.0932489487924031,-0.0636026899466234,4.26041801365651e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37784,-0.0676124966027851,0.00652068542022502,-0.0803930400264261,-0.0548319531791441,4.27690019002881e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37791,0.0240685022475499,0.00232166346809939,0.0195180418500751,0.0286189626450247,4.36626905741e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,40195,-0.0642364561422906,0.00620792881526938,-0.0764039966202185,-0.0520689156643626,5.1672068295887e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40164,0.0256348821952851,0.00247973387703027,0.0207746037963058,0.0304951605942645,5.71772851801514e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37737,-0.0433052216352346,0.00419291472121271,-0.0515233344888115,-0.0350871087816577,6.52738653656425e-25
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,39523,-0.0860612984078392,0.00836870838276806,-0.102463966838065,-0.0696586299776138,1.00735752779999e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39746,-0.0581719359110747,0.00566500264105351,-0.0692753410875396,-0.0470685307346098,1.17307286716123e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,40164,-0.0924231934623376,0.00900243799597115,-0.110067971934441,-0.0747784149902342,1.19395695847848e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,40297,0.0279982955315843,0.00272932095503858,0.0226488264597087,0.0333477646034599,1.29612566087172e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,40138,-0.0432437826887957,0.00421552843084205,-0.0515062184132462,-0.0349813469643453,1.30012859431706e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39746,-0.0621498008457147,0.00605884199720918,-0.0740251311602447,-0.0502744705311847,1.31293168002571e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,40248,-0.120019198177465,0.0117142219140916,-0.142979073129085,-0.0970593232258459,1.47829551659836e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,40100,0.0313760006929435,0.00306236618172856,0.0253737629767555,0.0373782384091315,1.4796154236646e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,40160,0.0279659073416993,0.00273631897134703,0.0226027221578591,0.0333290925255394,1.91896688550412e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40083,0.0225586202395514,0.00220835147060839,0.018230251357159,0.0268869891219439,2.02417741872255e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,40065,-0.0330695841015514,0.00324159923224408,-0.0394231185967498,-0.026716049606353,2.3249502189051e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39727,-0.0722556387765239,0.00708871875356851,-0.0861495275335182,-0.0583617500195296,2.5479693960672e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,37737,-0.119449231162402,0.0117285465705646,-0.142437182440709,-0.0964612798840954,2.85582027195804e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,40233,0.0341156471205078,0.00335215096361842,0.0275454312318157,0.0406858630091999,2.97730656849585e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40297,0.0237730639416636,0.00233665958164727,0.0191932111616349,0.0283529167216922,3.07677161457997e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,40144,0.0355630006000481,0.00349564735527658,0.028711531783706,0.0424144694163902,3.09587489513171e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,37470,0.0262489112573629,0.00257975303234359,0.0211925953139694,0.0313052272007563,3.15998674041345e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,39967,-0.0474431086560619,0.00467812841728144,-0.0566122403539335,-0.0382739769581903,4.2989890500661e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39746,-0.0452499845232668,0.00446504478384645,-0.0540014722996058,-0.0364984967469278,4.63693114652313e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,40065,-0.0699926969003177,0.00691075204082447,-0.0835377709003337,-0.0564476229003018,4.92023295410974e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38272,0.0284166855874187,0.00280559335978786,0.0229177226022345,0.0339156485726029,5.00479750485042e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,40274,-0.0238609551221798,0.00235893360900204,-0.0284844649958238,-0.0192374452485359,5.59853279479515e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,39881,0.024983705944954,0.00247199260648828,0.0201386004362369,0.029828811453671,6.12467131038497e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40065,-0.0773667499289772,0.00767210131041289,-0.0924040684973865,-0.0623294313605679,7.67960765170172e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40065,-0.0539267450204675,0.00535074972975604,-0.0644142144907893,-0.0434392755501456,8.14465564354062e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,40164,-0.0522562780518417,0.0051863016579363,-0.0624214293013969,-0.0420911268022865,8.34653578880823e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,40094,0.0199081063435788,0.00197597494221517,0.0160351954568371,0.0237810172303205,8.41599831601299e-24
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39746,-0.0580748911500079,0.00577441672398615,-0.0693927479290208,-0.0467570343709951,1.01118541008987e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39815,-0.0629938849743547,0.00626727680313268,-0.0752777475084948,-0.0507100224402147,1.07384877485178e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40100,-0.0768979434891367,0.00765129896398038,-0.0918944894585383,-0.0619013975197352,1.08060017839412e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39727,-0.0493179442938109,0.00491296157970216,-0.0589473489900272,-0.0396885395975947,1.22413758282927e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REN,Renin,40126,-0.0642147162041531,0.00640199761667392,-0.076762631532834,-0.0516668008754722,1.32000678425384e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,37470,0.048574111766048,0.00484131411812218,0.0390851360945285,0.0580630874375675,1.32639064911085e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37430,0.0325195674667247,0.0032531814484459,0.0261433318277708,0.0388958031056787,1.9241937362741e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37366,-0.0443155362450106,0.00443590552732934,-0.0530099110785761,-0.0356211614114451,2.0462596298484e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,40055,-0.0788970000924917,0.00790169005750678,-0.094384312605205,-0.0634096875797784,2.08795236119176e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40274,-0.0341857978016779,0.00342549773261153,-0.0408997733575965,-0.0274718222457593,2.19077730277914e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,37808,-0.0329110902611684,0.00330206424836783,-0.0393831361879693,-0.0264390443343674,2.5684032248596e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,37784,-0.0819548987324218,0.00823171547241352,-0.0980890610583523,-0.0658207364064913,2.86270833367429e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,40095,0.0256226310363444,0.00257471235806898,0.0205761948145292,0.0306690672581596,2.90854813570837e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,37791,-0.0665144078493956,0.00668638028715288,-0.0796197132122152,-0.0534091024865759,3.10790578048052e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40248,-0.0293724108693695,0.00295404904869053,-0.0351623470048029,-0.023582474733936,3.16273340106262e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37470,-0.0434703962296072,0.00437639069776435,-0.0520481219972253,-0.0348926704619891,3.61864121976822e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,40248,-0.0586006415067743,0.0059037842547132,-0.0701720586460122,-0.0470292243675364,3.75279599319564e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,40100,-0.0810725251219421,0.00817356141483954,-0.0970927054950276,-0.0650523447488566,4.03253607412593e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,40065,-0.0490081279483792,0.00494152969828098,-0.0586935261570099,-0.0393227297397485,4.08532407667141e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39815,-0.0754746069526345,0.00761108898290612,-0.0903923413591304,-0.0605568725461385,4.14504959136486e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39727,-0.0448275125964661,0.00452355496960542,-0.0536936803368927,-0.0359613448560395,4.43053997634773e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40065,-0.0489340636112075,0.00494029651290926,-0.0586170447765096,-0.0392510824459053,4.62700104470837e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40040,-0.0675394215252265,0.00681912447973224,-0.0809049055055017,-0.0541739375449513,4.6592679076969e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,40100,-0.0595506981324643,0.00601513142221367,-0.0713403557200031,-0.0477610405449255,4.85802949492652e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,40233,-0.0529260495460447,0.0053473260965139,-0.0634068086952119,-0.0424452903968774,4.9728523388724e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37403,-0.0701877875050683,0.00710304823609776,-0.0841097620478199,-0.0562658129623167,6.04496298141193e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40126,-0.0300283656247183,0.0030417367966013,-0.0359901697460569,-0.0240665615033798,6.41476176083483e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37462,-0.0404442651445968,0.00410502699709504,-0.0484901180589031,-0.0323984122302905,8.04558118254636e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37403,0.0285413781592531,0.00289980491792056,0.0228577605201288,0.0342249957983774,8.87544222553867e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40186,-0.0251467206488318,0.00255743141564938,-0.0301592862235046,-0.020134155074159,9.4575390285864e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37470,-0.0323014424664651,0.00328434674257971,-0.0387387620819214,-0.0258641228510089,9.55267623963636e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,40248,0.014481437413914,0.00147346688582244,0.011593442317702,0.0173694325101259,9.89727693502977e-23
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39955,-0.098520081037878,0.0100317316003112,-0.118182274974488,-0.0788578871012681,1.06656135147061e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,40031,-0.0341544090175466,0.00347915581844981,-0.0409735544217083,-0.027335263613385,1.10839757175545e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40100,-0.091160162162067,0.00930525731814087,-0.109398466505623,-0.0729218578185109,1.3518923442981e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39607,-0.0892180788966981,0.00910875834893286,-0.107071245260607,-0.0713649125327897,1.38370440794414e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,40248,-0.0236463271524299,0.002419967541921,-0.0283894635345951,-0.0189031907702648,1.73077043422123e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40174,-0.0304902518609057,0.00312276037005414,-0.0366108621862118,-0.0243696415355996,1.8634862193729e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40143,-0.0260521138863533,0.00266987100823582,-0.0312850610624955,-0.0208191667102111,1.97811420652106e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,40233,0.0260911669030082,0.00267447823588183,0.0208491895606798,0.0313331442453366,2.01967629095103e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,40228,-0.0539163805520431,0.0055304550454538,-0.0647560724411326,-0.0430766886629537,2.15494762612836e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37808,-0.0259995594514622,0.00266885954021107,-0.0312305241502759,-0.0207685947526485,2.3729396983584e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,40065,0.0247997116556788,0.00254996167347062,0.0198017867756764,0.0297976365356812,2.71502620474476e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40020,-0.0391093420075181,0.00402210744351761,-0.0469926725968126,-0.0312260114182236,2.76781206502681e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,37756,-0.0469504135171096,0.00482769319430474,-0.0564126921779469,-0.0374881348562723,2.79227179362405e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40186,-0.090888049871691,0.00937747523562409,-0.109267901333514,-0.0725081984098678,3.75452004190973e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,40100,-0.0463042142518955,0.00477754331335515,-0.0556681991460716,-0.0369402293577194,3.76151432881852e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,37403,0.0263279814011618,0.00272257307754757,0.0209917381691686,0.031664224633155,4.78863963834716e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,40100,-0.0734936849820292,0.00760245526642174,-0.0883944973042158,-0.0585928726598426,4.79447808525775e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,40248,0.0399685165170242,0.00413595984922207,0.0318620352125489,0.0480749978214994,4.9506115059576e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37656,-0.0938680920339357,0.00973164032877325,-0.112942107078331,-0.0747940769895402,6.05778110673246e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,40207,-0.0321462743248622,0.0033380159943401,-0.0386887856737688,-0.0256037629759556,6.83921542754119e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,40126,-0.0513299119147839,0.00534388021862423,-0.0618039171432874,-0.0408559066862804,8.71337120854767e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39746,-0.0525919672101039,0.00547588169272677,-0.0633246953278483,-0.0418592390923594,8.83406626230138e-22
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,39746,-0.0634513057635386,0.00662174532680997,-0.0764299266040861,-0.050472684922991,1.09235052579614e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37430,-0.0645401934278939,0.00673858469892552,-0.0777478194377879,-0.0513325674179999,1.17004247162437e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39653,-0.0472378973140847,0.00493700245934774,-0.0569144221344062,-0.0375613724937631,1.25245744693309e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,37403,-0.0385234339960539,0.00402667763219039,-0.0464157221551471,-0.0306311458369607,1.29660239110151e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37430,0.0176213346958432,0.00184355524050983,0.014007966424444,0.0212347029672425,1.40914506071301e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37430,-0.0725793698222903,0.00759620195770937,-0.0874679256594007,-0.05769081398518,1.45937619582029e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39746,-0.0601023186232854,0.00629286067604376,-0.0724363255483312,-0.0477683116982397,1.47701937617996e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,40274,0.0334925220414943,0.00351230585702299,0.0266084025617292,0.0403766415212594,1.69949635269572e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,40027,-0.0621766104631261,0.00652107611946137,-0.0749579196572704,-0.0493953012689818,1.72026572622014e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40182,-0.0887843920295445,0.00931700119654837,-0.107045714374779,-0.0705230696843097,1.80967630672662e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,37430,-0.0528142614912647,0.00554384844186525,-0.0636802044373206,-0.0419483185452089,1.90906811667468e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,37501,-0.0192382848341967,0.00202002941738709,-0.0231975424922753,-0.015279027176118,1.96061082953875e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,40174,-0.0508912186760352,0.00534734902877635,-0.0613720227724368,-0.0404104145796335,2.03385810688234e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39955,-0.0625317807154007,0.00657097288044651,-0.0754108875610759,-0.0496526738697255,2.05188857634489e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,40068,-0.0258475966584272,0.00271736102544655,-0.0311736242683024,-0.020521569048552,2.13683755269226e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,40126,-0.102995680851949,0.0108513497422865,-0.124264326346831,-0.0817270353570678,2.59796386843808e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40100,-0.0529379253325343,0.00558396246835039,-0.0638824917705011,-0.0419933588945676,2.89019867032008e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37430,-0.0597595502446654,0.00630716526871929,-0.0721215941713552,-0.0473975063179756,3.12809087597815e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37430,-0.0616692518490751,0.00651039405141038,-0.0744296241898394,-0.0489088795083107,3.20143449259016e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,40065,-0.0871996344887075,0.00921766079154567,-0.105266249640137,-0.069133019337278,3.50698792516744e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39991,-0.0803904221283137,0.00850810652172609,-0.0970663109108969,-0.0637145333457306,3.90978670417982e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,40122,-0.0488091937425275,0.0051698991514838,-0.0589421960794357,-0.0386761914056192,4.19981699385732e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40100,-0.0319090186753997,0.00338445395616056,-0.0385425484294744,-0.025275488921325,4.74815919441859e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,37777,0.0306759705853606,0.00325348688249527,0.0242991362956698,0.0370528048750513,4.83100652662665e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39810,-0.0818040223512438,0.00869112075916458,-0.0988386190392063,-0.0647694256632812,5.5250284142514e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,40233,0.0197097735785706,0.00209581499290404,0.0156019761924786,0.0238175709646625,5.93977697622486e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,40131,0.0239946695348231,0.00255287576976675,0.0189910330260803,0.0289983060435659,6.24847664114389e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,39727,0.0620987857439177,0.00661559396152247,0.0491322215793337,0.0750653499085018,7.04454244960863e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,40133,-0.0213198827737217,0.002273784151252,-0.0257764997101756,-0.0168632658372678,7.74041853432202e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40160,-0.0435684893743149,0.00465405748338506,-0.0526904420417496,-0.0344465367068802,8.91243945304366e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,40028,-0.0713561746168082,0.00762544243369177,-0.0863020417868441,-0.0564103074467723,9.2427563208407e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,37762,-0.0475037744745496,0.00507591787888755,-0.0574525735171691,-0.03755497543193,9.35182853730571e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,40107,0.0233037940499741,0.00249074961142427,0.0184219248115826,0.0281856632883657,9.36884271507946e-21
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40274,-0.0839094849113416,0.00898390958670103,-0.101517947701276,-0.0663010221214076,1.08918838140558e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,37430,-0.0477641561800886,0.00511401538660857,-0.0577876263378414,-0.0377406860223358,1.11996482621687e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40160,-0.0641154759016507,0.00687271885732822,-0.077586004862014,-0.0506449469412873,1.20864349191915e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40095,0.044244524527968,0.00474346789853751,0.0349473274468344,0.0535417216091015,1.22661437830024e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,37697,-0.0823334581497293,0.00883037282828064,-0.0996409888931594,-0.0650259274062993,1.29683638956126e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,39991,0.0286677142776135,0.00307559953154226,0.0226395391957907,0.0346958893594363,1.3041246791033e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40229,-0.0687020902878416,0.00738046559004092,-0.0831678028443218,-0.0542363777313614,1.46174126890247e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,40233,-0.0504929469610392,0.00543356585804761,-0.0611427360428126,-0.0398431578792659,1.69541439774611e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,37808,-0.0349262139649682,0.00375887161678348,-0.0422936023338639,-0.0275588255960726,1.75074307428414e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,40095,0.0212761729095337,0.00229096505828797,0.0167858813952893,0.0257664644237782,1.79157856233189e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40037,-0.0870038894711758,0.00938809833504418,-0.105404562207862,-0.0686032167344892,2.15057058568883e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37737,-0.0334445382481081,0.00361855278222493,-0.040536901701269,-0.0263521747949473,2.76923402445923e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,37808,0.0192549397027506,0.00208391931169793,0.0151704578518226,0.0233394215536785,2.83865240049922e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,39704,-0.0573461971084477,0.00621775566651231,-0.0695329982148119,-0.0451593960020836,3.261189530325e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39923,0.0313748044766924,0.00340387323132547,0.0247032129432945,0.0380463960100903,3.42889605905103e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,40118,-0.06395790684962,0.00695233127061472,-0.0775844761400249,-0.0503313375592152,4.04114830068631e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,40100,0.0352936554495053,0.00383868407195117,0.027769834668481,0.0428174762305297,4.24420461812483e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37784,-0.0676957897995892,0.00736543225027277,-0.0821320370101238,-0.0532595425890545,4.46023529390586e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39727,-0.0703586194903981,0.00765969972791008,-0.0853716309571018,-0.0553456080236943,4.61053148154793e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37515,-0.0922717959703473,0.0100677135202256,-0.11200451446999,-0.0725390774707051,5.67957743439223e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37696,-0.11457797636563,0.0125283207079455,-0.139133484953203,-0.0900224677780567,6.78975783408209e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39815,-0.0567590942546452,0.00620835127062392,-0.0689274627450681,-0.0445907257642223,6.86062068594475e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37737,-0.0527113591504881,0.0057664402695392,-0.0640135820787849,-0.0414091362221912,7.07101469012849e-20
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37737,-0.0724537229536485,0.00796274920734799,-0.0880607114000506,-0.0568467345072465,1.03904707252605e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39810,-0.0402634824466365,0.00442928651000233,-0.0489448840062411,-0.0315820808870319,1.10642438879614e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,39494,0.0258176880994445,0.00284143935920277,0.020248466955407,0.0313869092434819,1.15201983763461e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,40174,0.0224485635714014,0.00247155027350653,0.0176043250353285,0.0272928021074742,1.1818837368021e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,40073,-0.0545690033579073,0.00601273005086272,-0.0663539542575982,-0.0427840524582163,1.2632562180518e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40186,-0.0697925396944554,0.00769095855397867,-0.0848668184602536,-0.0547182609286572,1.27333472493702e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39991,-0.0448088859781339,0.00493826765297539,-0.0544878905779657,-0.0351298813783022,1.28461470426355e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,40095,0.0193241323548514,0.0021298736014437,0.0151495800960217,0.023498684613681,1.29432944090466e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,37696,-0.084260074492545,0.00932378532022961,-0.102534693720195,-0.065985455264895,1.82916802232393e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37737,-0.0559439580103818,0.00620177580790227,-0.0680994385938702,-0.0437884774268933,2.12352847115602e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39991,-0.0439654914137272,0.00487856190015728,-0.0535274727380355,-0.0344035100894189,2.25531048094153e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39727,-0.0495768202924823,0.00550783013679957,-0.0603721673606094,-0.0387814732243551,2.49254084821559e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,40090,-0.082958979777912,0.00922503005493129,-0.101040038685577,-0.0648779208702467,2.68130171604949e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,40065,-0.0761815040476875,0.00847420018427637,-0.0927909364088692,-0.0595720716865058,2.75553122018528e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,37496,0.0249440542811066,0.00277420748121014,0.0195066076179347,0.0303815009442785,2.77344077102051e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40121,-0.07491243856562,0.00834378310813766,-0.0912662534575698,-0.0585586236736702,3.05874428824485e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,40126,-0.0208748994002648,0.00232714856860393,-0.0254361105947285,-0.0163136882058011,3.29009529557375e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,37782,-0.0194911051483291,0.00217361448368971,-0.0237513895363609,-0.0152308207602972,3.4440737897254e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,37606,0.0861391043053726,0.00961372467833548,0.0672962039358351,0.10498200467491,3.67871952777035e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37697,-0.0641312300779053,0.00716010463550175,-0.0781650351634888,-0.0500974249923219,3.78547118938617e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40121,-0.0224812246254169,0.00251512264077209,-0.0274108650013302,-0.0175515842495036,4.38050975371601e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40174,0.0227608358925075,0.00254644187674417,0.017769809814089,0.0277518619709261,4.38414062638209e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,40058,-0.0351409537314406,0.00393889317390819,-0.0428611843523007,-0.0274207231105806,5.10126467745332e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,39991,-0.0493840015082288,0.00553585255883874,-0.0602342725235527,-0.0385337304929048,5.13905642386209e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40099,0.0141684696874547,0.00158862285090848,0.0110547688996741,0.0172821704752353,5.23064469951881e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,40076,-0.091991776945925,0.010315484811853,-0.112210127177157,-0.0717734267146932,5.27287611653299e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,40095,-0.072670001774708,0.00814997519748848,-0.0886439531617854,-0.0566960503876306,5.33134544080775e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40065,-0.110380724593386,0.0124005986878188,-0.134685898021511,-0.0860755511652613,6.11984396933746e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,40174,-0.0461616341472203,0.00518692068011541,-0.0563279986802465,-0.0359952696141941,6.20493561254793e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40097,-0.0824606811892754,0.00927148561751481,-0.100632792999604,-0.0642885693789463,6.52826301335563e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,40097,-0.0290672012441329,0.00327068669851878,-0.0354777471732297,-0.0226566553150361,6.93961122072407e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,40126,-0.0309671593470786,0.00348629126139574,-0.0378002902194143,-0.0241340284747429,7.23218789528764e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40065,-0.0362641464030511,0.00408271450618093,-0.0442662668351657,-0.0282620259709364,7.24730797865125e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,37575,-0.0872352874131558,0.00983427946892669,-0.106510475172252,-0.0679600996540595,8.2116261559853e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,37756,-0.0821828022782818,0.00926840498560383,-0.100348876050065,-0.0640167285064983,8.46196731456324e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,40065,-0.0394530784980596,0.00445287173888619,-0.0481807071062765,-0.0307254498898427,8.83908898341133e-19
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,40274,-0.0744790257937211,0.00844428654064004,-0.0910298274133756,-0.0579282241740666,1.26157257695691e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,40233,-0.0462069941024157,0.00524051580207703,-0.0564784050744867,-0.0359355831303447,1.29355270112646e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40065,-0.0604384790069491,0.00685558893153662,-0.0738754333127609,-0.0470015247011374,1.31016152218957e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,40095,0.0363029853592824,0.00412634021716161,0.0282153585336457,0.0443906121849192,1.53783327049845e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37784,-0.0610023516842653,0.00693934790525851,-0.074603473578572,-0.0474012297899586,1.66515681658712e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,40297,0.0232948835869542,0.00265099644732021,0.0180989305502066,0.0284908366237019,1.687872255572e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,40100,-0.0307715360601579,0.0035033074397267,-0.0376380186420222,-0.0239050534782935,1.74542068151948e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37697,-0.0899535915381124,0.0102566919882507,-0.110056707835084,-0.0698504752411411,1.99847758171614e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,37403,-0.0349863031961443,0.00398986225789447,-0.0428064332216175,-0.0271661731706712,2.02917723691075e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,37730,-0.066069826325903,0.00754537735922241,-0.0808587659499789,-0.0512808867018271,2.25866496404812e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37756,-0.07540274294171,0.00861451105348253,-0.0922871846065358,-0.0585183012768843,2.32564358021018e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39727,-0.0210498843257475,0.00241063874137447,-0.0257747362588414,-0.0163250323926535,2.75592100091638e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40297,-0.0564082203664562,0.00646050911214862,-0.0690708182262675,-0.0437456225066449,2.76677099152568e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,40095,0.031018437718539,0.0035537695433614,0.0240530494135507,0.0379838260235273,2.84206902776368e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,40186,-0.0371398666358689,0.00425756706175473,-0.0454846980769082,-0.0287950351948297,2.96976653774701e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,40100,-0.0376231937422041,0.00431583397060457,-0.0460822283245891,-0.0291641591598192,3.12618017908262e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37430,-0.0608970414662227,0.00698966083786091,-0.0745967767084301,-0.0471973062240153,3.3311759172378e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,39722,0.0951690261198352,0.0109324626797775,0.0737413992674713,0.116596652972199,3.49086041728451e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40160,-0.0682374972991194,0.0078498599968399,-0.0836232228929256,-0.0528517717053132,3.87966287915253e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40100,-0.0413022186198604,0.00476182053614438,-0.0506353868707033,-0.0319690503690174,4.5917429024507e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40174,-0.0743314361574179,0.0085798816890314,-0.0911480042679194,-0.0575148680469163,5.01601802495253e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40065,-0.0239972914033671,0.00277113622509112,-0.0294287184045457,-0.0185658644021885,5.1852575537397e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,37784,-0.0538921714292265,0.00622563288493353,-0.0660944118836962,-0.0416899309747568,5.41798448245026e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40164,-0.0356511107574876,0.00411940722598779,-0.0437251489204237,-0.0275770725945515,5.42773455352081e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40174,-0.0453165479542014,0.00523905566034521,-0.055585097048478,-0.0350479988599248,5.65320240052601e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,40058,-0.024257978448204,0.00280538906023662,-0.0297565410062678,-0.0187594158901402,5.79853267926635e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37193,-0.0270750938676344,0.00313427804569048,-0.0332182788371877,-0.020931908898081,6.37545166366834e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,40190,0.0199304168266044,0.00230842452607087,0.0154059047555055,0.0244549288977033,6.49720049534412e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40274,-0.0289817762649081,0.00335748480453904,-0.0355624464818046,-0.0224011060480116,6.59574289808128e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,40065,0.0350375332146954,0.00406220092022222,0.0270756194110598,0.0429994470183309,7.00195499972312e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39979,-0.0291698594223341,0.00338319602146954,-0.0358009236244144,-0.0225387952202538,7.20783708983043e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,37784,-0.0578832950464648,0.00671402625857684,-0.0710427865132754,-0.0447238035796542,7.36310365198994e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37697,-0.0559469906603948,0.00650027674483691,-0.0686875330802751,-0.0432064482405145,8.3480643651643e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37697,-0.0369362957809453,0.00429367599760286,-0.0453519007362469,-0.0285206908256437,8.67077832299031e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40095,-0.0403441944992763,0.00469155657950661,-0.0495396453951093,-0.0311487436034434,8.76947394697203e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37756,0.0206308268668937,0.00240028164728988,0.0159262748382055,0.0253353788955819,9.23407578712199e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,40186,-0.0807734861990687,0.00939982616578096,-0.0991971454839994,-0.062349826914138,9.25186789642474e-18
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37756,-0.0487447716242136,0.00568496663582158,-0.0598873062304239,-0.0376022370180033,1.10582770871419e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37756,-0.0474716381222561,0.0055426177193939,-0.0583351688522682,-0.036608107392244,1.20024640404457e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37403,-0.0333318514655147,0.0038926326125364,-0.040961411386086,-0.0257022915449433,1.22496034270346e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40126,-0.0271608413548819,0.00317390203545525,-0.0333816893443742,-0.0209399933653896,1.25839556677821e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,37518,-0.0193372556448306,0.00226404151327011,-0.02377477701084,-0.0148997342788212,1.47636808282958e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,40233,0.0226004507469608,0.00264908237192759,0.0174082492979827,0.0277926521959389,1.57529155370438e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,39726,-0.0302935487445387,0.00355440846171173,-0.0372601893294937,-0.0233269081595837,1.70128787317958e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37791,0.027363584587748,0.00321085272069675,0.0210703132551824,0.0336568559203136,1.73197592792791e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37470,-0.0450472493477229,0.00528606502521347,-0.0554079367971413,-0.0346865618983045,1.74121832182607e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,40100,-0.0679343316928812,0.00797673033290113,-0.0835687231453675,-0.052299940240395,1.7913363554593e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,40174,-0.0427039007410789,0.00501687550725657,-0.0525369767353017,-0.032870824746856,1.8613772826254e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,37403,-0.0697715140042886,0.00823052088878258,-0.0859033349463025,-0.0536396930622748,2.55535710252573e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39746,-0.0627323248677146,0.00741195823854448,-0.0772597630152618,-0.0482048867201674,2.82357642573634e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,39815,-0.0362878840124036,0.00428755761593555,-0.0446914969396373,-0.0278842710851699,2.82565921386985e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,37470,-0.034597191578213,0.00408970597668288,-0.0426130152925114,-0.0265813678639145,2.96779257492315e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40065,-0.041539544958393,0.00491383182355993,-0.0511706553325705,-0.0319084345842156,3.07156865222411e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,37770,0.0255704399883888,0.00302605528197546,0.0196393716357169,0.0315015083410607,3.21055690185023e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39810,-0.0701888150915803,0.00831071599168621,-0.0864778184352853,-0.0538998117478754,3.29335877432556e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37410,-0.0612322573407097,0.0072523140146915,-0.075446792809505,-0.0470177218719144,3.41573109896092e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,39746,-0.0741728678587259,0.00878976649560569,-0.091400810190113,-0.0569449255273387,3.49787416328629e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,40258,0.0361443113577159,0.00428487337242349,0.0277459595477658,0.0445426631676659,3.58525818392553e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39746,-0.0507525419229069,0.0060258280367985,-0.062563164875032,-0.0389419189707819,4.00947828019697e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,40138,-0.0805469469451964,0.00957716241748104,-0.0993181852834592,-0.0617757086069336,4.43740205716642e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37737,-0.081112981807878,0.0096426256055913,-0.100012527994837,-0.062213435620919,4.44234777007048e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37696,-0.0385319899365974,0.00458343062359736,-0.0475155139588482,-0.0295484659143465,4.64074927707858e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,37784,-0.0484446342800064,0.00576754727077778,-0.0597490269307309,-0.037140241629282,4.93293257348391e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40095,0.0325490461251532,0.0038769161482959,0.0249502904744932,0.0401478017758131,5.02818594384836e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,40213,-0.0444075629017447,0.0052939589582449,-0.0547837224599047,-0.0340314033435847,5.34364380091851e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,39991,-0.0396324708366277,0.00472651785998315,-0.0488964458421947,-0.0303684958310608,5.49739581974594e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40274,-0.0512475784924896,0.0061175287156861,-0.0632379347752343,-0.0392572222097448,5.87183055865607e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,40100,-0.0623517192331981,0.00744384425962982,-0.0769416539820726,-0.0477617844843237,5.92145238188608e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,37403,-0.0409483329665914,0.00488958133975496,-0.0505319123925111,-0.0313647535406717,6.10690428141754e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,39570,-0.0303082691890538,0.00362110493499062,-0.0374056348616354,-0.0232109035164722,6.26730432899182e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40186,-0.0940507830935982,0.0112383210955591,-0.116077892440894,-0.0720236737463022,6.30732213595326e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39746,-0.0697495725276937,0.00834484017790092,-0.0861054592763795,-0.0533936857790079,6.8989736286713e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,40277,0.0313882610113121,0.00375972355786131,0.0240192028379039,0.0387573191847203,7.47611130845939e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40297,0.0206247345819516,0.00247512894142934,0.0157734818567501,0.0254759873071531,8.53648064286084e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,40071,-0.0258432813070315,0.00310417585630902,-0.0319274659853972,-0.0197590966286658,9.09966679389658e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39705,-0.0433525450867881,0.00521015648397579,-0.0535644517953806,-0.0331406383781955,9.472255434715e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,37784,-0.0218640598354743,0.00262795308989236,-0.0270148478916633,-0.0167132717792852,9.66083478961742e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37376,-0.0539133382370129,0.00648226348670441,-0.0666185746709536,-0.0412081018030723,9.9151547673907e-17
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,40274,-0.0203810917297438,0.00245145739911718,-0.0251859482320135,-0.0155762352274741,1.00090852745983e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,37470,-0.0379710135129781,0.00457167364518109,-0.0469314938575331,-0.0290105331684232,1.08966962216542e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40274,-0.041767440497228,0.00503081361324373,-0.0516278351791857,-0.0319070458152703,1.10268459082787e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40095,-0.034145097557303,0.00411900885801222,-0.0422183549190069,-0.0260718401955991,1.22736770911397e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40100,-0.0749179929276985,0.00904186457251443,-0.0926400474898268,-0.0571959383655702,1.26868721246522e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37696,-0.0630401050683816,0.00761199880785373,-0.0779596227317749,-0.0481205874049882,1.33032347654708e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39991,-0.0440700673516671,0.00532266779211851,-0.0545024962242194,-0.0336376384791149,1.33451937605627e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40100,-0.0408587670943714,0.0049350712601245,-0.0505315067642154,-0.0311860274245274,1.33859730064552e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37784,-0.0747932063872389,0.00903458356297685,-0.0925009901706735,-0.0570854226038043,1.36475995994633e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39727,-0.0363332949570262,0.00438970687283836,-0.0449371204277894,-0.027729469486263,1.36755421206875e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,39991,0.0187299035667625,0.00226296351356491,0.0142944950801753,0.0231653120533497,1.36818441634488e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,37737,-0.0557772263714606,0.00674535525417573,-0.068998122669645,-0.0425563300732761,1.47864358567649e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40126,0.0234276459990872,0.00283567322429821,0.0178697264794627,0.0289855655187117,1.54916271617062e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",37808,-0.0121596829376271,0.00147205973041654,-0.0150449200092435,-0.00927444586601065,1.58867489014314e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,40248,0.033768080185108,0.00408896196760286,0.0257537147286064,0.0417824456416096,1.59289629078422e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,39991,-0.071742933400708,0.00869144884929924,-0.0887781731453346,-0.0547076936560815,1.6479089804427e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,40100,-0.0456821523515025,0.00553635062098546,-0.056533399568634,-0.034830905134371,1.69036715216057e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37808,0.0190039395218571,0.00230546084803782,0.0144852362597029,0.0235226427840112,1.83496149076004e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,37515,-0.0958112977277493,0.0116271697823417,-0.118600550501139,-0.0730220449543596,1.88062058904289e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37784,-0.0543094858159709,0.00660123794109848,-0.0672479121805239,-0.0413710594514179,2.09355390536116e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,40126,0.0225823568580972,0.00274871450319268,0.0171948764318395,0.0279698372843548,2.27442227919499e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37362,-0.0469811663257143,0.00571874728285615,-0.0581899110001123,-0.0357724216513162,2.31698418102087e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37745,-0.0503097999249018,0.00612712590603274,-0.062318966700726,-0.0383006331490777,2.39472863751893e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,39955,0.0374654103123015,0.00457149028366249,0.028505289356323,0.04642553126828,2.69021662310732e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,37696,-0.0517116074755883,0.0063172384159999,-0.0640933947709482,-0.0393298201802285,2.95097876622404e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37470,-0.0156946345530993,0.00191745060465244,-0.0194528377382181,-0.0119364313679805,2.97099451546059e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,40297,0.0120666711325978,0.00147514397072505,0.00917538894997674,0.0149579533152189,3.05209182258037e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39961,0.0247637183322389,0.00304807923571534,0.0187894830302368,0.0307379536342409,4.83337936387882e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,37784,-0.0314900587443156,0.00388244053624962,-0.0390996421953648,-0.0238804752932663,5.46161068406253e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39815,-0.0424147882483737,0.00523387594230735,-0.0526731850952961,-0.0321563914014513,5.72059884109995e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40297,0.0211520333097671,0.00261082111201485,0.016034823930218,0.0262692426893162,5.81271408437751e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37430,-0.0749907291236895,0.00925830893249768,-0.0931370146313849,-0.056844443615994,5.99271037602027e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40065,0.0238487298090441,0.00295415650778591,0.0180585830537837,0.0296388765643045,7.35928965304886e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,37756,-0.03161853752766,0.0039172262238608,-0.0392963009264271,-0.0239407741288928,7.52667911429373e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,37470,-0.0454832560262839,0.00563710053040587,-0.0565319730658794,-0.0344345389866883,7.73373883149797e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39810,-0.0531053476605624,0.00658412374970816,-0.0660102302099904,-0.0402004651111344,7.81808344607259e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40065,-0.0201035957871697,0.00249277748990182,-0.0249894396673773,-0.0152177519069622,7.86845609287857e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37470,-0.0574045566051305,0.00711755989267293,-0.0713549739947694,-0.0434541392154916,7.94791998752116e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40100,-0.0757022151252961,0.00940717118847796,-0.0941402706547129,-0.0572641595958792,9.06838243072709e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,40174,-0.0512148986845991,0.00637009198980383,-0.0637002789846146,-0.0387295183845836,9.62675175315692e-16
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37756,-0.055538251709253,0.00691628953062785,-0.0690941791892836,-0.0419823242292224,1.05565080500626e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37756,-0.0667528532828586,0.00834715719526077,-0.0831132813855697,-0.0503924251801475,1.37880735233681e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,40100,-0.0235564333873437,0.00295130896193534,-0.0293409989527369,-0.0177718678219504,1.54296747204325e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40065,-0.0602130638204749,0.00755774488291356,-0.0750262437909855,-0.0453998838499644,1.73630938752378e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40117,0.0259796754757621,0.00326108218824424,0.0195879543868034,0.0323713965647208,1.74274492926234e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37696,-0.0735022494582721,0.00922485181299111,-0.0915829590117347,-0.0554215399048095,1.74591978268402e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39991,-0.0322429130112913,0.00404911309550219,-0.0401791746784756,-0.024306651344107,1.79532125598745e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,40297,-0.0308386199186243,0.00387353106996966,-0.0384307408157648,-0.0232464990214838,1.81605698956809e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,40174,-0.0184568928875104,0.00231870521389091,-0.0230015551067365,-0.0139122306682842,1.83715730363278e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,40065,0.0152581977428042,0.00191771093594888,0.0114994843083444,0.019016911177264,1.89104916787295e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40126,-0.0566636622622565,0.00714091518009313,-0.0706598560152391,-0.042667468509274,2.24518101440127e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37756,-0.0565251287047268,0.007128858870654,-0.0704976920912087,-0.042552565318245,2.38343479734895e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,40274,0.00617333325061157,0.000778947920820051,0.00464659532580427,0.00770007117541887,2.42828900956982e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37470,-0.0480042926579738,0.00607095896629975,-0.0599033722319213,-0.0361052130840263,2.84371255253936e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40100,-0.0435099124086942,0.00550746150150039,-0.054304536951635,-0.0327152878657535,2.96931897092261e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),37533,0.125471148462214,0.0158796060063442,0.0943471206897798,0.156595176234649,2.97745279324476e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39991,-0.0553738479064939,0.00701021379354874,-0.0691138669418494,-0.0416338288711384,2.99810519627413e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,40021,0.0298397148085341,0.00377811044891434,0.022434618328662,0.0372448112884062,3.02109400636965e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37515,-0.0474226743391959,0.00600397010462082,-0.0591904557442527,-0.0356548929341391,3.04628506913871e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,39727,-0.0476751187519337,0.00605184251205487,-0.0595367300755612,-0.0358135074283062,3.55569223930459e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37362,-0.0397978578372118,0.00505320458658854,-0.0497021388269253,-0.0298935768474982,3.6563890386215e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,37697,-0.0275881578631628,0.00350310824211039,-0.0344542500176992,-0.0207220657086265,3.6618212433943e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37403,-0.0858190824359856,0.0109111102056758,-0.10720485843911,-0.0644333064328611,3.97312580579692e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,37756,-0.0468277045876082,0.00595445012191916,-0.0584984268265698,-0.0351569823486467,3.9959336714905e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,37697,-0.0580600378701214,0.00738493166703525,-0.0725345039375105,-0.0435855718027323,4.072960909552e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,40233,-0.047091707049918,0.00599112605520407,-0.0588343141181179,-0.035349099981718,4.0801466744026e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,40164,0.0334893786345337,0.00426691134750496,0.025126232393424,0.0418525248756434,4.4760757030392e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,39955,-0.0386431852449327,0.00492502900845386,-0.0482962421015022,-0.0289901283883631,4.56372326131362e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37697,-0.0277326453299129,0.0035345667514015,-0.0346603961626598,-0.0208048944971659,4.61875599415318e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,40034,-0.0556219821212507,0.00709077253787287,-0.0695198962954815,-0.0417240679470199,4.63560937708862e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,37430,-0.0349421498705196,0.00446469648650039,-0.0436929549840604,-0.0261913447569788,5.41142344694611e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37714,-0.0420460372428029,0.00537647184556127,-0.052583922060103,-0.0315081524255028,5.66297091884614e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37362,-0.0436823782209063,0.00558790318330474,-0.0546346684601835,-0.032730087981629,5.81335765016506e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40100,0.0371234726471837,0.00475392775874686,0.0278057742400399,0.0464411710543276,6.1275509406379e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40143,0.0168031638716721,0.00215369211837506,0.0125819273196569,0.0210244004236872,6.47399274785835e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,37376,-0.0562559784226433,0.00721026509153655,-0.0703880980020549,-0.0421238588432316,6.54926530317977e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,39810,-0.0267909413071238,0.00343742865153242,-0.0335283014641274,-0.0200535811501203,6.9123901402233e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,37737,-0.0954625291717987,0.0122560653969645,-0.119484417349849,-0.0714406409937482,7.25325778452388e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,40065,0.0201466566778498,0.00258891717078019,0.0150723790231206,0.025220934332579,7.59071721206545e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,37403,-0.0293088897058363,0.00376597318995985,-0.0366901971581576,-0.021927582253515,7.64505715173424e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,39975,-0.0161319118079386,0.00207392827616076,-0.0201968112292137,-0.0120670123866635,7.80263371134404e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,37470,-0.0492407924298604,0.0063306865072486,-0.0616489379840677,-0.0368326468756532,7.9139865686069e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,40229,-0.0184943782642016,0.0023789276240816,-0.0231570764074016,-0.0138316801210017,8.05592428744816e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37696,-0.0327127005971484,0.00420806022974371,-0.0409604986474461,-0.0244649025468507,8.17568392476078e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39746,-0.0252076602926945,0.00324443131533185,-0.031566745670745,-0.0188485749146441,8.37728510605728e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37737,0.0284292734987188,0.00365944148074554,0.0212567681964575,0.03560177880098,8.50641246474545e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,40100,-0.0278516461392375,0.00359332637302381,-0.0348945658303642,-0.0208087264481108,9.68011452888693e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39746,-0.0428985906558501,0.00553515214197073,-0.0537474888541128,-0.0320496924575875,9.74885046282394e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,40121,0.0249863599842747,0.00322524870920674,0.0186648725142295,0.0313078474543199,9.97422755093238e-15
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,39727,-0.0360718003984093,0.00465925455358826,-0.0452039393234423,-0.0269396614733763,1.04003852428136e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,40174,-0.0477498325936017,0.00618037714562891,-0.0598633717990343,-0.035636293388169,1.17616562609864e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,37430,-0.0532601633114056,0.00689822594813766,-0.0667806861697554,-0.0397396404530558,1.24000183181307e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39991,-0.056316290809547,0.00730752767636772,-0.0706390450552278,-0.0419935365638663,1.36984064776702e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,37644,-0.0643194474849611,0.00835169817394049,-0.0806887759058844,-0.0479501190640377,1.44196604893327e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,40126,0.0262722899166371,0.00341645541864408,0.0195760372960947,0.0329685425371795,1.55934010800666e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40248,0.0400798739431821,0.00521687321383991,0.0298548024440559,0.0503049454423083,1.64832745199226e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37696,-0.0526849135058591,0.00686510084496828,-0.066140511161997,-0.0392293158497213,1.77921842678042e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37362,-0.0255433976071678,0.00333297805269146,-0.032076034590443,-0.0190107606238925,1.93323295899969e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37756,-0.0379971253247182,0.00496017738179451,-0.0477190729930354,-0.0282751776564009,1.98083795215236e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40065,0.0434602358181288,0.00567430686054762,0.0323385943714554,0.0545818772648021,1.981474206249e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39746,-0.0681228823451195,0.00889652571631899,-0.0855600727491047,-0.0506856919411342,2.01297160217095e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39991,-0.0258344650763949,0.00338437177459432,-0.0324678337545997,-0.01920109639819,2.41783595664309e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40095,-0.0297245974207853,0.00389431579426969,-0.0373574563775539,-0.0220917384640167,2.42898062740963e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40233,-0.0331849329424797,0.00435111661635024,-0.0417131215105262,-0.0246567443744333,2.54408037422443e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37696,-0.0396379790515289,0.0052078899460203,-0.0498454433457287,-0.0294305147573291,2.90030275766405e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,40174,0.0187877438884879,0.00247003225955403,0.013946480659762,0.0236290071172139,2.98035524747775e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,40070,-0.047095541269384,0.00619734088562986,-0.0592423294052185,-0.0349487531335495,3.14562786178076e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,39815,-0.0542807758336502,0.0071443462833235,-0.0682836945489643,-0.0402778571183362,3.18725851094927e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39815,-0.0300087244196722,0.00395009038792571,-0.0377509015800066,-0.0222665472593378,3.20578377042683e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,40143,-0.0332342039002187,0.00437502007629469,-0.0418092432497563,-0.0246591645506811,3.21728694428842e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40126,0.0176081170982391,0.00231844745874159,0.0130639600791056,0.0221522741173726,3.25649562541659e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40126,0.011953486500977,0.00157451873416514,0.00886742978201336,0.0150395432199407,3.33131708798223e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,40160,-0.0588600570742205,0.00776246267043252,-0.0740744839082683,-0.0436456302401728,3.57452546055605e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37756,-0.0535086111575441,0.00705766448285591,-0.0673416335439417,-0.0396755887711465,3.63807370978586e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,40174,-0.0356202090587838,0.00470408321041815,-0.0448402121512034,-0.0264002059663643,3.87331406140494e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,40095,-0.0516297337605501,0.00682469977469922,-0.0650061453189606,-0.0382533222021396,4.0899185125792e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40248,-0.0367564707254584,0.00486195919165999,-0.046285910741112,-0.0272270307098049,4.25124337981615e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40100,0.0166785116366356,0.00220629951107713,0.0123541645949244,0.0210028586783468,4.27024534882723e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCN,Decorin,39810,0.0155335705325843,0.00205598446704602,0.0115038409771741,0.0195633000879945,4.4142815427018e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37441,-0.0582709887127845,0.00771404676639566,-0.07339052037492,-0.043151457050649,4.50697088646947e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,37430,-0.0463104201213106,0.00614328661960653,-0.0583512618957394,-0.0342695783468818,5.07399576262226e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39746,-0.0445549049441738,0.00591331488724147,-0.0561450021231671,-0.0329648077651805,5.16918400923744e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40164,-0.0483080675511898,0.00641644647171234,-0.060884302635746,-0.0357318324666336,5.39892845847649e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40164,-0.0184133851818445,0.0024470341717097,-0.0232095721583955,-0.0136171982052935,5.56669970761388e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,40274,-0.0238452253369241,0.00317171175125719,-0.0300617803693882,-0.01762867030446,5.8554938202472e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37696,-0.0202657081580731,0.00269736958957024,-0.0255525525536308,-0.0149788637625154,6.14245179452715e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39991,-0.0243373616443469,0.00324143128147667,-0.0306905669560412,-0.0179841563326526,6.31891397519797e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37403,-0.032922883116404,0.00438540694138872,-0.0415182807215259,-0.0243274855112821,6.42676929376566e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40233,-0.0234775469486238,0.00312816208513636,-0.0296087446354911,-0.0173463492617565,6.45928075411334e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,40065,-0.0223526291432159,0.00297859130494918,-0.0281906681009163,-0.0165145901855155,6.50188306662659e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37808,-0.0169482678048369,0.00225869387030629,-0.0213753077906372,-0.0125212278190365,6.60260438167117e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,40186,-0.0223375834213159,0.00297793243782151,-0.0281743309994461,-0.0165008358431858,6.66909439371887e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39915,-0.0784183395620016,0.0104669294174409,-0.0989335212201858,-0.0579031579038174,7.14908368969303e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40297,0.010471584883159,0.00139894200686102,0.00772965854971139,0.0132135112166066,7.50970738228849e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,37376,-0.08808316880605,0.0117663464564187,-0.111145207860631,-0.0650211297514694,7.55859049834887e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,39955,-0.0435196996946483,0.00581596766706687,-0.0549189963220993,-0.0321204030671972,7.6658432292529e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40100,-0.0289303115538879,0.00386697483868442,-0.0365095822377093,-0.0213510408700664,7.74482239526168e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,39991,0.0285674712191681,0.00381968329572328,0.0210808919595504,0.0360540504787857,7.8878188212065e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,37430,-0.0603290432519777,0.00806557236004946,-0.0761375650776746,-0.0445205214262808,7.920428071555e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,37730,-0.0654248416576885,0.0087490897420909,-0.0825730575521866,-0.0482766257631903,8.02515928093559e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,40186,-0.0620621045257273,0.0083047436060329,-0.0783394019935518,-0.0457848070579028,8.24475124351277e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,40074,-0.0591016390937691,0.00790861277136795,-0.0746025201256503,-0.0436007580618879,8.24890599657726e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39746,-0.0575897509729592,0.00771108364361098,-0.0727034749144368,-0.0424760270314817,8.55298412787013e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37697,-0.0386940559665615,0.00518386483014559,-0.0488544310336469,-0.0285336808994762,8.89501551222163e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,39991,-0.0224862733175176,0.00301541630650667,-0.0283964892782707,-0.0165760573567646,9.31101400053321e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,40297,-0.0284511317284946,0.00381586946440795,-0.0359302358787342,-0.020972027578255,9.37959347566021e-14
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,40274,-0.05123627304061,0.00688150656305453,-0.0647240259041969,-0.0377485201770231,1.01546000817013e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,40054,-0.0274479146116968,0.00368682626524353,-0.0346740940915741,-0.0202217351318194,1.02109651564288e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37737,-0.0509641742109121,0.00684689002205196,-0.0643840786541339,-0.0375442697676902,1.0415593804539e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37696,-0.0557986734056864,0.00749860653312608,-0.0704959422106135,-0.0411014046007593,1.05917076284604e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40095,-0.0518274661574468,0.00696931008839794,-0.0654873139307067,-0.0381676183841868,1.0872184109867e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40174,0.0300220524104502,0.00403726299126805,0.0221090169475648,0.0379350878733355,1.08931031084517e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40050,-0.0594576501958545,0.00800295205358311,-0.0751434362208774,-0.0437718641708316,1.14682266280004e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37470,-0.0695665497211458,0.00936380223241749,-0.0879196020966841,-0.0512134973456075,1.15970599159121e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40171,0.0161980498692119,0.00218452459225412,0.0119163816683939,0.02047971807003,1.2791025837799e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,37697,-0.0137273238615711,0.00185108288766239,-0.0173554463213894,-0.0100992014017528,1.28204869182847e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40100,-0.0361904715940046,0.0048842949087941,-0.045763689615241,-0.0266172535727681,1.33187929617623e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,40056,-0.0199610718617598,0.00269641316661297,-0.0252460416683212,-0.0146761020551983,1.40117868659505e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,40095,0.0595458698297201,0.00806296195738223,0.0437424643932509,0.0753492752661892,1.60000795457182e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40133,0.0180040479338317,0.00243913584723399,0.0132233416732531,0.0227847541944103,1.64585516166899e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40126,0.0189065843610611,0.00256493344465742,0.0138793148095326,0.0239338539125897,1.77564636601663e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40100,-0.0639279696795223,0.00867283159932099,-0.0809267196141914,-0.0469292197448532,1.77736288604932e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40095,-0.0349854203532995,0.0047490038639383,-0.0442934679266185,-0.0256773727799804,1.83358072487109e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,40174,-0.0474978181708246,0.00644812546317495,-0.0601361440786475,-0.0348594922630017,1.84347582951638e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37696,-0.0721086120861709,0.00979033150179047,-0.0912976618296802,-0.0529195623426616,1.87212639818305e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40297,-0.027139105257923,0.00368608337478027,-0.0343638286724924,-0.0199143818433537,1.89241589245321e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,37376,-0.0181350675576644,0.00246450779709258,-0.0229655028399659,-0.013304632275363,1.97226751782187e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,37404,0.0227090109731078,0.00308890558560659,0.0166547560253189,0.0287632659208968,2.07296724250515e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40070,-0.0432748765169187,0.00589030261176639,-0.0548198696359808,-0.0317298833978565,2.13040766493196e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37403,-0.0645617825440038,0.00879507787617187,-0.0818001351813007,-0.047323429906707,2.25204634629094e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,40233,-0.0425266626720295,0.00579558440461494,-0.0538860081050748,-0.0311673172389843,2.27750429638793e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39727,-0.0422987448871276,0.00576667346380503,-0.0536014248761854,-0.0309960648980697,2.32799907134853e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,37470,-0.0174545772423411,0.00238125792506633,-0.0221218427754711,-0.0127873117092111,2.43765708492241e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37697,-0.0292176399625505,0.00399015013198596,-0.037038334221243,-0.021396945703858,2.5755625161712e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37737,-0.0410856371538992,0.00561379567805102,-0.0520886766828792,-0.0300825976249192,2.6478134929315e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,39810,-0.0390988364679423,0.00534543725786775,-0.0495758934933631,-0.0286217794425215,2.71239011891392e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,40248,0.0295210292657583,0.00403798274102022,0.0216065830933587,0.037435475438158,2.78201785917477e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,37362,-0.0439024030395033,0.00601016487552896,-0.0556823261955401,-0.0321224798834666,2.94211584344673e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,37362,-0.0445893308271401,0.00610907817497154,-0.0565631240500843,-0.0326155376041959,3.07183707332962e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37784,-0.0424369181076426,0.00581465507816629,-0.0538336420608485,-0.0310401941544367,3.0798575032267e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37403,-0.0589623216334616,0.00808323719303992,-0.0748054665318198,-0.0431191767351033,3.17454214560156e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39991,0.0185600442452426,0.00255081863317443,0.0135604397242207,0.0235596487662644,3.59993863204521e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37756,-0.0470137480550095,0.00646226645435158,-0.0596797903055386,-0.0343477058044804,3.65494930699554e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,40065,-0.0335147392137387,0.00460824381317353,-0.0425468970875588,-0.0244825813399186,3.68881893599249e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,39727,-0.0469994042542836,0.0064720167169203,-0.0596845570194474,-0.0343142514891198,3.99984908091558e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,39727,-0.040563710468154,0.00559780863728688,-0.0515354153972363,-0.0295920055390717,4.48615658191232e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40095,0.0234784229738961,0.00324208696670025,0.0171239325191636,0.0298329134286286,4.63516008711226e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37489,-0.0419511852297533,0.00579198024223402,-0.0533034665045319,-0.0305989039549746,4.63582469118321e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,40100,-0.0440011688991245,0.00608858564936485,-0.0559347967718796,-0.0320675410263694,5.1722655915718e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,40065,-0.0583723322271387,0.00807813272229224,-0.0742054723628315,-0.0425391920914459,5.20555365309012e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,40095,-0.0344166154751126,0.00476571190327168,-0.0437574108055251,-0.0250758201447001,5.36999116948483e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,40248,-0.0716140813924552,0.00991726436274653,-0.0910519195434384,-0.052176243241472,5.38984191156039e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40185,0.0136628632024548,0.00189449177995572,0.00994965931374163,0.0173760670911681,5.76938286181325e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,37737,-0.0693809734373364,0.00962052947685453,-0.0882372112119713,-0.0505247356627016,5.82215260027435e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39991,0.0756007813780246,0.010498570599203,0.0550235830035866,0.0961779797524625,6.24872431058538e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,40100,-0.0429844773381606,0.00597038166449765,-0.054686425400576,-0.0312825292757452,6.31265332090061e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40094,-0.0126722616203889,0.00176049140866396,-0.0161228247813703,-0.00922169845940755,6.38145367007944e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37756,-0.0489797691446723,0.00682166628015878,-0.0623502350537835,-0.0356093032355611,7.33963752548035e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39810,-0.0484189373998772,0.00675101522926438,-0.0616509272492354,-0.035186947550519,7.72286530592642e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,37784,-0.0300894118343563,0.00419583015378037,-0.0383132389357658,-0.0218655847329467,7.82250161820922e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37756,-0.0733936191257774,0.0102498165932897,-0.0934832596486252,-0.0533039786029296,8.46160790115866e-13
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39727,-0.0355992492061537,0.0049898833468155,-0.0453794205659121,-0.0258190778463953,1.0166345926512e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37362,-0.043428018479646,0.00609513169524366,-0.0553744766023236,-0.0314815603569684,1.09578830735912e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,37791,-0.0178541776859704,0.00250719439751258,-0.022768278705095,-0.0129400766668457,1.12490026847068e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40186,-0.0268218959584432,0.00377313139459685,-0.034217233491853,-0.0194265584250334,1.22213478882739e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,40057,-0.0302543366470184,0.00425827428474158,-0.0386005542451119,-0.0219081190489249,1.25675703960299e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40065,-0.0742201125986374,0.0104545839025918,-0.0947110970477173,-0.0537291281495576,1.30803370057512e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37470,-0.0473878673281229,0.00667534151004424,-0.0604715366878096,-0.0343041979684362,1.32234656648235e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39815,-0.0384684101312233,0.00542321761781434,-0.0490979166621394,-0.0278389036003072,1.36685650232162e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37784,-0.0473343373726727,0.00667347121319697,-0.0604143409505388,-0.0342543337948067,1.37943766008867e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,40075,-0.039045680606122,0.00550648765727205,-0.0498383964143753,-0.0282529647978688,1.39002284028952e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39727,-0.0431600655977817,0.00608709715049759,-0.055090776012757,-0.0312293551828064,1.39568629346171e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37737,-0.0580000866582412,0.00818368664953294,-0.0740401124913257,-0.0419600608251566,1.4367430699302e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,40233,-0.0150615776211075,0.00212839550791457,-0.0192332328166201,-0.0108899224255949,1.5406788407691e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37756,-0.068556619555658,0.00968979977850676,-0.0875486271215312,-0.0495646119897847,1.56777360880669e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,40077,-0.0297149508542708,0.00420409285262655,-0.0379549728454189,-0.0214749288631228,1.63712857868237e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37696,-0.0408820573603022,0.00578940455958417,-0.0522292902970871,-0.0295348244235172,1.72893776272919e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37430,-0.0466913781721902,0.00661585125649191,-0.0596584466349143,-0.033724309709466,1.78137739529775e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,37732,-0.0480063326067969,0.00680502791721675,-0.0613441873245417,-0.0346684778890521,1.81755274213213e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40297,-0.0198596945927296,0.00281936261746722,-0.0253856453229653,-0.0143337438624938,1.94430863486471e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39746,-0.0494922948841095,0.00702665473053936,-0.0632645381559667,-0.0357200516122524,1.95452254842907e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37403,-0.0486680248966621,0.00691604760624947,-0.0622234782049111,-0.0351125715884132,2.06352386518172e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,40100,-0.0309199848969012,0.00439654470717503,-0.0395372125229642,-0.0223027572708381,2.1082183247812e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37782,-0.0296758765618621,0.00422043556538961,-0.0379479302700258,-0.0214038228536985,2.14321165661472e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,40065,-0.057398534309799,0.00816721894173491,-0.0734062834355994,-0.0413907851839986,2.18314691185345e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,39991,-0.0422942717610531,0.00601963750184282,-0.054092761264665,-0.0304957822574412,2.21287691570629e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,37782,-0.0573092154359542,0.00816028966120636,-0.0733033831719187,-0.0413150476999898,2.27781512014331e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,40196,-0.0377340762896045,0.00537678076656642,-0.0482725665920747,-0.0271955859871343,2.34301878288845e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39991,-0.0501629375346884,0.00714840284362767,-0.0641738071081986,-0.0361520679611781,2.35439299478609e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37403,-0.0583778174511127,0.00831826424352283,-0.0746816153684175,-0.042074019533808,2.36224012149348e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,40126,0.0214895054306323,0.00306445476804152,0.015483174085271,0.0274958367759937,2.43651544408728e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40100,0.0253076862797421,0.00360991175177014,0.0182322592462727,0.0323831133132116,2.46979910300948e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37696,-0.0249829743545587,0.00356756272272731,-0.0319753972911043,-0.0179905514180132,2.62976586017282e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,37441,-0.0647379353586916,0.00924558097422184,-0.0828592740681664,-0.0466165966492168,2.64668933159407e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37756,-0.0391828553975915,0.0055974303416198,-0.0501538188671663,-0.0282118919280167,2.67947086056592e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37376,-0.043197533661914,0.00617080405157999,-0.0552923096030108,-0.0311027577208172,2.68013810110836e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37515,-0.0333042628901598,0.00475818566975223,-0.0426303068028742,-0.0239782189774454,2.6968658893424e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39815,0.024287405022336,0.00347584138684052,0.0174747559041286,0.0311000541405434,2.91351927862061e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,37362,-0.0422319825746385,0.00605416502062851,-0.0540981460150704,-0.0303658191342066,3.19210807368797e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40233,-0.0295554777423377,0.00424608202824307,-0.0378777985176941,-0.0212331569669813,3.52054724853986e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,37791,-0.0519151505325351,0.00745732760613469,-0.0665315126405591,-0.0372987884245111,3.52092086798617e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40065,-0.0203146514243815,0.0029194785813697,-0.0260368294438661,-0.0145924734048969,3.58060522184384e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40174,-0.0455376571301006,0.00655309063737308,-0.0583817147793519,-0.0326935994808494,3.82237929008692e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,40126,-0.0794240974612096,0.0114323123835861,-0.101831429733038,-0.0570167651893808,3.86903906215678e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,37696,-0.0641784896573483,0.00924125894218897,-0.0822913571840387,-0.0460656221306579,3.96743312524194e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37782,-0.0169319246964884,0.00243855403752748,-0.0217114906100423,-0.0121523587829346,4.00422632894925e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40100,-0.0697293389207873,0.0100536851737612,-0.0894345618613592,-0.0500241159802154,4.20046093112062e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40100,-0.0450062235717637,0.0064900979160236,-0.05772681548717,-0.0322856316563574,4.23319992383855e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,40204,-0.0436560031076893,0.00629815726472381,-0.056000391346548,-0.0313116148688307,4.32402212834802e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,37759,-0.0278357088468536,0.00401692639925888,-0.035708884589401,-0.0199625331043062,4.41445949484645e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,40100,-0.0520752443939224,0.00752069239918092,-0.066815801496317,-0.0373346872915278,4.55304511629006e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37696,-0.0167549545425048,0.00242257577729771,-0.0215032030660084,-0.0120067060190013,4.85301352792228e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,40160,-0.035733257876923,0.00516985769675499,-0.0458661789625628,-0.0256003367912833,4.96795629653174e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,40274,-0.0392988025412178,0.00568744919935977,-0.0504462029719629,-0.0281514021104726,5.04061128811517e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37784,-0.0665962268300963,0.00963755339281531,-0.0854858314800144,-0.0477066221801783,5.06397638046951e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,37403,-0.0210634055883945,0.003049453744742,-0.0270403349280888,-0.0150864762487001,5.17142240554006e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37756,-0.0323187916006577,0.00468125926858997,-0.041494059767094,-0.0231435234342213,5.29010940184015e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39730,0.0175351285831225,0.0025405511478805,0.0125556483332767,0.0225146088329683,5.32573490851483e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,39647,-0.0529757189888149,0.00768373523136247,-0.0680358400422854,-0.0379155979353445,5.61738429939058e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39991,-0.0627095648929624,0.00910109431618503,-0.080547709752685,-0.0448714200332397,5.78008169674718e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,37279,0.0384296284214774,0.00558027775182728,0.027492284027896,0.0493669728150589,5.97684402983215e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40126,-0.0421005019311008,0.00611817130572046,-0.0540921176903129,-0.0301088861718887,6.1588930905552e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40233,-0.0407915949991112,0.00593385194624679,-0.0524219448137549,-0.0291612451844675,6.45900294404614e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37756,-0.0406114760488545,0.00591341233742671,-0.0522017642302109,-0.0290211878674982,6.81484493856008e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,37754,0.0223672645770324,0.00325805759835718,0.0159814716842523,0.0287530574698124,6.93363671037075e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40100,0.0212101204011036,0.00309634521948949,0.0151412837709042,0.027278957031303,7.65752976111925e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40164,-0.025945495945485,0.00378991897164748,-0.0333737371299141,-0.018517254761056,7.87972554947615e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39746,-0.0391201099709144,0.00571483298848869,-0.0503211826283523,-0.0279190373134766,7.91836721842642e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39746,-0.0280267422380428,0.00409859298837203,-0.036059984495252,-0.0199934999808337,8.32685605463984e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40092,0.0137917904880949,0.00201709512318385,0.00983828404665454,0.0177452969295352,8.35981414393997e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37470,-0.017714232038602,0.00259334343389463,-0.0227971851690355,-0.0126312789081685,8.82846196147535e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40297,-0.01331317155525,0.00194984096866435,-0.0171348598538321,-0.00949148325666785,8.93435817415441e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,40114,-0.0197501354275723,0.00289462241192317,-0.0254235953549417,-0.0140766755002029,9.23983344960637e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40297,0.0155177101430479,0.00227522589231768,0.0110582673941053,0.0199771528919906,9.41398454935324e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,37566,-0.0201951344817926,0.00296097292800497,-0.0259986414206823,-0.0143916275429028,9.47422652183945e-12
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,37430,-0.0329880614711166,0.00484289299068595,-0.042480131732861,-0.0234959912093721,1.00743515403415e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C3,Complement C3,37162,-0.0288845068469445,0.00424083502756471,-0.0371965435009714,-0.0205724701929177,1.01255905428566e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37737,0.0401165359340857,0.00589494195687853,0.0285624496986038,0.0516706221695676,1.05202067323347e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37755,0.0090220430940896,0.00132676956759379,0.00642157474160577,0.0116225114465734,1.09080033172789e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40126,-0.0391938263757703,0.00576835396919951,-0.0504998001554013,-0.0278878525961393,1.12502868032023e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40233,0.0167142333823232,0.00246264072141581,0.0118874575683482,0.0215410091962982,1.1846968417875e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,37696,-0.0409137361707786,0.00605384222509415,-0.0527792669319631,-0.0290482054095941,1.45453852048267e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,40126,0.0161400048367082,0.00239473520412302,0.011446323836627,0.0208336858367893,1.64151091136722e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39933,-0.0171111404793896,0.00253941114349432,-0.0220883863206385,-0.0121338946381407,1.65982898632966e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,40117,0.0273736637995305,0.00406310417999542,0.0194099796067395,0.0353373479923216,1.67173314674751e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,40297,-0.0533934416983996,0.0079364245862976,-0.0689488338875429,-0.0378380495092563,1.78337046172358e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37696,-0.0465934292127842,0.00693037894219195,-0.0601769719394804,-0.033009886486088,1.85226054717191e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39810,0.0126738827807609,0.00188735166941456,0.00897467350870838,0.0163730920528135,1.9444173511371e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37756,-0.0407452816900994,0.00607186213580452,-0.0526461314762763,-0.0288444319039225,2.01800623899135e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39727,-0.0372548116341401,0.00556594858789952,-0.0481640708664231,-0.026345552401857,2.257238408882e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,37791,0.0314835847485343,0.00470525418520973,0.0222612865455232,0.0407058829515454,2.30255049109952e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39810,0.019368877160518,0.00289530773890004,0.0136940739922739,0.0250436803287621,2.31283229593432e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40116,0.0300530475851222,0.00449719973913926,0.0212385360964093,0.0388675590738352,2.42636310145256e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,37470,-0.0311036907312832,0.00465921629469266,-0.0402357546688808,-0.0219716267936855,2.55971524079905e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37403,-0.0345766880371625,0.00518211224269196,-0.0447336280328387,-0.0244197480414863,2.62040953743998e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40065,-0.0538087369448201,0.00806730454066542,-0.0696206538445244,-0.0379968200451159,2.64437822072454e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37403,-0.042219539235072,0.00633502832472689,-0.0546361947515367,-0.0298028837186073,2.76396209822825e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40107,-0.0339793853441543,0.00510675595849556,-0.0439886270228056,-0.023970143665503,2.95076982537429e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37697,-0.0493833542617114,0.00742410175423199,-0.0639345937000061,-0.0348321148234167,3.00979331540189e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40065,-0.0336041904304757,0.00506339791101884,-0.0435284503360726,-0.0236799305248787,3.31375193626711e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,40100,-0.031789331183018,0.00479538285636617,-0.0411882815814957,-0.0223903807845403,3.48659353805547e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40233,-0.0399606730100621,0.00603728642272887,-0.0517937543986107,-0.0281275916215135,3.7334571639038e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37358,-0.0503791665838512,0.0076245216261056,-0.0653232289710182,-0.0354351041966843,4.06160656843138e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37222,-0.0319807246420457,0.00484729620423664,-0.0414814252023495,-0.0224800240817418,4.34230287453332e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39810,-0.034164769697439,0.00518363836046996,-0.0443247008839602,-0.0240048385109179,4.51452467074635e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,40174,-0.0378262426493012,0.0057441852575496,-0.0490848457540984,-0.026567639544504,4.68876143543913e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,39967,-0.0174487385421553,0.00265036149234533,-0.0226434470671521,-0.0122540300171584,4.74149955358973e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,40114,-0.0550654144194604,0.00836980557009737,-0.0714702333368513,-0.0386605955020696,4.88458928705918e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,37479,0.0124938607358596,0.00189898608605726,0.00877184800718734,0.0162158734645318,4.90980733854232e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37470,-0.0498475690300433,0.00758472270044943,-0.0647136255229241,-0.0349815125371624,5.14998900136824e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37376,-0.0481148072309067,0.00732764143311652,-0.062476984439815,-0.0337526300219983,5.35869334630862e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37430,-0.0552247674752592,0.00841183474351021,-0.0717119635725392,-0.0387375713779792,5.39667313373917e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,40095,-0.0435722093565199,0.00663931684113792,-0.0565852703651502,-0.0305591483478896,5.44832031143387e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,40274,-0.0244643453681564,0.00372829279185087,-0.0317717992401841,-0.0171568914961286,5.48099066674275e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37697,-0.0636350148838907,0.00971785469091761,-0.0826820100780893,-0.0445880196896922,6.03600110394235e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37696,-0.0867555709731716,0.0132632649306434,-0.112751570237233,-0.0607595717091105,6.33359996341076e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,37737,-0.0334504737816628,0.00511674477600325,-0.0434792935426292,-0.0234216540206964,6.48622599568659e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,39700,-0.0526752662148675,0.00805840016289511,-0.068469730534142,-0.0368808018955931,6.48924526169228e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39746,-0.045081914193679,0.00689848072397055,-0.0586029364126613,-0.0315608919746967,6.55996465725798e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40100,0.020059385064553,0.00307218142831314,0.0140379094650593,0.0260808606640468,6.8084524062791e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,37791,0.0180718296614425,0.00277449297650784,0.0126338234274872,0.0235098358953979,7.60218021197042e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39991,-0.0555753430301741,0.00854326230535294,-0.0723201371486659,-0.0388305489116823,7.99792778691534e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,37756,-0.0321005570840496,0.00493508859068047,-0.0417733307217833,-0.0224277834463159,8.07102912328035e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,37470,-0.0398107094924062,0.00612271843022843,-0.051811237615654,-0.0278101813691585,8.20817904331663e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39815,-0.0539731000812268,0.00830317583745944,-0.0702473247226473,-0.0376988754398063,8.26331946727548e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,39691,-0.0261616047522793,0.0040270580053364,-0.0340546384427386,-0.01826857106182,8.47840267562576e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,37430,-0.0190798167471256,0.00293912916094709,-0.0248405099025819,-0.0133191235916693,8.79868940995753e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39957,0.0166766332404756,0.00257160620765948,0.011636285073463,0.0217169814074882,9.14711995789085e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37696,-0.0511465129918956,0.00789084463238074,-0.0666125684713618,-0.0356804575124293,9.38745692489487e-11
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,40095,-0.0311653516854566,0.00481609036531329,-0.0406048888014707,-0.0217258145694426,1.00191554733793e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39746,-0.0258812678292424,0.00400615896226979,-0.0337333393952912,-0.0180291962631936,1.07603797405623e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37756,-0.028134920312884,0.00435599032453266,-0.036672661348968,-0.0195971792767999,1.09132085957819e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39915,-0.0214850262514504,0.00332798374634022,-0.0280078743942772,-0.0149621781086236,1.10806506008972e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,39864,-0.0242566673040208,0.00376381469470175,-0.0316337441056363,-0.0168795905024054,1.19266862069349e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37784,-0.0273521045541859,0.00424421980032955,-0.0356707753628318,-0.01903343374554,1.1992864591915e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40100,-0.0469898516650641,0.00729846655626252,-0.0612948461153386,-0.0326848572147895,1.24323274880399e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40092,-0.0210347671204631,0.00326828051217805,-0.0274405969243321,-0.0146289373165941,1.2620398848317e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40148,-0.0693268479800481,0.0107847249844761,-0.0904649089496213,-0.048188787010475,1.32811401439226e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37756,-0.0684613707594022,0.0106528930618807,-0.0893410411606883,-0.047581700358116,1.34980500585012e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37737,-0.0558595650075508,0.00869941765552204,-0.072910423612374,-0.0388087064027276,1.39924276642307e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40186,-0.0762106482569349,0.0118717040223482,-0.0994791881407374,-0.0529421083731324,1.40618588165217e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40158,-0.0636679591042039,0.00992134064513434,-0.0831137867686672,-0.0442221314397406,1.42710555299362e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,40186,-0.0245451003039842,0.00382487713459036,-0.0320418594877813,-0.0170483411201871,1.42748217684103e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37470,-0.0412751082008059,0.00643110527532929,-0.0538800745404513,-0.0286701418611605,1.42822821998395e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,40126,-0.0381627859488052,0.00595401783306813,-0.0498326609016187,-0.0264929109959916,1.50084586862253e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,37737,-0.0404577007224153,0.00631903216471447,-0.0528430037652557,-0.028072397679575,1.57978324235032e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39792,-0.0221951821540997,0.00346742581889005,-0.0289913367591242,-0.0153990275490752,1.58789277627403e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,40095,0.0192343983835016,0.00300767833393574,0.0133393488489875,0.0251294479180156,1.64996184681133e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39955,-0.0426263071164286,0.00666832944053016,-0.0556962328198677,-0.0295563814129895,1.68022591918004e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,40143,0.0188960942817059,0.00296091568833368,0.0130926995325719,0.0246994890308399,1.79879432274929e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40056,0.0332545859010849,0.00521709808369005,0.0230290736570524,0.0434800981451174,1.89141127968477e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,40100,-0.0447579827220356,0.00702476030529296,-0.0585265129204098,-0.0309894525236614,1.92469664872636e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,40233,-0.0363560425448014,0.00570849448294837,-0.0475446917313802,-0.0251673933582226,1.95831828931776e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,40143,0.0191535880367704,0.00300829237074042,0.0132573349901192,0.0250498410834216,1.98208602898775e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,40133,-0.0160870748873476,0.00252778305453266,-0.0210415296742316,-0.0111326201004636,2.01886162331878e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPART,Spartin,37470,-0.0443149487145085,0.00696368577938663,-0.0579637728421062,-0.0306661245869107,2.03524726906393e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,40229,-0.0191421878944192,0.00300989641698362,-0.0250415848717071,-0.0132427909171313,2.0764344983268e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40100,-0.0373467490678106,0.00587302330753607,-0.0488578747505813,-0.0258356233850399,2.08658585309201e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40174,-0.0479451756683904,0.00753983194972196,-0.0627232462898454,-0.0331671050469353,2.08787146308736e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,39810,-0.0307576474644004,0.00484902589508499,-0.0402617382187669,-0.0212535567100338,2.31553550032544e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37791,-0.0471757415797943,0.00743714107509688,-0.0617525380869842,-0.0325989450726044,2.32211052781839e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,37784,-0.0306833550667851,0.00484241040530826,-0.0401744794611893,-0.0211922306723809,2.427906517395e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40174,-0.0350611054148379,0.00554072105618689,-0.0459209186849642,-0.0242012921447116,2.55254806329814e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,37470,-0.0420695433383001,0.00666429674681139,-0.0551315649620504,-0.0290075217145498,2.83154907741867e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40100,-0.0455253262860552,0.00721290381576317,-0.059662617764951,-0.0313880348071594,2.83509043015727e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40174,0.013618018081175,0.00215829735485726,0.00938775526565472,0.0178482808966952,2.87223171349409e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40100,-0.0570957080420115,0.00905559711675265,-0.0748446783908467,-0.0393467376931763,2.9588598974506e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,37470,-0.0613659283918029,0.00973315727194044,-0.0804429166448062,-0.0422889401387996,2.97824863020644e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37784,-0.0511016500545378,0.00811510931935584,-0.0670072643204753,-0.0351960357886004,3.12782924825756e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,40065,-0.03389134854508,0.00538512847400858,-0.0444462003541369,-0.0233364967360232,3.18651771303389e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,37737,-0.0474496791695993,0.00754127299037487,-0.0622305742307341,-0.0326687841084646,3.23242125291996e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,37376,-0.0232680775023819,0.00370632525293311,-0.0305324749981308,-0.016003680006633,3.54071295837406e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40126,0.0553655362997121,0.00882811853736864,0.0380624239664696,0.0726686486329546,3.66961291565367e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,39746,-0.0547196127296739,0.00872786232228941,-0.0718262228813612,-0.0376130025779867,3.71852998064614e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,39983,0.0161771754805648,0.00258155346730563,0.0111173306846458,0.0212370202764838,3.79112713780138e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,37696,-0.0384098365985269,0.00613319015918615,-0.0504308893105318,-0.0263887838865221,3.90264945078245e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39810,-0.0193538731140463,0.00309879715253188,-0.0254275155330088,-0.0132802306950838,4.33266021599065e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37696,0.0310980927276605,0.00498030509586112,0.0213366947397727,0.0408594907155483,4.38948687324919e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39746,-0.0441031272923448,0.00706398290113226,-0.0579485337785641,-0.0302577208061256,4.39519081764749e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37737,-0.0458300032799456,0.00734261111470512,-0.0602215210647676,-0.0314384854951236,4.46146661163204e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,40065,-0.0463482297881109,0.00742784300732287,-0.0609068020824637,-0.0317896574937581,4.49440857912349e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37403,-0.0497801559188699,0.00798284186637113,-0.0654265259769573,-0.0341337858607825,4.63170033000338e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39727,-0.0373876000433353,0.0060008096745105,-0.0491491870053759,-0.0256260130812947,4.77362524696251e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,40100,0.0233612068190718,0.00374987872592201,0.0160114445162647,0.030710969121879,4.78801111212117e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37470,-0.0462537901591522,0.00742504188248053,-0.0608068722488141,-0.0317007080694904,4.8254868076896e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37756,-0.0471179607889333,0.00756971484161447,-0.0619546018784977,-0.032281319699369,4.97490327074413e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,40097,-0.0506120036123431,0.00813774690543899,-0.0665619875470035,-0.0346620196776827,5.11699683530386e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,37696,-0.032999275940278,0.00530722927817849,-0.0434014453255079,-0.0225971065550482,5.19329715948466e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,37403,-0.0260131320896791,0.00418582653215028,-0.0342173520926936,-0.0178089120866645,5.30421754939796e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,40100,-0.0340308314674115,0.00547686414064288,-0.0447654851830716,-0.0232961777517515,5.31079392154908e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37784,-0.0224606375567681,0.00361643439905581,-0.0295488489789175,-0.0153724261346187,5.43115595138941e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40032,0.0129868815800891,0.002092483430157,0.00888561405698142,0.0170881491031969,5.55683845042566e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37756,-0.0418453747433465,0.00674244957068515,-0.0550605759018894,-0.0286301735848036,5.5872301661409e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,40243,-0.0388903191020691,0.00627409108640759,-0.051187537631428,-0.0265931005727102,5.83981375975367e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37696,-0.0498394182120385,0.0080436955186052,-0.0656050614285047,-0.0340737749955723,5.96001803332299e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40126,-0.0468621514605754,0.00756601091401074,-0.0616915328520364,-0.0320327700691143,6.02065692404629e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37696,-0.0362523573416129,0.00585240705682975,-0.0477230751729992,-0.0247816395102266,6.02257333773332e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,40124,0.0349131844558037,0.00563697806151515,0.023864707455234,0.0459616614563734,6.0272808504726e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37696,0.0385598805676124,0.00622560891255327,0.026357687099008,0.0507620740362168,6.04866305708791e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40069,-0.0379135119570608,0.00612250121800618,-0.0499136143443529,-0.0259134095697687,6.07039371523929e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37362,-0.0374785490702412,0.00605670982104503,-0.0493497003194894,-0.0256073978209929,6.2799905466235e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAX,Protein max,39727,-0.0582505086855554,0.0094160663763556,-0.0767059987832123,-0.0397950185878984,6.31669679192896e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37430,-0.0317674352351368,0.00513681635035652,-0.0418355952818356,-0.0216992751884381,6.42652609374894e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40186,0.0157072249219006,0.00254398793662994,0.0107210085661059,0.0206934412776953,6.8108856463183e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37515,-0.0591653761715615,0.00958524987215886,-0.0779524659209929,-0.0403782864221301,6.91887796658295e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37697,-0.0194907722517591,0.00315808536741362,-0.0256806195718898,-0.0133009249316284,6.95279726941572e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39746,-0.0330524581539022,0.00536133595231299,-0.0435606766204357,-0.0225442396873687,7.22682077634479e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,40297,0.012970068187285,0.00210501050482299,0.00884424759783194,0.0170958887767381,7.37909483698993e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37737,0.0171900778816854,0.00279016634750446,0.0117213518405767,0.0226588039227941,7.43977903735608e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,39746,-0.0344902022904188,0.00560363299443968,-0.0454733229595206,-0.023507081621317,7.69644964899341e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39607,-0.0667846791971876,0.0108928230895199,-0.0881346124526467,-0.0454347459417285,8.94536910328725e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,40233,-0.022862648656981,0.00372953990573937,-0.0301725468722302,-0.0155527504417319,8.98835264384425e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,40100,-0.0432265604795086,0.00705584388523556,-0.0570560144945703,-0.0293971064644469,9.20709020963526e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,37715,-0.0162938635721997,0.00266089718005459,-0.0215092220451067,-0.0110785050992927,9.41581525143519e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,37808,0.0413090034916098,0.00674908908952045,0.0280807888761497,0.0545372181070699,9.57859418132163e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,40100,-0.0169594138742658,0.00277200435803542,-0.0223925424160153,-0.0115262853325164,9.69492601242854e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37737,-0.0292829839108519,0.00478848296746512,-0.0386684105270835,-0.0198975572946203,9.9081656531677e-10
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,39746,-0.023758425572011,0.00388661579699354,-0.0313761925341184,-0.0161406586099037,1.00223598048955e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40186,-0.0608305776568374,0.00995671128373703,-0.080345731772962,-0.0413154235407128,1.02293909649106e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37737,-0.0212758254303839,0.00348323020936239,-0.0281029566407342,-0.0144486942200336,1.03655909188464e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,40126,-0.0233796929083815,0.00382913381775512,-0.0308847951911815,-0.0158745906255814,1.0473881571996e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40095,-0.0321254282244282,0.00526205427375466,-0.0424390546009873,-0.021811801847869,1.05155202967149e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40065,0.0124176773661249,0.00203480407428478,0.00842946138052669,0.016405893351723,1.06795405249556e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39746,-0.0465191595925727,0.00762409590630109,-0.0614623875689228,-0.0315759316162225,1.07545654900267e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39746,-0.0302785896940036,0.00497094156071605,-0.0400216351530071,-0.0205355442350001,1.14809990911852e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39727,-0.0615719371646527,0.0101198946309445,-0.0814069306413039,-0.0417369436880015,1.19833766312204e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,37430,-0.0642177871804945,0.0105692966485563,-0.0849336086116648,-0.0435019657493243,1.26760577761649e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,40274,-0.0267499202173655,0.00440421699303976,-0.0353821855237234,-0.0181176549110075,1.27850920348467e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37403,-0.0245644303477864,0.00404481672672832,-0.0324922711321739,-0.0166365895633989,1.2900623656353e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39810,-0.0605951995361908,0.00997982565759365,-0.0801556578250743,-0.0410347412473073,1.29487472356494e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,40095,-0.0661402373208164,0.0108946465279516,-0.0874937445156016,-0.0447867301260311,1.30139070726888e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,40274,-0.0220351445248396,0.00363395847808413,-0.0291577031418845,-0.0149125859077947,1.36069702319712e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40248,0.0334856506682217,0.0055276139470125,0.0226515273320772,0.0443197740043662,1.41051189346079e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37737,-0.0544483952891405,0.00898889224962352,-0.0720666240984026,-0.0368301664798784,1.42166117371647e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39477,0.0203936895459402,0.00336758293188158,0.0137932269994523,0.026994152092428,1.42976577519272e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,37784,-0.0391429392769242,0.00646381225453797,-0.0518120112958186,-0.0264738672580297,1.43562696867763e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37362,-0.037116602384857,0.00613079427386223,-0.049132959161627,-0.025100245608087,1.4509899709883e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37782,0.0323559312342847,0.00534706112336201,0.0218756914324951,0.0428361710360742,1.47660334802611e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39746,-0.0287560445040821,0.00475295296050397,-0.0380718323066699,-0.0194402567014943,1.48091737327908e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39955,-0.0518458462349994,0.00857441492711637,-0.0686516994921475,-0.0350399929778513,1.51352001405641e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37470,-0.0644568058154616,0.0106956413329053,-0.085420262827956,-0.0434933488029673,1.72122786857857e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37515,-0.039827414557577,0.00661220534267306,-0.0527873370292162,-0.0268674920859378,1.75468841077587e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,40065,-0.073953296716993,0.0122906957343085,-0.0980430603562378,-0.0498635330777483,1.8163320043294e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40297,0.01786538905631,0.00297375240757683,0.0120368343374594,0.0236939437751606,1.92300644424397e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37696,-0.0318003436829383,0.00530126260273444,-0.0421908183842978,-0.0214098689815788,2.04170086325233e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,37470,-0.0166504687732482,0.00278055392301501,-0.0221003544623576,-0.0112005830841388,2.17787922120539e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,37784,-0.0134925874682715,0.00225488701089209,-0.01791216600962,-0.00907300892692305,2.23706636489996e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,40174,-0.0170054175433175,0.00284407367969991,-0.0225798019555293,-0.0114310331311057,2.29024877819795e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,40174,0.0147204587081338,0.00246343220019419,0.00989213159575318,0.0195487858205144,2.34211075246657e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40186,-0.0206206125745634,0.00345187043664428,-0.0273862786303862,-0.0138549465187406,2.36857574073747e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,37700,-0.0517939554844766,0.00867072284301111,-0.0687885722567783,-0.0347993387121748,2.38272170002855e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,37756,-0.0410188879470781,0.0068682196537106,-0.0544805984683509,-0.0275571774258054,2.39937393197097e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40041,0.0137728512523584,0.00230855914029318,0.0092480753373838,0.0182976271673331,2.48411093907878e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40065,-0.0507892505453687,0.00851844819536898,-0.0674854090082919,-0.0340930920824455,2.54127063094031e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37791,0.0175373314822001,0.00294334918135714,0.0117683670867401,0.0233062958776601,2.61313688305702e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,37470,-0.0304075228037127,0.00510853813662386,-0.0404202575514954,-0.0203947880559299,2.71212909015315e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39810,-0.0261551464915502,0.00440963704862848,-0.034798035106862,-0.0175122578762384,3.06886814219247e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40065,-0.0321018791004403,0.00541490567756363,-0.042715094228465,-0.0214886639724156,3.12295540380716e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,39746,-0.0222804962385101,0.00375884937217771,-0.0296478410079784,-0.0149131514690418,3.14239944409616e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40099,-0.0502233564392267,0.00847408296520533,-0.0668325590510292,-0.0336141538274242,3.15574626817396e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40050,0.0186260503323814,0.00314296084068176,0.0124658470846451,0.0247862535801176,3.16412806803173e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40121,-0.0268788064161427,0.00453826159979404,-0.035773799151739,-0.0179838136805464,3.23305780240949e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39746,-0.0294412780150384,0.00497950444884747,-0.0392011067347794,-0.0196814492952973,3.44147648833378e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,40248,-0.015172331986544,0.00257133524902961,-0.020212149074642,-0.010132514898446,3.69666521565655e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,39756,-0.0262784542916093,0.00446890746424245,-0.0350375129215245,-0.0175193956616941,4.18089544658368e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37697,-0.0370337724611991,0.00629932240360813,-0.049380444372271,-0.0246871005501272,4.22669478374081e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,40261,-0.0281376050903729,0.00478823714192042,-0.0375225498885369,-0.0187526602922089,4.27710801903614e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,40297,0.0155322216863272,0.0026451982942769,0.0103476330295445,0.02071681034311,4.39563927465646e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,37764,-0.0241971425011599,0.00413957928647881,-0.0323107179026583,-0.0160835670996614,5.17455597081522e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,37475,0.0166316306468746,0.00284549512215248,0.0110544602074557,0.0222088010862935,5.19012359645195e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,39727,-0.0186751893676821,0.00319927732932682,-0.0249457729331627,-0.0124046058022015,5.41244885586764e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,39757,-0.0472675032467936,0.00809879618901337,-0.0631411437772598,-0.0313938627163274,5.4432098922916e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37470,-0.0370695640941975,0.00635773308358578,-0.0495307209380256,-0.0246084072503693,5.65297351015871e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,37696,-0.0402980274382768,0.00691458378964009,-0.0538506116659714,-0.0267454432105822,5.74093116164305e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37430,-0.0159125924758598,0.00273147856670342,-0.0212662904665985,-0.0105588944851211,5.82457718503289e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,37362,-0.0313205359910959,0.00537835993034058,-0.0418621214545635,-0.0207789505276284,5.90222722818453e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,37430,-0.0386318288845605,0.00664120084203379,-0.0516485825349467,-0.0256150752341742,6.13277730226571e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40164,0.0223031320777517,0.00383487371989705,0.0147867795867535,0.0298194845687499,6.14906482072373e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40248,-0.0329834758260774,0.00568109800721317,-0.0441184279202152,-0.0218485237319396,6.52780394378915e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39727,-0.0394278961490704,0.00679123543036327,-0.0527387175925825,-0.0261170747055584,6.53688113189251e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37784,-0.0512505295401914,0.00882795277520195,-0.0685533169795872,-0.0339477421007956,6.56419729023761e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37515,-0.0182227376625111,0.00314433886391632,-0.0243856418357871,-0.0120598334892351,6.97270515484919e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,37782,-0.0356750553162232,0.00615937917025608,-0.0477474384899251,-0.0236026721425213,7.11272604718691e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37403,-0.047583163906858,0.00821540783660338,-0.0636853632666007,-0.0314809645471154,7.11935319503932e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37430,-0.0232543005426566,0.00401535283183884,-0.0311243920930608,-0.0153842089922525,7.14422017850202e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39955,-0.0398908559814158,0.00689441851029498,-0.053403916261594,-0.0263777957012377,7.34889533265767e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37403,-0.041555352077419,0.00718158924922356,-0.0556312670058972,-0.0274794371489409,7.35869824774173e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37696,-0.0471941283913809,0.00818066114444935,-0.0632282242345017,-0.0311600325482602,8.15325670566277e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,37694,-0.0147816159570166,0.00256237583486599,-0.019803872593354,-0.00975935932067929,8.16642188085858e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39810,-0.0482599086596235,0.00839901735065504,-0.0647219826669074,-0.0317978346523396,9.31668896018087e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,40100,0.0201385874245781,0.00350667956015255,0.0132654954866791,0.0270116793624771,9.47840885325299e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40186,-0.0449941275988322,0.00784544414040641,-0.0603711981140288,-0.0296170570836357,9.92652406313174e-09
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39997,-0.0152585720352166,0.00266317105373858,-0.0204783873005442,-0.010038756769889,1.02607383568278e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,40020,-0.0299813284924087,0.00523341732494105,-0.0402388264492931,-0.0197238305355242,1.02998064351355e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37756,-0.0352478220949752,0.00615275130882733,-0.0473072146602767,-0.0231884295296736,1.03339688245623e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,37403,-0.022526202034187,0.00393428624512525,-0.0302374030746324,-0.0148150009937415,1.0534883373477e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37430,-0.0399514857416312,0.00698228981862017,-0.0536367737861267,-0.0262661976971357,1.07710532004094e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40233,0.0118707284410927,0.00207710628127832,0.00779960012978721,0.0159418567523982,1.11664250096244e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39746,-0.0271948338345558,0.00475901204047086,-0.0365224974338787,-0.0178671702352329,1.12151715766447e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37609,-0.0159598766034731,0.00279695325629882,-0.0214419049858188,-0.0104778482211274,1.18041441018196e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,39967,0.0160520915682484,0.00281586277253737,0.0105330005340751,0.0215711826024216,1.21562036279915e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,37675,-0.0214289072000634,0.00375993877116924,-0.0287983871915551,-0.0140594272085716,1.22890353527142e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37697,-0.0484425310198208,0.00850172604696565,-0.0651059140718735,-0.0317791479677681,1.23828561756394e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37515,-0.0253984066266698,0.00446143148123738,-0.0341428123298951,-0.0166540009234445,1.27600243954496e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40186,-0.0608461168389627,0.0106952271466945,-0.0818087620464839,-0.0398834716314416,1.29990130913052e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,37784,0.0132693577115604,0.0023322311674629,0.00869818462333314,0.0178405307997877,1.30049879494053e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37756,-0.043779740403045,0.00769674502690931,-0.0588653606557873,-0.0286941201503028,1.31177069575366e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,37808,-0.033322042661307,0.00587202251243178,-0.0448312067856733,-0.0218128785369407,1.41808346358695e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,37779,-0.0185054142759465,0.00327422392391552,-0.0249228931668209,-0.0120879353850721,1.61986415402369e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37403,-0.0445875271218945,0.00789447650815467,-0.0600607010778776,-0.0291143531659113,1.65799181842736e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,40126,-0.0179398367567699,0.00317869951064351,-0.0241700877976312,-0.0117095857159086,1.69249980195312e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,40100,-0.0327148578744932,0.00579774773766489,-0.0440784434403164,-0.02135127230867,1.7032036962924e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39815,-0.0278384643967155,0.00493459933077874,-0.0375102790850418,-0.0181666497083891,1.71563691777044e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,37376,-0.0249699433317378,0.00442889252095045,-0.0336505726728006,-0.0162893139906749,1.75674453601261e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,37737,-0.0469544626070152,0.00833539489620207,-0.0632918366035712,-0.0306170886104591,1.80547863483699e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40072,-0.0197762396361164,0.00351248116426983,-0.0266607027180853,-0.0128917765541475,1.83017370124213e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,40083,-0.0420961742007097,0.00749477915941332,-0.0567859413531598,-0.0274064070482596,1.97916793000586e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,37362,-0.0403275232680155,0.00718381831682792,-0.0544078071689982,-0.0262472393670328,2.0217289137627e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40143,-0.0239806937485131,0.00427276658309339,-0.0323553162513762,-0.0156060712456501,2.02855598807881e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40095,-0.0146172232271844,0.00260555257913941,-0.0197241062822977,-0.0095103401720712,2.05721196223572e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,40233,-0.0113237573931879,0.00202035856528818,-0.0152836601811527,-0.00736385460522302,2.11952984097079e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,40126,-0.0433822598373966,0.00774972653440388,-0.0585717238448282,-0.028192795829965,2.2059082184461e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,40100,-0.0267224151277577,0.00479071579811957,-0.036112218092072,-0.0173326121634433,2.47387781241378e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,37376,0.0157765263249891,0.00283279541940556,0.0102242473029542,0.0213288053470239,2.60954859177923e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,37782,0.0123717003050578,0.00222241449443972,0.00801576789595594,0.0167276327141597,2.64495901346109e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,39727,-0.030054928863772,0.00540195031946182,-0.0406427514899171,-0.0194671062376268,2.68523142526938e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37784,-0.0450713631306348,0.0081031386999232,-0.0609535149824843,-0.0291892112787853,2.7150597114639e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,40100,-0.0356289820251983,0.00640797504301141,-0.0481886131095006,-0.0230693509408959,2.74029878447204e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40095,-0.0136690928645719,0.00245906692122803,-0.0184888640301788,-0.00884932169896493,2.76312356517258e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,37430,0.034983830395567,0.00629990041884579,0.0226360255746292,0.0473316352165047,2.86200398706699e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,40140,-0.046107593695703,0.00830523894133721,-0.062385862020724,-0.0298293253706821,2.87611643588001e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37696,-0.0514782023612045,0.0092821227858026,-0.0696711630213776,-0.0332852417010314,2.97960431218713e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,40274,-0.0272770365876282,0.00492397124234597,-0.0369280202226264,-0.0176260529526301,3.07923229477506e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,39815,-0.0255252751615064,0.00460784109335809,-0.0345566437044882,-0.0164939066185245,3.08264348384262e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37376,-0.0216149808978722,0.00390416761518619,-0.0292671494236372,-0.0139628123721073,3.14797544082487e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39727,-0.0299171995737263,0.00540753369178251,-0.04051596560962,-0.0193184335378326,3.20880297391879e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,37737,-0.0310049264528475,0.00561332602111608,-0.042007045454235,-0.02000280745146,3.38654258978307e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,40126,0.0177842338210313,0.00322107732743097,0.0114709222592666,0.024097545382796,3.42027931446189e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,37697,-0.0315750251595601,0.00571957862900501,-0.0427853992724099,-0.0203646510467103,3.44364631796706e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,40065,0.00756665144081071,0.00137271960655184,0.0048761210119691,0.0102571818696523,3.60071482663831e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,40297,0.00847156026659374,0.00153904905979273,0.00545502410939999,0.0114880964237875,3.76153708539303e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37430,-0.0506838074948331,0.00924302153595454,-0.068800129705304,-0.0325674852843622,4.24869979986784e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40054,-0.0143192692129386,0.00261421915378614,-0.0194431387543594,-0.00919539967151777,4.38161119303738e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40174,-0.0124348222516786,0.00227292912145234,-0.0168897633297252,-0.00797988117363197,4.54762261508236e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39919,-0.0173176208409551,0.00316757594044828,-0.0235260696842337,-0.0111091719976764,4.64407870149234e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37343,-0.0491145508919015,0.00898716846181055,-0.0667294010770502,-0.0314997007067529,4.71605508867543e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,40297,0.00954019269236211,0.00174782426262201,0.00611445713762297,0.0129659282471013,4.87869838483947e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37697,-0.021380614577039,0.0039193689062625,-0.0290625776333135,-0.0136986515207645,4.98195113313882e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37515,-0.0207763907629501,0.00381393956370208,-0.0282517123078062,-0.0133010692180941,5.20112351679217e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,40297,-0.0260219725818227,0.00477941509585151,-0.0353896261696917,-0.0166543189939538,5.26963946219459e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,37470,-0.0266540676424668,0.00489702138166983,-0.0362522295505396,-0.0170559057343939,5.33652683262132e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37756,-0.0485249012327253,0.00891863482202999,-0.0660054254839041,-0.0310443769815466,5.39670212351848e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,37681,-0.0433543824031097,0.00797724386950463,-0.0589897803873388,-0.0277189844188806,5.58433264909047e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37756,-0.0232169143159799,0.00427241819403187,-0.0315908539762824,-0.0148429746556774,5.60312386693658e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39991,0.0247198703861617,0.0045524662013188,0.0157970366315768,0.0336427041407465,5.72017409000767e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,40186,0.00999344756296823,0.00184505071807272,0.0063771481555457,0.0136097469703908,6.17198321972562e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37403,-0.0238334207824339,0.00440072019527844,-0.0324588323651796,-0.0152080091996881,6.21046937924015e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39746,-0.0331498484902768,0.00612166866015915,-0.0451483190641888,-0.0211513779163649,6.21564234230559e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,40297,-0.0272997767584726,0.00504379627500973,-0.0371856174574917,-0.0174139360594535,6.30385306501584e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MDK,Midkine,40116,-0.0247103250488757,0.00456617640285552,-0.0336600307984725,-0.0157606192992789,6.33819056175958e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,40071,-0.0327722823302592,0.00605932930065269,-0.0446485677595385,-0.0208959969009799,6.44659137653277e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37697,-0.0279880788926559,0.00517635190178547,-0.0381337286201554,-0.0178424291651564,6.52327903282992e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,39966,-0.0221595361371912,0.00410017584809322,-0.0301958807994539,-0.0141231914749285,6.59369354893553e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37725,-0.0198227658659732,0.00367104662953398,-0.0270180172598598,-0.0126275144720866,6.78795977798906e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37586,-0.027293711729389,0.00506119544434586,-0.0372136548003068,-0.0173737686584711,7.05927035231158e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,39973,-0.0329129215474393,0.00610646716876296,-0.0448815971982147,-0.0209442458966639,7.15477054466444e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37470,0.0130065767823875,0.00241384527130531,0.00827544005062909,0.0177377135141459,7.23567634087827e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,39815,-0.0212965047064748,0.00395950274269788,-0.0290571300821626,-0.0135358793307869,7.61741354735581e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37737,0.0129530428327446,0.00240960458920832,0.0082302178378963,0.0176758678275929,7.76232647274182e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39810,-0.0425939312380989,0.00792828246563896,-0.0581333648707512,-0.0270544976054465,7.88264630236275e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,37697,-0.0154813003747903,0.0028873133847214,-0.0211404346088443,-0.00982216614073639,8.3763296385595e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40233,0.0223227326644529,0.00416522997532357,0.0141588819128187,0.0304865834160871,8.47168733819217e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40233,-0.0276585557335962,0.0051628717916264,-0.0377777844451839,-0.0175393270220084,8.57053192456023e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,40213,0.0150573607308141,0.00281288395459698,0.00954410817980403,0.0205706132818242,8.77202825484427e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,39815,0.0163620514330852,0.00305894123307462,0.0103665266162589,0.0223575762499114,8.97448342477917e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39815,0.0195789363250779,0.00366691786243737,0.0123917773147007,0.0267660953354552,9.46102786257538e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40065,-0.0213019229257274,0.00399172069967048,-0.0291256954970815,-0.0134781503543732,9.60672707699086e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,40274,-0.0180578885810597,0.00338492213285914,-0.0246923359614636,-0.0114234412006558,9.696541842482e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,40194,-0.0289083433514984,0.00542282274678889,-0.0395370759352047,-0.0182796107677922,9.90936028686087e-08
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39991,-0.0335866353883841,0.00630406260228386,-0.0459425980888604,-0.0212306726879077,1.00808750759638e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39746,-0.014258759582293,0.00267638887290069,-0.0195044817731784,-0.00901303739140769,1.00922540086149e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37552,-0.0064957789352567,0.00121950539483463,-0.00888600950913259,-0.00410554836138082,1.01741248765002e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,37430,0.020375881117841,0.00382924974811134,0.0128705516115428,0.0278812106241392,1.04848111040912e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,40248,-0.0195894566846111,0.00368560882698634,-0.0268132499855043,-0.0123656633837179,1.08034891007202e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,37244,-0.0341326555025824,0.00643802961894201,-0.0467511935557088,-0.0215141174494561,1.16622790336297e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,37289,-0.0261641689725893,0.00493595356510167,-0.0358386379601886,-0.0164896999849901,1.17249819592565e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39815,-0.0316731658578548,0.00598230527356539,-0.043398484194043,-0.0199478475216667,1.21001630178629e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,40274,-0.0242809281414365,0.00459561827440431,-0.033288339959269,-0.0152735163236041,1.28421963843803e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,37470,-0.0450681301715202,0.00853276886616403,-0.0617923571492017,-0.0283439031938387,1.30002027257951e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37756,-0.0278289678549727,0.00527201274477198,-0.0381621128347258,-0.0174958228752196,1.32204749810257e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,37808,-0.0124309063047635,0.00235633202224345,-0.0170493170683607,-0.00781249554116638,1.34439500355651e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,37376,-0.0326337111028265,0.00618878589394416,-0.0447637314549571,-0.020503690750696,1.36346094895688e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40065,0.00946178968559944,0.00179672229875001,0.00594021398004942,0.0129833653911495,1.41170406186745e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40297,0.0140268149384132,0.00266364479112699,0.00880607114780426,0.0192475587290221,1.41232291975217e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,40274,-0.0257266367189445,0.00488571923238695,-0.0353026464144229,-0.0161506270234661,1.41498104222223e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,39886,-0.0321036787372318,0.0061020211961422,-0.0440636402816705,-0.0201437171927931,1.45066971127686e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,40204,-0.0346646460555731,0.0066015983372559,-0.0476037787965946,-0.0217255133145515,1.53285622368187e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37737,-0.0170503415014075,0.00324689121569095,-0.0234142482841618,-0.0106864347186533,1.53374858268591e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,40100,-0.0177212339948729,0.00337503192654992,-0.0243362965709107,-0.0111061714188351,1.53515885903802e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37403,-0.0267803930776978,0.00510673612407745,-0.0367895958808896,-0.016771190274506,1.59493242304048e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,39810,-0.0399573197854038,0.00762965015101116,-0.0549114340813857,-0.025003205489422,1.65262694643486e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,37782,-0.0321920426879173,0.006146621615115,-0.0442394210535427,-0.0201446643222919,1.65372911702022e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39815,-0.0312773142307022,0.00598097214169423,-0.0430000196284229,-0.0195546088329816,1.7222667016867e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37756,-0.0424787147239082,0.00812518460048686,-0.0584040765408625,-0.026553352906954,1.73919622041708e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,37737,-0.02157683285273,0.0041342800507148,-0.029680021752131,-0.013473643953329,1.82595682415385e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39967,0.0157896589887173,0.00302736027395747,0.00985603285176062,0.0217232851256739,1.8552611519004e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,40095,0.0148601350763156,0.00284916587072018,0.00927576996970404,0.0204445001829271,1.85550179146145e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,37791,-0.0191768207203483,0.00367964699628938,-0.0263889288330755,-0.0119647126076211,1.90019889682533e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40065,-0.0162521992360637,0.00311884335648893,-0.022365132214782,-0.0101392662573454,1.90247188848533e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37470,-0.0410799207095784,0.0078899139532011,-0.0565441520578525,-0.0256156893613042,1.9522273838481e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40122,0.0186740538533311,0.00359300061093922,0.0116317726558902,0.025716335050772,2.04696037243519e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40126,0.013123933434151,0.00252545838424535,0.00817403500103015,0.0180738318672719,2.05453019960475e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37697,-0.0237247088431714,0.0045690260002163,-0.0326799998035953,-0.0147694178827474,2.1055231285306e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37343,-0.0289460789803565,0.00558753843265399,-0.0398976543083583,-0.0179945036523547,2.24665691432921e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37362,-0.0329181014597816,0.0063588559726664,-0.0453814591662077,-0.0204547437533554,2.2919658067321e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,39727,-0.0285859179299998,0.0055509669249528,-0.0394658131029073,-0.0177060227570924,2.64119813140195e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37791,-0.028061082392439,0.00544895941240286,-0.0387410428407486,-0.0173811219441294,2.64470560984275e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,37362,-0.0183619599532775,0.00356684468508242,-0.0253529755360391,-0.011370944370516,2.67210993944183e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37756,-0.0581467212596098,0.0113109738568815,-0.0803162300190976,-0.035977212500122,2.77547185926665e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40122,-0.0461918750552141,0.00898918619500685,-0.0638106799974276,-0.0285730701130007,2.80110748788817e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37782,0.0182244472611022,0.00354772807443983,0.0112709002352001,0.0251779942870043,2.83197839475307e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40160,0.0391347605690811,0.00763574621913225,0.0241686979795819,0.0541008231585803,3.00740723551974e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,40126,-0.0317489910179366,0.00619639386181571,-0.0438939229870954,-0.0196040590487778,3.03018415633922e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37410,-0.0262205625380158,0.0051181340462935,-0.0362521052687511,-0.0161890198072805,3.04919586596152e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37784,-0.0133853861085846,0.0026136095545009,-0.0185080608354063,-0.0082627113817628,3.07476961535452e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,39815,0.0230079420771092,0.00450648087098558,0.0141752395699775,0.0318406445842409,3.33822887980052e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37380,-0.0164275178420797,0.00321927142641541,-0.022737289837854,-0.0101177458463055,3.39289593015428e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39991,-0.013528219126895,0.00265346158969556,-0.0187290038426983,-0.00832743441109167,3.46691838759528e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40095,-0.0137246216490003,0.00269833850668011,-0.0190133651220933,-0.00843587817590727,3.6929384799491e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39727,-0.0384621772257755,0.00756502163417058,-0.0532896196287498,-0.0236347348228011,3.73520130486975e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37756,-0.0217308799409414,0.00428689710323448,-0.0301331982632809,-0.0133285616186018,4.04985599253837e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39746,-0.0240922869480302,0.00476321759414025,-0.0334281934325451,-0.0147563804635153,4.28613041563966e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37430,-0.0146898336485496,0.00290451628377684,-0.0203826855647522,-0.00899698173234696,4.30398155256017e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39991,-0.0188068041349388,0.00372031607046434,-0.0260986236330489,-0.0115149846368287,4.34912068342719e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,40065,-0.0340776793036239,0.00674382257018079,-0.0472955715411783,-0.0208597870660696,4.39446685785486e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40126,-0.0126940393772466,0.00251385093108734,-0.0176211872021777,-0.00776689155231538,4.47613636786843e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37403,-0.0161858943285344,0.00320509063410131,-0.022467871971373,-0.00990391668569587,4.47681905481578e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39815,-0.0199022840547024,0.00394331928366996,-0.0276311898506955,-0.0121733782587093,4.53718655300018e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,37756,0.0164678885717519,0.00326632574836718,0.0100658901049522,0.0228698870385516,4.67442323458864e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40126,-0.0329372766685134,0.00653344245870251,-0.0457428238875704,-0.0201317294494565,4.67448764277121e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40100,0.0214373532601452,0.00425571332857944,0.0130961551361295,0.0297785513841609,4.77373467640884e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,37430,-0.0271959668593238,0.0053992671996279,-0.0377785305705945,-0.0166134031480531,4.7930379170322e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,39942,-0.0470302977302093,0.00935050016969838,-0.0653572780628181,-0.0287033173976004,4.96717655783635e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37784,-0.0336704063478085,0.00669658113671993,-0.0467957053757796,-0.0205451073198374,5.02059512818011e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37430,-0.039286580069565,0.00782745467097968,-0.0546283912246852,-0.0239447689144449,5.26089316228884e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39810,-0.0171636605674549,0.00342105988722567,-0.0238689379464172,-0.0104583831884925,5.3054459503933e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37697,-0.0391860232712961,0.0078103431462629,-0.0544942958379714,-0.0238777507046208,5.31107196247537e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37430,-0.0253335565032829,0.00505156505420801,-0.0352346240095306,-0.0154324889970352,5.37363148643086e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39725,0.021206666144308,0.00422904930013906,0.0129177295160355,0.0294956027725806,5.3761153521774e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,37343,-0.0289616331119041,0.00578247886161325,-0.0402952916806661,-0.0176279745431421,5.5577347575247e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,37782,-0.0292451196599096,0.00584057411216366,-0.0406926449197504,-0.0177975944000689,5.59236176538682e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37696,0.0148245519216995,0.00296165450770311,0.00901970908660139,0.0206293947567976,5.6433996608811e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,39746,-0.0340215688306147,0.00679803274912932,-0.0473457130189082,-0.0206974246423212,5.65942744956193e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40297,-0.0154411766928345,0.00308907060437355,-0.0214957550774067,-0.00938659830826233,5.83498468168179e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37515,-0.0151821556115345,0.00304047266948718,-0.0211414820437293,-0.0092228291793396,6.01054580639158e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,40233,-0.0295070680094138,0.005925126506887,-0.0411203159629123,-0.0178938200559152,6.42593247417707e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,40065,-0.035196878717434,0.00706790089620946,-0.0490499644740045,-0.0213437929608634,6.43226053982519e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40100,-0.0229598392498787,0.00461119106811811,-0.0319977737433902,-0.0139219047563672,6.45420127319225e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,40274,-0.0152536134886154,0.00306439636662503,-0.0212598303672005,-0.00924739661003039,6.50244471715984e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40081,-0.0491148528126805,0.00987089475807118,-0.0684618065385,-0.029767899086861,6.56950309852303e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40126,-0.0344768275533719,0.0069304196711528,-0.0480604501088314,-0.0208932049979124,6.60374763228218e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40174,-0.0394021270180211,0.00793065139762566,-0.0549462037573674,-0.0238580502786748,6.82399633859809e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,40126,-0.024010171217282,0.00483292813239606,-0.0334827103567783,-0.0145376320777857,6.83462509178213e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,40126,-0.0150712444530183,0.00303416689105116,-0.0210182115594786,-0.00912427734655803,6.8649798009966e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37772,-0.0216598528713858,0.00436214142357836,-0.0302096500615994,-0.0131100556811722,6.94022859990977e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,40248,0.0271956311061675,0.00547891568231611,0.016456956368828,0.0379343058435071,6.98874607716305e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37782,-0.0235750101974152,0.0047542091327044,-0.0328932600975158,-0.0142567602973145,7.18155705703682e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37784,-0.0276158087106305,0.00557225631254337,-0.0385374310832155,-0.0166941863380455,7.28625776545998e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37430,-0.0276361407659512,0.00557911532680201,-0.0385712068064832,-0.0167010747254193,7.38086650482276e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,39727,-0.0140481354165652,0.00283989941971056,-0.0196143382791979,-0.00848193255393255,7.62841363338311e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37756,-0.0221139107552102,0.00447196961094314,-0.0308789711926587,-0.0133488503177616,7.70709956720022e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,39727,-0.032337074331722,0.00654147920074053,-0.0451583735651734,-0.0195157750982705,7.75904878374622e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,37756,0.0197655753224704,0.00400076941940655,0.0119240672604335,0.0276070833845072,7.88926461009393e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40126,0.0125683028662348,0.00254611185314992,0.007577923634061,0.0175586820984087,8.04480725710893e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,37403,-0.025597121695907,0.00519261566202893,-0.0357746483934838,-0.0154195949983303,8.34511230396054e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37362,-0.0299795568496671,0.00610231022522164,-0.0419400848911015,-0.0180190288082327,9.08760107221914e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40097,-0.0322800818610364,0.00658394393209837,-0.0451846119679492,-0.0193755517541236,9.54040284191556e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,37784,-0.0231438284994957,0.00472034009395922,-0.0323956950836558,-0.0138919619153357,9.54956431887109e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,40233,0.033852827683473,0.00691625948847443,0.0202969590860631,0.0474086962808829,9.94421468467652e-07
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37430,-0.0363554099834524,0.00743270399574786,-0.0509235098151182,-0.0217873101517866,1.01385383189716e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,37737,0.0134673011515676,0.00275376064997686,0.00806993027761291,0.0188646720255222,1.0175092945512e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,37777,-0.009850356928551,0.00201444074068472,-0.013798660780293,-0.00590205307680894,1.02078569651022e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37452,-0.0240952866322077,0.00492886480097635,-0.0337558616421214,-0.0144347116222941,1.02764620255049e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,40143,0.013028685344379,0.00267083922601316,0.0077938404613932,0.0182635302273648,1.08149771586134e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37756,-0.0269034393079,0.00551645851575224,-0.0377156979987744,-0.0160911806170256,1.08989839146556e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40126,-0.0292007462258695,0.00598841504352094,-0.0409380397111705,-0.0174634527405684,1.09205659324519e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39746,-0.0252576045333114,0.00518031031072222,-0.035411012742327,-0.0151041963242959,1.09515827029575e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37674,-0.0308435883881619,0.0063444171765853,-0.0432786460542691,-0.0184085307220547,1.17819412856316e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,37737,-0.0161729267303562,0.00332946005746695,-0.0226986684429914,-0.009647185017721,1.20219042506473e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37756,-0.0349722745948473,0.00720936102909918,-0.0491026222118817,-0.0208419269778129,1.24261094731308e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,37430,0.00983217322791642,0.00202747258497687,0.00585832696136174,0.0138060194944711,1.25225830136033e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40212,0.0151402589231825,0.00312604035311011,0.00901321983108666,0.0212672980152783,1.28932132549621e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39746,0.0135099456580313,0.00279344927476155,0.00803478507949866,0.0189851062365639,1.33568795049504e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40065,-0.0234908007965433,0.00486009528422268,-0.0330165875536197,-0.0139650140394668,1.35495017489522e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,39700,-0.027087723675142,0.00561490493216617,-0.0380929373421877,-0.0160825100080963,1.41887441519955e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,37470,0.00946233034934809,0.00196165234643507,0.00561749175033535,0.0133071689483608,1.42549041407869e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37430,-0.0424729574881926,0.008811616831071,-0.0597437264770918,-0.0252021884992935,1.45105052530691e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,40095,-0.0154102479358227,0.00319843260360298,-0.0216791758388845,-0.00914132003276084,1.4631829027728e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,39584,-0.0337262352914932,0.00700114212342495,-0.0474484738534061,-0.0200039967295803,1.46962179969266e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40121,-0.016637782543215,0.00345418938091727,-0.0234079937298129,-0.00986757135661717,1.4731911612951e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,40095,-0.0115312866234189,0.00239632242947425,-0.0162280785851884,-0.00683449466164933,1.50764145491754e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40186,-0.0117393106034639,0.00244215355985087,-0.0165259315807716,-0.00695268962615622,1.54666115077509e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40065,-0.0154135203005503,0.00320795268265697,-0.021701107558558,-0.00912593304254266,1.56358550497399e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,40126,-0.033061448288475,0.00688658540124523,-0.0465591556749157,-0.0195637409020344,1.5945359993023e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37515,-0.0290999759676956,0.00607211750489339,-0.0410013262772866,-0.0171986256581046,1.66617405043054e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37430,-0.024192305082868,0.0050499465782849,-0.0340902003763064,-0.0142944097894296,1.68117936446582e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,37430,-0.0129896015322647,0.00271263279085445,-0.0183063618023394,-0.00767284126218999,1.6983887245137e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37376,-0.0264401552839022,0.00552251246908604,-0.0372642797233108,-0.0156160308444935,1.70570129907691e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39746,-0.0255158951204111,0.00534101523755954,-0.0359842849860278,-0.0150475052547945,1.79269899838219e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37784,-0.0131703965771583,0.00275988468303872,-0.0185797705559142,-0.00776102259840237,1.84265414028486e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39727,-0.0160645451072612,0.00336711352713028,-0.0226640876204365,-0.00946500259408585,1.84995903424193e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,40248,-0.0242787015114709,0.00508911736111531,-0.0342533715392569,-0.0143040314836849,1.85218861346207e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37403,-0.01559485164258,0.00326933966087059,-0.0220027573778864,-0.00918694590727365,1.86206098815827e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,39717,-0.0476204663560882,0.00998405995082624,-0.0671892238597076,-0.0280517088524688,1.86252439572879e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,37470,0.0140265305657033,0.00294282779352724,0.00825858809038992,0.0197944730410167,1.89627555617023e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,37784,-0.0278274565420282,0.00584541705353364,-0.0392844739669541,-0.0163704391171023,1.95085991304807e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,40028,-0.0242445617242482,0.00509423361158689,-0.0342292596029585,-0.0142598638455379,1.96091136303833e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,39746,-0.0349526193914675,0.00734544412586243,-0.0493496898781578,-0.0205555489047771,1.96909597876701e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37784,0.0145706309581425,0.00306338840911094,0.00856638967628506,0.0205748722399999,1.99162568437391e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37470,-0.0179476352793722,0.00377581997476148,-0.0253482424299047,-0.0105470281288397,2.02256760709044e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37403,0.0190092408675057,0.00399989701774445,0.0111694427127266,0.0268490390222849,2.03144359298893e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,40140,-0.028955492195464,0.00609376337706887,-0.040899268414519,-0.017011715976409,2.03541341334007e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,37730,0.0200239796662395,0.00421457392182939,0.0117634147794539,0.0282845445530251,2.04403668222629e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,37403,-0.0242530849636898,0.00510647760802618,-0.0342617810754211,-0.0142443888519585,2.06133086276984e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,40233,-0.0339998377687076,0.00716318342594854,-0.0480396772835667,-0.0199599982538485,2.08813007823961e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39741,-0.0209328391115922,0.00441517300614999,-0.0295865782036461,-0.0122791000195382,2.14462651184392e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37403,-0.0226578826017287,0.00478008544215291,-0.0320268500683484,-0.013288915135109,2.1593076264872e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,40251,0.011510629523397,0.00242859530332267,0.00675058272888456,0.0162706763179094,2.15980604699577e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39947,0.0122982199066143,0.00259488478675825,0.00721224572456808,0.0173841940886604,2.16246900994784e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37696,-0.0416273081214675,0.00880357667602458,-0.0588823184064757,-0.0243722978364594,2.28567788382827e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39746,-0.0207440515487253,0.00438737285392906,-0.0293433023424262,-0.0121448007550243,2.28622654622787e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37808,-0.00798596914510905,0.00168932113346386,-0.0112970385666982,-0.00467489972351989,2.2982070935575e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,39727,-0.0301001123235796,0.00637536459514094,-0.0425958269300558,-0.0176043977171033,2.36404245337907e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39991,-0.0148008263345884,0.00313556518314943,-0.0209465340935613,-0.00865511857561556,2.3754438369103e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37696,-0.0404303340976338,0.00857846596627851,-0.0572441273915397,-0.0236165408037279,2.46577368769371e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39810,0.0129125567910756,0.0027422970714265,0.00753765453107968,0.0182874590510716,2.51524815814042e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,37403,-0.0219039102829217,0.00466051177150479,-0.0310385133550711,-0.0127693072107723,2.62977539166428e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,37470,-0.047254069217513,0.0100787808787262,-0.0670084797398163,-0.0274996586952097,2.78048017864323e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40297,0.0095414671843457,0.00203827631429202,0.00554644560833333,0.0135364887603581,2.87639852754112e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,40164,0.0195809726839709,0.00419333359766291,0.0113620388325516,0.0277999065353902,3.04360678846857e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,39815,-0.0206170875308274,0.00442158740574754,-0.0292833988460926,-0.0119507762155622,3.14523047068351e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39746,-0.0169233183265466,0.00363673287098094,-0.0240513147536692,-0.00979532189942391,3.29180900867165e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37737,-0.0166287556679627,0.00357534761990424,-0.023636437002975,-0.00962107433295037,3.33598484586509e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,40215,0.0183676403642181,0.00395003221041045,0.0106255772318136,0.0261097034966226,3.34632506145978e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40039,0.0252969759271749,0.00544048572711577,0.014633623902028,0.0359603279523218,3.35041404888908e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,40100,0.0247773724192826,0.0053317735828856,0.0143270961968268,0.0352276486417383,3.39352365979028e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37645,0.0120823026369426,0.00260959142901512,0.00696750343607294,0.0171971018378122,3.69226969195333e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,37362,-0.0256934562854661,0.00555064252093616,-0.036572715626501,-0.0148141969444313,3.71166778559119e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,37696,-0.0342847519014464,0.00740967548793309,-0.0488077158577953,-0.0197617879450976,3.74473427338128e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37421,-0.0119647412828624,0.00258962933259204,-0.0170404147747428,-0.00688906779098203,3.8696388920891e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,39967,-0.021989085984409,0.00476692796604411,-0.0313322647978555,-0.0126459071709626,4.00375420918979e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37746,-0.00824887588973357,0.00178877076871996,-0.0117548665964247,-0.00474288518304246,4.03545183989486e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,37470,-0.0149103657346866,0.00323376373572459,-0.0212485426567068,-0.00857218881266641,4.04862951918667e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37696,-0.0220223525647609,0.00477957561909962,-0.0313903207781962,-0.0126543843513257,4.1115180329434e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37376,-0.020624233283658,0.00447672008335077,-0.0293986046470255,-0.0118498619202905,4.12431077711786e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40174,-0.0100739356373283,0.00219018719811359,-0.014366702545631,-0.00578116872902569,4.26651717236919e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40274,-0.0304093641655869,0.00661198289617597,-0.0433688506420918,-0.017449877689082,4.27548269065077e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37782,-0.0249439566617347,0.00543573964463841,-0.035598006365226,-0.0142899069582434,4.4969689234669e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37784,-0.0293521725891964,0.00639815023703814,-0.0418925470537912,-0.0168117981246017,4.52450683398087e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39991,-0.0241686858960005,0.00527398518699715,-0.0345056968625149,-0.0138316749294861,4.62753112578691e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37470,-0.0261964906050808,0.00571777808478367,-0.0374033356512567,-0.0149896455589048,4.65749037858104e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,37737,-0.015484303781248,0.00337999739403099,-0.0221090986735487,-0.00885950888894726,4.66613591737242e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39810,0.0140842730018677,0.00308317416467553,0.00804125163910363,0.0201272943646317,4.95974691901002e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39991,0.0244806875313162,0.00536108947320921,0.0139729521638262,0.0349884228988063,5.00065910322231e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37791,-0.00950689678982185,0.00208337495308085,-0.0135903116978603,-0.00542348188178339,5.08246991530634e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39727,-0.0301473635827859,0.00660823072018581,-0.0430994957943501,-0.0171952313712217,5.10403272201148e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37470,-0.0251587011695884,0.00551974935165454,-0.0359774098988313,-0.0143399924403455,5.21274318783918e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39877,-0.00852117400034831,0.00187163815820376,-0.0121895847904277,-0.00485276321026895,5.33440925322308e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40274,0.0119029784271748,0.00261558951096466,0.00677642298568404,0.0170295338686655,5.38445317463698e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40065,-0.028575032749787,0.00628543204180416,-0.0408944795517232,-0.0162555859478509,5.50250865114105e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40186,0.0113844084846051,0.00250928560544525,0.00646620869793246,0.0163026082712778,5.75060282599143e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,37470,-0.0283355803608351,0.00624767808243072,-0.0405810294023994,-0.0160901313192709,5.80140788270693e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,39911,-0.0189507988047735,0.00418131169627799,-0.0271461697294784,-0.0107554278800687,5.8793043006186e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37737,-0.0130124897999677,0.00287326943266936,-0.0186440978879996,-0.00738088171193575,5.98332261988878e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,37470,-0.0232555893469593,0.00514520835772725,-0.0333401977281047,-0.0131709809658139,6.24278793000602e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37470,-0.051037048637608,0.0113082198103071,-0.0732011594658099,-0.0288729378094061,6.43952806254953e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37403,-0.0175436757405971,0.003892861184374,-0.0251736836619701,-0.00991366781922402,6.64431925877478e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40100,-0.0496640661360013,0.0110329089366085,-0.0712885676517539,-0.0280395646202487,6.797907399047e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37470,-0.0168299844721496,0.00374141581427907,-0.0241631594681366,-0.00949680947616266,6.90941335239025e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,40126,0.0162523090933887,0.00361445278409366,0.00916798163656515,0.0233366365502123,6.95837606378625e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40100,-0.0182378241092372,0.00407461690274367,-0.0262240732386148,-0.0102515749798596,7.66056275216097e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39746,-0.0141793176497858,0.00317159333360846,-0.0203956405836584,-0.0079629947159132,7.85159715290583e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40164,-0.0209641356048922,0.00469272488516714,-0.0301618763798198,-0.0117663948299646,7.97400301041308e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,37696,-0.0417830104385324,0.00935612388434772,-0.0601210132518539,-0.0234450076252108,8.04127364535485e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,37470,0.00881826110127952,0.00197686980617002,0.00494359628118628,0.0126929259213728,8.23696457526865e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,40025,-0.0311515915218012,0.00699873318228438,-0.0448691085590785,-0.0174340744845238,8.60516773714409e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37737,-0.0183740135479895,0.00413290554205877,-0.0264745084104246,-0.0102735186855543,8.82810231976774e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,40094,-0.0388491953580421,0.00873933171761919,-0.0559782855245757,-0.0217201051915085,8.83616207586812e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37430,-0.0202582157201953,0.00455806920647712,-0.0291920313648905,-0.0113244000755002,8.88379525416529e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37784,-0.0354990728401865,0.00799083797162318,-0.0511611152645679,-0.019837030415805,8.96476203399936e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39991,-0.0244122778284442,0.00549839966826477,-0.0351891411782431,-0.0136354144786452,9.06261554341183e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39746,-0.020695642951702,0.00466207585852277,-0.0298333116344067,-0.0115579742689974,9.0947969984516e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39746,-0.0231518686452024,0.00522366596839795,-0.0333902539432623,-0.0129134833471424,9.39639967080651e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40081,0.0112914120037781,0.00255084318988482,0.00629175935160385,0.0162910646559523,9.64048624188739e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,39969,-0.0205112713431218,0.00463828626098089,-0.0296023124146443,-0.0114202302715993,9.83806068086116e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37376,-0.0246987361034571,0.005586770413577,-0.035648806114068,-0.0137486660928462,9.90773901194939e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40065,-0.0244161478558798,0.00552549237459068,-0.0352461129100775,-0.013586182801682,9.9910449444865e-06
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37362,-0.0110835497052846,0.00250965198851083,-0.0160024676027658,-0.00616463180780338,1.01188970320804e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,39713,-0.0345012213029699,0.00784001200477178,-0.0498676448323226,-0.0191347977736172,1.08654633629581e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,36873,-0.00972471184050805,0.00221043819423965,-0.0140571707012178,-0.00539225297979833,1.09429831225612e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40248,0.0234104907362831,0.00532194648107508,0.0129794756333759,0.0338415058391902,1.09533692140578e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40274,0.0103762170600055,0.00235952107335194,0.00575155575623567,0.0150008783637753,1.10171449432172e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40164,0.0131754016297256,0.00299760786948158,0.00730009020554174,0.0190507130539095,1.11342635380208e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,37678,-0.0182553069806242,0.00415561657289745,-0.0264003154635032,-0.0101102984977452,1.12706220798702e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37782,-0.00956599782376135,0.00217857719674574,-0.013836009129383,-0.00529598651813971,1.13732118039841e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,40126,0.0332804452885156,0.00758092568126915,0.018421830953228,0.0481390596238031,1.14079847793505e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,40095,-0.0141784754200581,0.00323118253540514,-0.0205115931894522,-0.00784535765066407,1.15138943230169e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,40126,-0.0268552335637862,0.00612387625770582,-0.0388580310288896,-0.0148524360986828,1.1656348575314e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,37470,-0.0344746030922655,0.00787375012345856,-0.0499071533342443,-0.0190420528502867,1.20474382979825e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37737,-0.0148591220037464,0.00339624419914099,-0.0215157606340628,-0.0082024833734301,1.22266921177172e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40209,-0.0119093286036983,0.00272736228668066,-0.0172549586855924,-0.00656369852180417,1.2699426906425e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,37362,-0.0481762470237749,0.0110335470329546,-0.0698019992083659,-0.0265504948391839,1.27327957084561e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37696,-0.0179385113373721,0.00411129753970102,-0.0259966545151861,-0.00988036815955807,1.29129679946214e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,40065,-0.033824310839125,0.00775298975067205,-0.0490201707504422,-0.0186284509278077,1.29265009829372e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,37697,0.0461944259960941,0.0106091455425896,0.0254005007326186,0.0669883512595697,1.345515963161e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,37403,0.0104618694084729,0.00241161859999673,0.00573509695247928,0.0151886418644664,1.44800569089554e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37396,-0.0151366916763632,0.00349451018582373,-0.0219859316405777,-0.00828745171214866,1.49169522728434e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,37697,-0.0188282940946552,0.00435386676222358,-0.0273618729486134,-0.010294715240697,1.53996807799064e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39746,-0.0298904045820167,0.00691755390067492,-0.0434488102273396,-0.0163319989366939,1.56339505212603e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37791,-0.0193618712405011,0.00448249078879718,-0.0281475531865435,-0.0105761892944586,1.57553208377857e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39775,-0.0119619395997987,0.00277080416797586,-0.0173927157690314,-0.00653116343056604,1.59058945275434e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40248,0.0126191605667425,0.00292552524631173,0.0068851310839715,0.0183531900495135,1.61688787935225e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37430,-0.0205673561682367,0.00477070403357111,-0.0299179360740361,-0.0112167762624374,1.63584824758372e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37670,0.0104882141914945,0.00243705186530039,0.00571159253550576,0.0152648358474833,1.69217073948637e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40226,0.0157204506900211,0.00365426820866074,0.00855808500104606,0.0228828163789962,1.70326241192707e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37788,-0.0075187148113804,0.00174789601318086,-0.0109445909972149,-0.00409283862554591,1.70791498753088e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,37791,-0.00962453000835982,0.00223777215866384,-0.0140105634393409,-0.0052384965773787,1.71282591694851e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,37282,-0.0219978199206755,0.00511950085091339,-0.0320320415884657,-0.0119635982528852,1.74504631895932e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,40274,0.0158196709263349,0.00369089768794499,0.00858551145796276,0.0230538303947071,1.82887273236505e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37784,-0.0125166934366291,0.00292732475162227,-0.0182542499498087,-0.00677913692344945,1.91766152949359e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37470,-0.0140889721719973,0.00329512182218944,-0.0205474109434886,-0.00763053340050596,1.91890276071835e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,37808,0.0117958893805889,0.00275965678180186,0.00638696208825729,0.0172048166729206,1.92978334744779e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,39746,-0.0227126068743188,0.00533161655054439,-0.0331625753133858,-0.0122626384352518,2.05662826645748e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,40049,-0.0275275488463847,0.00647571063144431,-0.0402199416840156,-0.0148351560087539,2.14158524201118e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,39746,-0.0145724595598986,0.00343267366160155,-0.0213004999366377,-0.00784441918315958,2.19666126957678e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,37403,-0.0192262440256718,0.00453101391351839,-0.0281070312961678,-0.0103454567551758,2.21834388288054e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,39990,-0.0275490652974352,0.00649382009525523,-0.0402769526841355,-0.014821177910735,2.22471368606871e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37756,0.0132693365972624,0.00313286069692458,0.00712892963129023,0.0194097435632346,2.29543171901093e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37737,-0.0115483223053699,0.00272664523426053,-0.0168925469645205,-0.00620409764621923,2.29723194372903e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39691,-0.0252263159053653,0.00595919605974188,-0.0369063401824594,-0.0135462916282713,2.31765364091282e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40186,-0.0104539055863202,0.00246983461588951,-0.0152947814334636,-0.00561302973917671,2.32279961025753e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39746,-0.0229556839496489,0.00542414527522213,-0.0335870086890843,-0.0123243592102135,2.32839051838408e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,37730,-0.00984983816602273,0.00232812078170853,-0.0144129548981715,-0.00528672143387401,2.34413123121077e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40065,-0.0123625358977216,0.00292443917183359,-0.0180944366745154,-0.00663063512092774,2.37837622622402e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37430,-0.0191733070160289,0.00453692553702902,-0.0280656810686058,-0.010280932963452,2.39447354663014e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,37203,-0.0301283714834774,0.00714012538702849,-0.0441230172420532,-0.0161337257249016,2.4644474218306e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37756,-0.025359123502328,0.00602250968597675,-0.0371632424868424,-0.0135550045178135,2.56228167252852e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37434,0.0184651859915613,0.00439415000780501,0.00985265197626351,0.0270777200068591,2.66077622874386e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,39815,0.0108298716950817,0.00259052028959702,0.00575245192747157,0.0159072914626919,2.92379995689604e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,40137,-0.0111405440081639,0.00266519766090245,-0.0163643314235327,-0.00591675659279508,2.93081286080234e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,40229,-0.0226711945225597,0.00544033086993238,-0.0333342430276272,-0.0120081460174923,3.09945211153351e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40251,-0.0120390847056769,0.00288909692161651,-0.0177017146720453,-0.00637645473930855,3.10173992639783e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,37362,-0.015141115524163,0.00363688268851515,-0.0222694055936527,-0.00801282545467333,3.15837893416432e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,37376,-0.0183198671211101,0.00440097430844207,-0.0269457767656565,-0.00969395747656361,3.16566305494612e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,37784,-0.0364501952946126,0.00877026578979967,-0.0536399162426199,-0.0192604743466052,3.25732370168034e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37737,-0.0395060629990579,0.00950732858372573,-0.0581404270231603,-0.0208716989749554,3.26856056438621e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39967,0.0170206116878838,0.00409658633636856,0.00899130246860138,0.0250499209071661,3.27276379349123e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39991,0.0261071067925602,0.00629081530972039,0.0137771087855082,0.0384371047996122,3.3419417392305e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,40114,-0.0159339073874406,0.00384402214593144,-0.0234681907934662,-0.00839962398141493,3.41432291119414e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37697,-0.0246079639655187,0.00593651430308537,-0.036243531999566,-0.0129723959314713,3.41648799171082e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37791,0.0144882373817766,0.00349677958166831,0.00763454940170671,0.0213419253618465,3.44442094345808e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37515,-0.0165181260889897,0.00398926228569455,-0.0243370801689511,-0.00869917200902843,3.48503956463746e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,40248,-0.01358499000622,0.00328506280572478,-0.0200237131054406,-0.00714626690699945,3.56196182096771e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,40126,0.0167933326661023,0.00406198189524843,0.00883184815141534,0.0247548171807892,3.57936646122696e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,37697,-0.0132667850668348,0.00321153079559735,-0.0195613854262056,-0.00697218470746401,3.63430897697287e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40100,-0.0341376371917411,0.00827329849719063,-0.0503533022462347,-0.0179219721372474,3.70646128196874e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37756,-0.0222998451509467,0.00540730608904133,-0.0328981650854677,-0.0117015252164257,3.74576505503541e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,37421,-0.0246218312880406,0.00597175212255217,-0.0363264654482429,-0.0129171971278384,3.762170999339e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,37609,-0.0371561960106444,0.00901864796652064,-0.0548327460250249,-0.019479645996264,3.8130745161671e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37430,0.0126876349951995,0.00308619722838948,0.0066386884275561,0.0187365815628429,3.96218977721551e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39727,-0.0238341557268981,0.00580800643966508,-0.0352178483486417,-0.0124504631051546,4.08754209739116e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37362,-0.0434515337061832,0.0105884043478283,-0.0642048062279267,-0.0226982611844397,4.09109913406642e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37362,-0.0190449463324626,0.00464300448706068,-0.0281452351271015,-0.00994465753782364,4.12359369723961e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37470,-0.0201881927773397,0.00492239978323882,-0.0298360963524878,-0.0105402892021916,4.13349874080562e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39664,-0.0212103779121395,0.00517373223142766,-0.0313508930857377,-0.0110698627385413,4.15963724236781e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40212,-0.015762007137674,0.00385432174733096,-0.0233164777624427,-0.00820753651290531,4.34568024574129e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,37430,-0.0152507090518867,0.00373300285486998,-0.0225673946474318,-0.00793402345634151,4.42705085716317e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37696,-0.0428456442043737,0.0104965378726382,-0.0634188584347445,-0.0222724299740029,4.49343882149776e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37362,-0.0256292285019089,0.00628312104694197,-0.0379441457539151,-0.0133143112499026,4.54897014514282e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39727,0.0147539099297832,0.00362307577105368,0.00765268141851804,0.0218551384410485,4.680480775274e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40229,0.0107922742893914,0.00265253095130409,0.0055933136248354,0.0159912349539475,4.75121899505713e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39810,-0.0132021142559011,0.00324615942724254,-0.0195645867332965,-0.00683964177850575,4.78609010264567e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,40143,0.00880374124548022,0.00217391667779586,0.00454286455700034,0.0130646179339601,5.15266542878386e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39689,-0.027661211131074,0.00684113220162458,-0.0410698302462582,-0.0142525920158899,5.29481652931392e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37430,0.00947245037386988,0.00234420838256574,0.00487780194404103,0.0140670988036987,5.35788239297301e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37791,-0.0226325916542823,0.0056039899836291,-0.0336164120221954,-0.0116487712863693,5.40590221892508e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39746,-0.0173499351940887,0.00430365798603864,-0.0257851048467245,-0.00891476554145298,5.57050359079958e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40140,0.00816673998135068,0.00202882359133095,0.00419024574234201,0.0121432342203593,5.71561034830078e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,40278,-0.00861986867151356,0.00214268692098215,-0.0128195350366386,-0.00442020230638854,5.77468696783027e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37737,-0.0173352428472263,0.0043139922304342,-0.0257906676188773,-0.00887981807557527,5.89236810322566e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37515,-0.0269907811552041,0.00673145325103332,-0.0401844295272294,-0.0137971327831788,6.11465718891616e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,37737,-0.0079652864147687,0.00198654759776915,-0.0118589197063962,-0.00407165312314117,6.11509353833907e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37515,-0.0279300562450335,0.00697613928421821,-0.0416032892421012,-0.0142568232479658,6.27161056441766e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39746,-0.0184423061474164,0.00461445259389967,-0.0274866332314597,-0.00939797906337299,6.45491841829474e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,40097,-0.0139063787528806,0.00348051591672991,-0.0207281899496712,-0.00708456755608994,6.48552744698165e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37697,-0.0176862209339561,0.00442998323453772,-0.02636898807365,-0.00900345379426219,6.57635535617939e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39815,-0.0244640209284339,0.00615013191226502,-0.0365182794764733,-0.0124097623803944,6.98735594640358e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40047,-0.0115355085338372,0.00290868904097823,-0.0172365390541545,-0.00583447801351985,7.34525935216595e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40100,-0.0426427061568184,0.010755165747539,-0.0637228310219948,-0.021562581291642,7.37661994486725e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37696,0.0180861425667709,0.00456184088334042,0.00914493443542366,0.0270273506981181,7.38872263620258e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,40054,-0.0251773205318673,0.00635816815143968,-0.0376393301086891,-0.0127153109550455,7.53332986817285e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,37376,-0.0158588769436946,0.004009641268272,-0.0237177738295078,-0.00799998005788152,7.68832368477283e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40100,-0.034466057009658,0.00875085951392969,-0.0516177416569602,-0.0173143723623559,8.23169070215213e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,40074,0.0242130429945308,0.00615860822715372,0.0121421708693095,0.0362839151197521,8.47545224827608e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39949,0.0234381414186552,0.00596170278874366,0.0117532039527177,0.0351230788845928,8.48019493648168e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40297,0.0147730341190268,0.00376290456665401,0.00739774116838498,0.0221483270696687,8.67479352417928e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37545,-0.0197431836545443,0.00503211765323999,-0.0296061342548947,-0.00988023305419393,8.77415268498472e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40065,-0.0196398344304945,0.00502484967702835,-0.02948853979747,-0.00979112906351892,9.32469587560822e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,40186,-0.0237668642546868,0.00608595326810266,-0.035695332660168,-0.0118383958492056,9.45406713525393e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39746,-0.0201798859360578,0.00517508850271892,-0.0303230594013869,-0.0100367124707287,9.68320669206198e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40058,-0.0151873289258981,0.00389677814546735,-0.0228250140910141,-0.00754964376078213,9.7634568206812e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37430,-0.0110181983588996,0.00282763460119447,-0.0165603621772407,-0.00547603454055842,9.80371289678119e-05
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40141,-0.0139751910349267,0.00359233258393752,-0.0210161628994443,-0.00693421917040919,0.000100540607972239
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40095,-0.013290084846953,0.00341741735884158,-0.0199882228702825,-0.00659194682362346,0.000101104905915669
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,39746,-0.0241327818063676,0.00620707459135616,-0.0362986480054256,-0.0119669156073095,0.00010152249401818
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40095,0.0113715107386226,0.00292779549795228,0.00563303156263611,0.017109989914609,0.000103181505917767
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,37362,-0.0212340081373382,0.00546720622120284,-0.0319497323308958,-0.0105182839437807,0.000103312567401391
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40100,-0.052655350046381,0.0135620868606236,-0.0792370402932032,-0.0260736597995587,0.000103795438250613
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37362,-0.0235341705359038,0.00606735777421847,-0.035426191773372,-0.0116421492984356,0.000105486530742828
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37782,0.00907589518352563,0.00234069836506188,0.00448812638800435,0.0136636639790469,0.000106072093361849
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40100,-0.0287476472300532,0.00742407473180898,-0.0432988337043988,-0.0141964607557076,0.00010828730145047
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37756,-0.0242174024178506,0.0062550855964188,-0.0364773701868314,-0.0119574346488697,0.000108625074953743
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,40126,-0.0157446949709099,0.00407449639858908,-0.0237307079121445,-0.00775868202967531,0.000111899890968634
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40199,-0.0282775840770041,0.00732718266052611,-0.0426388620916353,-0.0139163060623729,0.000114179503444373
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40274,-0.0240910011413962,0.00625245136003044,-0.0363458058070558,-0.0118361964757365,0.00011711649374022
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40095,0.0109116490546424,0.00283566396441345,0.00535374768439201,0.0164695504248927,0.000119556690702855
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40052,0.0119522712197301,0.00310947692672773,0.00585769644334375,0.0180468459961165,0.000121614161782894
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,40153,0.00972224675335684,0.00253229445932666,0.00475894961307658,0.0146855438936371,0.000123868049086907
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37696,-0.0161610082210095,0.00421694647346463,-0.0244262233090002,-0.00789579313301884,0.000127487825195976
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36960,0.0384940741715122,0.0100457205610089,0.0188044618719347,0.0581836864710896,0.00012778577318945
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37372,-0.020524941053787,0.00536252178547871,-0.0310354837533253,-0.0100143983542488,0.000130072677999941
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,37737,-0.03309462592149,0.00866042066345111,-0.0500690504218542,-0.0161202014211258,0.000133320072191365
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,40126,0.0240670392404204,0.00630357188454754,0.0117120383467072,0.0364220401341336,0.000135055632622113
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37343,0.00985656165340374,0.00258148189082288,0.00479685714739089,0.0149162661594166,0.000135069501161222
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37784,-0.0102660878330306,0.00268995454360246,-0.0155383987384914,-0.00499377692756979,0.000135995154571218
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,37430,-0.0179668487660068,0.00470923023061862,-0.0271969400180193,-0.00873675751399428,0.000136680947678935
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,39727,-0.0231461887025306,0.00608286310465059,-0.0350686003876458,-0.0112237770174154,0.000142272660254355
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,40233,-0.044825836937752,0.0117853364208546,-0.067925096322627,-0.021726577552877,0.000143188450719446
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37282,0.0198250817958151,0.00522258872067282,0.00958880790329638,0.0300613556883338,0.000147710894909355
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37515,0.0100097232738733,0.00263744689514883,0.00484032735938156,0.015179119188365,0.000148171599897154
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40164,-0.0141184715339004,0.00373604599522054,-0.0214411216845326,-0.00679582138326813,0.00015804894331032
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37737,-0.0212509008143341,0.00562449170655104,-0.0322749045591741,-0.0102268970694941,0.000158605271782743
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37470,0.013769542450236,0.00365456836289815,0.00660658845895563,0.0209324964415164,0.000165444262969536
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,40174,0.00730537042047859,0.00194023162681449,0.00350251643192219,0.011108224409035,0.000167018227793994
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,40012,-0.00974412140760054,0.00259004940062614,-0.0148206182328278,-0.00466762458237331,0.000169085447156173
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,39991,-0.0126194419107328,0.00335801123799636,-0.0192011439372057,-0.00603773988425996,0.000171896061466442
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37756,-0.0231550390719947,0.00616562000762551,-0.0352396542869407,-0.0110704238570487,0.000173727150066074
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,39815,0.0109129441509813,0.0029062949705138,0.00521660600877421,0.0166092822931883,0.000174027050386273
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,40160,0.00991707291513605,0.00264387693843898,0.00473507411579566,0.0150990717144765,0.000176792698956882
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,37697,-0.0127950473267441,0.00341863619337995,-0.0194955742657688,-0.00609452038771937,0.00018279798478337
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37376,0.0109380275787453,0.00292409367528123,0.00520680397519412,0.0166692511822965,0.000184334249063919
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37430,-0.0140451416000318,0.00376132385655433,-0.0214173363588782,-0.00667294684118526,0.000189196835100898
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37343,0.0273438054031511,0.00732422589709334,0.0129883226448481,0.041699288161454,0.000189772229949999
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40065,-0.0346100874746897,0.00929267357643783,-0.0528237276845079,-0.0163964472648716,0.000196431297918121
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,37808,-0.00696759647255942,0.00187220439047362,-0.0106371170778877,-0.00329807586723111,0.000198776470961275
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,40233,-0.00781016531979521,0.00210334534223979,-0.0119327221905852,-0.00368760844900523,0.000205350546616204
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37756,0.0158008409343227,0.00425538577347889,0.00746028481830409,0.0241413970503413,0.000205540033056828
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40126,0.0258024914299027,0.00696423589379591,0.0121525890780627,0.0394523937817427,0.000212117675846215
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39810,-0.0185580675337586,0.00502327402849425,-0.0284036846296073,-0.00871245043790987,0.000221157028569234
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,36981,-0.0411794697849466,0.0111474104507757,-0.063028394268467,-0.0193305453014262,0.000221619696124887
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37362,-0.0135756065456944,0.00368650326527463,-0.0208011529456327,-0.00635006014575613,0.000231885779582201
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,40081,-0.0134101633351899,0.0036453488025802,-0.0205550469882471,-0.00626527968213271,0.000235207888744721
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40174,-0.00877388520035774,0.00238964439414481,-0.0134575882128816,-0.0040901821878339,0.000241808656941893
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37344,-0.013539223155933,0.00369264480422623,-0.0207768069722164,-0.0063016393396496,0.000246844432771434
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37756,-0.014425270268767,0.00394062187305384,-0.0221488891399525,-0.00670165139758147,0.000252541968214875
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37362,-0.0118148150195555,0.00322967798325069,-0.0181449838667268,-0.0054846461723841,0.000255001461641925
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,37362,-0.0155306665156046,0.00425594581848978,-0.0238723203198446,-0.00718901271136463,0.000264127094754666
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37585,0.0137299297082723,0.00377834696647959,0.00632436965397233,0.0211354897625723,0.000280293233519569
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39815,-0.0236033984155257,0.00649861000961158,-0.0363406740343644,-0.010866122796687,0.000282073286494092
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39746,0.0117599594222421,0.00324558670560263,0.00539860947926092,0.0181213093652232,0.000291732332450619
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37430,0.0120740116190065,0.00333253973041307,0.00554223374739689,0.0186057894906161,0.000292242957277641
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37631,-0.0192126650281582,0.00530786664978081,-0.0296160836617285,-0.00880924639458778,0.000296097160591684
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,37470,-0.0371856075091911,0.0102737527129648,-0.057322162826602,-0.0170490521917802,0.0002963189377734
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37782,-0.0235428520908636,0.00651351267486433,-0.0363093369335977,-0.0107763672481295,0.000302079312822293
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39815,0.0131276998147843,0.00363740180413297,0.0059983922786837,0.0202570073508849,0.00030825307469171
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37652,-0.0156276401129727,0.00433434334652784,-0.0241229530721673,-0.00713232715377811,0.000312655005724781
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37403,-0.013209092892088,0.00366767127993032,-0.0203977286007515,-0.00602045718342462,0.000317578505469552
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,37808,-0.00844466470841607,0.00234725901802564,-0.0130452923837463,-0.00384403703308582,0.000322240065419889
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40274,-0.0106692715209626,0.00297340983713162,-0.0164971548017405,-0.00484138824018458,0.000333938826238588
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37362,0.013080759092256,0.00365416298148069,0.00591859964855383,0.0202429185359581,0.000345268293008814
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40297,0.0112380225547433,0.00314373171599416,0.00507630839139479,0.0173997367180919,0.000351618800228312
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,40248,0.00809801542302634,0.00226567807879178,0.00365728638859446,0.0125387444574582,0.000352330307543723
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37470,-0.0217459568286804,0.00609015287363203,-0.0336826564609992,-0.00980925719636163,0.000357345698225312
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37430,-0.0171032519982795,0.00479425537004284,-0.0264999925235634,-0.00770651147299552,0.000361775030389899
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,37737,-0.0214827033118001,0.0060270549877911,-0.0332957310878706,-0.00966967553572953,0.000365999332033798
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,37343,-0.0175926325805634,0.00493657271780802,-0.0272683151074672,-0.00791695005365972,0.00036693736164035
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39979,-0.0155526163307391,0.00436605092509934,-0.0241100761439338,-0.00699515651754442,0.00036890315957583
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,40274,-0.0146583808136215,0.00411680354682531,-0.0227273157653991,-0.00658944586184391,0.000371062900194596
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37515,-0.0225489016607385,0.00633274222317956,-0.0349610764181705,-0.0101367269033066,0.000371202935318571
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,39815,0.0096966575584373,0.00272729902521998,0.00435115146900614,0.0150421636478685,0.000378528690744516
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,39571,0.0084173422867777,0.00237372874253037,0.00376483395141818,0.0130698506221372,0.0003922459269554
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37697,-0.0106171574489846,0.00300438046133133,-0.016505743153194,-0.00472857174477522,0.000410883047463009
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40186,0.0131441869024449,0.00373431574210055,0.0058249280479278,0.0204634457569619,0.000433030423731934
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40100,-0.0193568680710385,0.00550763803625263,-0.0301518386220937,-0.00856189751998336,0.000441744653337306
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,37403,-0.0112185870549496,0.00319200544997799,-0.0174749177369065,-0.00496225637299279,0.000441939012020006
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37370,-0.00904299858646839,0.00257325743991741,-0.0140865831687065,-0.00399941400423027,0.000442552807178029
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40065,0.0123033420593585,0.00350460913534395,0.00543430815408439,0.0191723759646327,0.000448327891697036
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37696,-0.00954787558681575,0.00272022452026579,-0.0148795156465367,-0.0042162355270948,0.000449665428210415
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40095,-0.00832606930496709,0.00238412143841554,-0.0129989473242615,-0.00365319128567263,0.000480200269545156
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39991,0.0113430301881976,0.00325173870950346,0.00496962231757084,0.0177164380588244,0.000487452779025361
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37430,-0.00901926419891391,0.00258580347522624,-0.0140874390103573,-0.00395108938747048,0.000488272833019014
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37470,-0.0280456431082208,0.00804066874379566,-0.0438053538460603,-0.0122859323703813,0.000488302477557725
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37430,-0.0149040237469361,0.00427913392002175,-0.0232911262301787,-0.00651692126369343,0.000497548471842122
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39746,-0.0232452713479376,0.00667432739430283,-0.0363269530407711,-0.010163589655104,0.0004976067140143
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,37756,-0.0214150741736671,0.00619523070153481,-0.0335577263486753,-0.00927242199865884,0.000548534946245749
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,39976,0.0397362948969071,0.011524329222974,0.017148609619878,0.0623239801739363,0.000566177588561331
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37762,0.0328028285691812,0.00951527258907812,0.0141528942945881,0.0514527628437743,0.000567786633577406
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,37737,0.00824578429902277,0.00239298125689327,0.00355554103551197,0.0129360275625336,0.0005710883616983
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,40233,0.00960539373352193,0.00278815429209969,0.00414061132100654,0.0150701761460373,0.000572390797355913
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39955,-0.00736780516623474,0.00213876818634728,-0.0115597908114754,-0.00317581952099407,0.000572819604842088
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37784,-0.0147463347949418,0.00428489639761041,-0.0231447317342582,-0.00634793785562538,0.000580340641639871
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,40230,-0.029593155439409,0.00860455233436712,-0.0464580780147685,-0.0127282328640494,0.000584848776910594
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39471,0.0146183571090761,0.00426169790886972,0.00626542920769149,0.0229712850104608,0.000604820441124288
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,39947,-0.0178947131749308,0.00523405576948314,-0.0281534624831178,-0.00763596386674389,0.000630366925058817
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,40065,-0.00928403166373575,0.00271712219432029,-0.0146095911646035,-0.00395847216286798,0.000635088578413019
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37756,-0.0145886456752753,0.0042709067768072,-0.0229596229578174,-0.00621766839273321,0.000637804832668306
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,39800,-0.0133505999885255,0.00390883001923422,-0.0210119068262246,-0.00568929315082646,0.000638304182734683
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37808,0.00603186341698626,0.00176628368271894,0.00256994739885714,0.00949377943511538,0.000639711027783173
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39810,0.0101998013924976,0.0029886255756719,0.00434209526418067,0.0160575075208145,0.000644476106161843
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,40059,0.0195830547156934,0.00574126265965647,0.00833017990276668,0.0308359295286201,0.000649053470807923
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,40037,-0.0183479933527433,0.00538216851959429,-0.0288970436511481,-0.00779894305433848,0.000653585218084125
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39746,-0.0108183259702555,0.00317362927285125,-0.0170386393450439,-0.00459801259546702,0.000654131986752574
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,39931,-0.0119352582433576,0.00350215947435029,-0.0187994908130841,-0.00507102567363097,0.00065614488183852
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,37808,-0.00974457578118593,0.00286044545542534,-0.0153510488738196,-0.00413810268855226,0.000659559205914468
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,37407,-0.012768286965545,0.00375773027036238,-0.0201334382954552,-0.00540313563563471,0.000681165448757252
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,37403,0.00872833824867741,0.00257110216845541,0.0036889779985048,0.01376769849885,0.000688886694825172
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,37696,-0.0323655486036948,0.00963180810001688,-0.0512438924797279,-0.0134872047276618,0.00078084143720905
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37756,-0.0118923408400353,0.00354297511791587,-0.0188365720711504,-0.00494810960892019,0.000791289211488916
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,40100,0.0174272231398312,0.00520220398402795,0.00723090333113643,0.027623542948526,0.000810115469131319
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37430,-0.0288879968419661,0.00863860377142837,-0.0458196602339657,-0.0119563334499665,0.000827960669236794
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40164,-0.0192242372475476,0.00576267627717223,-0.0305190827508051,-0.00792939174428999,0.000851928300178093
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,40186,-0.010604400740893,0.00319573977185356,-0.0168680506937259,-0.00434075078805998,0.000907749420939344
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,40066,-0.00815044776325522,0.00245809307498295,-0.0129683101902218,-0.00333258533628864,0.00091602513724338
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40069,-0.0188090066657435,0.00569476711088453,-0.0299707502030771,-0.00764726312840978,0.000959198971131304
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40274,0.0108756438578279,0.00329332407241933,0.00442072867588601,0.0173305590397698,0.000960976075313314
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37515,0.0109714586213091,0.00332517222663905,0.00445412105709654,0.0174887961855216,0.000971109571849738
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,37403,0.0127875411273878,0.00387633762953904,0.00518991937349125,0.0203851628812843,0.00097336082241779
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,40065,-0.0123270673862021,0.0037369858537654,-0.0196515596595822,-0.00500257511282189,0.000973627967925372
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,40297,0.00803378475116565,0.00244471986593889,0.00324213381392543,0.0128254356884059,0.0010177751376532
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,40071,-0.0115658823184269,0.00352276852426297,-0.0184705086259824,-0.00466125601087154,0.00102868737081075
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39811,0.0123208682556764,0.00375377288971204,0.00496347339184083,0.019678263119512,0.00103207542846187
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,40027,-0.019583181096449,0.006015746925047,-0.0313740450695411,-0.00779231712335686,0.00113506524519346
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40193,0.00818455768826941,0.00251791686359319,0.00324944063562677,0.0131196747409121,0.0011543321939384
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37696,-0.0224966819916999,0.00692842387628659,-0.0360763927892216,-0.0089169711941782,0.00116913208769177
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,40160,-0.016647200356145,0.00513014446271148,-0.0267022835030595,-0.00659211720923049,0.00117705915142571
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,40126,-0.010653498115121,0.00328359407810156,-0.0170893425082,-0.00421765372204192,0.00117919081479771
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37376,-0.0177079768971527,0.00546834497657218,-0.0284259330512341,-0.00699002074307118,0.00120560522481764
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,37670,0.0166342820503912,0.00514555626557979,0.00654899176985486,0.0267195723309276,0.0012290672898022
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37661,-0.00910509331217174,0.00281681681544396,-0.0146260542704419,-0.00358413235390158,0.00123053981898733
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37362,-0.0295744570920831,0.00915363368935408,-0.0475155791232171,-0.0116333350609491,0.00123711151308442
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39630,-0.0109601916301216,0.00341497154458677,-0.0176535358575117,-0.00426684740273154,0.00133264168899031
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,40100,0.0138224199626277,0.00430690942407482,0.00538087749144101,0.0222639624338143,0.00133299382919567
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,37430,-0.0121402471613234,0.00378447697838904,-0.0195578220389659,-0.00472267228368092,0.00134029684946864
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,40121,0.00672405034310738,0.00209638860821989,0.00261512867099638,0.0108329720152184,0.00134188944370234
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37584,-0.0178093774107821,0.00555572471722032,-0.0286985978565339,-0.00692015696503028,0.00135108244766461
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40233,-0.020808244157026,0.00650984125917435,-0.0335675330250077,-0.00804895528904427,0.0013941425891322
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37343,-0.0221941653993464,0.00696876199949558,-0.0358529389183577,-0.00853539188033505,0.00145195041464898
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37430,0.0112674579626003,0.00354043042841676,0.00432821432290349,0.0182067016022972,0.00146348292988562
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39746,-0.0162991618750956,0.00513504767372692,-0.0263638553156003,-0.00623446843459079,0.00150598918528114
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RETN,Resistin,40046,-0.0117705901811229,0.00372187761337372,-0.0190654703033354,-0.0044757100589104,0.00156698555776399
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40100,-0.0106855888452442,0.00338183036478971,-0.017313976360232,-0.00405720133025633,0.00158229233485978
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,37377,0.019646628917715,0.00622378863141466,0.00744800320014223,0.0318452546352877,0.00159932389951303
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37662,-0.0151542142947214,0.00480902325977255,-0.0245798998838756,-0.00572852870556716,0.00162961897457847
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_A,,37756,0.0092856514036357,0.00295181501277699,0.00350009397859281,0.0150712088286786,0.00166030536718779
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,39934,-0.0165811883277521,0.00527395722657614,-0.0269181444918414,-0.00624423216366291,0.00166984718849932
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37782,0.00799223481220701,0.00254953521415222,0.00299514579246866,0.0129893238319454,0.00172355770604899
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,39746,0.0159402293648493,0.00509219798981432,0.00595952130481326,0.0259209374248854,0.00174942283666687
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37784,0.00707828196394059,0.00226131885119741,0.00264609701559368,0.0115104669122875,0.00175090379195443
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,39746,-0.0130138501916777,0.00415978560823339,-0.0211670299838151,-0.00486067039954022,0.00176036635690352
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,40297,0.0113439652170788,0.0036274615825601,0.00423414051526101,0.0184537899188966,0.00176771543979323
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,40174,-0.0114668399687059,0.00366914593270653,-0.0186583659968107,-0.00427531394060106,0.00178003448910529
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37697,-0.0154105623244435,0.00493835079740525,-0.0250897298873578,-0.00573139476152925,0.00180877697194039
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37343,0.0172938030250702,0.00555004243083689,0.00641571986062992,0.0281718861895105,0.00183739336188061
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,40215,0.0121040462861614,0.00388921096198234,0.00448119280067602,0.0197268997716468,0.00186023495551107
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37791,-0.0164773791899655,0.00529524179845858,-0.0268560531149443,-0.00609870526498671,0.00186385298467195
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,39727,-0.013881694815839,0.00446267233694736,-0.0226285325962558,-0.00513485703542213,0.00187036381917544
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,40153,0.0110513034888861,0.003561440169607,0.00407088075645636,0.0180317262213158,0.00191881597045451
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,37362,0.0143498849848427,0.00462644917894845,0.00528204459410373,0.0234177253755817,0.00192823813683974
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37376,0.0105196968934683,0.00339406878331536,0.00386732207817015,0.0171720717087664,0.00194306321899213
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PI3,Elafin,39842,-0.0149692982066885,0.00483279712915724,-0.0244415805798367,-0.00549701583354031,0.0019555126009406
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,37403,-0.0177661233240641,0.00573589269669429,-0.029008473009585,-0.00652377363854333,0.00195670228871119
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40095,-0.0117505658681724,0.00379929717319602,-0.0191971883276366,-0.0043039434087082,0.00198609249903737
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,37697,-0.0181751283101897,0.00588739700060407,-0.0297144264313737,-0.00663583018900576,0.00202520272126641
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39691,-0.0122218722756539,0.0039592115367404,-0.0199819268876651,-0.00446181766364274,0.00202587244593076
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,37515,0.00823899421278308,0.00267117076066329,0.00300349952188303,0.0134744889036831,0.00204379904305365
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37697,-0.00802368118929831,0.00260258387032153,-0.0131247455751285,-0.00292261680346811,0.00205368835899389
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,37567,0.00919299835178127,0.0029842702951668,0.00334382857325435,0.0150421681303082,0.00207091815051682
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,37470,0.0120353005666358,0.00390904923982484,0.00437356405657909,0.0196970370766925,0.00208247215382155
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37784,-0.0150108364425814,0.00488846939803888,-0.0245922364627377,-0.00542943642242525,0.00214014656370969
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37376,-0.0191101384738818,0.00622424261704815,-0.0313096540032962,-0.00691062294446747,0.00214305231743533
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40126,-0.00856570306091488,0.00279130977086435,-0.014036670211809,-0.00309473591002075,0.00215356650371973
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,37470,-0.00940096567464567,0.00306437273970961,-0.0154071362444765,-0.00339479510481484,0.00216064174019531
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,40095,-0.00686317362187985,0.00224145353769516,-0.0112564225557624,-0.00246992468799733,0.00220288121275623
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40059,0.0131907471148482,0.00431718504140913,0.0047290644336863,0.0216524297960101,0.00225136379452283
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,39727,-0.0125783039437332,0.00411858225158125,-0.0206507251568325,-0.00450588273063396,0.0022617266490615
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37696,-0.0310831938896082,0.0102129668306226,-0.0511006088776285,-0.0110657789015879,0.00234299688642403
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,37403,-0.0105149406405168,0.00346060051139724,-0.0172977176428554,-0.00373216363817824,0.00238254422608644
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37662,-0.0118917703067654,0.00391643804208501,-0.019567988869252,-0.00421555174427878,0.00239908877546227
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37697,-0.0100580088060775,0.00331901417498804,-0.016563276589054,-0.00355274102310092,0.00244684711768388
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37362,-0.0170413362564609,0.00564735409631219,-0.0281101502852328,-0.00597252222768899,0.00255299469345582
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,40126,-0.015504111526264,0.00514268227994232,-0.025583768794951,-0.00542445425757711,0.00257567989110097
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40212,0.008092919426487,0.00268602849150898,0.00282830358312939,0.0133575352698446,0.00259116496900398
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40169,-0.0138503057298334,0.00460108804378062,-0.0228684382956434,-0.00483217316402341,0.00261469343269038
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,40164,0.0158054657237162,0.00525365290462314,0.00550830603065488,0.0261026254167776,0.00262981229563734
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,37042,0.0189750040564666,0.00632254280116269,0.00658282016618772,0.0313671879467455,0.00269474429252315
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LXN,Latexin,39946,0.017940374495158,0.00598198295299634,0.00621568790728512,0.0296650610830308,0.00271236796192577
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37362,-0.0170141668739055,0.00568208036188053,-0.0281510443831914,-0.00587728936461971,0.00275546790108967
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40036,-0.00729469585834138,0.00243770025338414,-0.0120725883549743,-0.00251680336170846,0.00277181543865142
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,39815,-0.0224858512309988,0.00751439573448288,-0.0372140668705853,-0.00775763559141238,0.0027726043295159
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39815,-0.015158972732819,0.00507593714854892,-0.0251078095439748,-0.0052101359216631,0.00282693002125493
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,37403,-0.0317506454021049,0.010655140826094,-0.0526347214212492,-0.0108665693829605,0.00288931537522567
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40065,0.00832261517994116,0.00279752096939164,0.00283947407993355,0.0138057562799488,0.00293440227600337
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,39093,0.0129816188359071,0.00436437964176887,0.00442743473804015,0.0215358029337741,0.00293995199344725
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39815,0.0166017301562966,0.00558636540787073,0.00565245395686994,0.0275510063557232,0.00296488836731012
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37343,0.00894880349034412,0.00301327021643124,0.00304279386613889,0.0148548131145494,0.00298544598990249
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40160,-0.0237215339678652,0.00799392554920926,-0.0393896280443154,-0.00805343989141509,0.0030073859055875
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,40100,0.0131175281471559,0.00443614171423503,0.00442269038725522,0.0218123659070565,0.00311144551644912
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,40065,-0.0194968858052519,0.00659563518662415,-0.0324243307710352,-0.00656944083946854,0.00312094158092462
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40248,-0.00830300212821038,0.00281200260036294,-0.0138145272249217,-0.00279147703149903,0.00315470778230198
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,39718,-0.0150455831197102,0.00510007929568014,-0.0250417385392433,-0.00504942770017713,0.00318185737508875
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40065,0.0118980038905476,0.00404658364071128,0.00396669995475353,0.0198293078263418,0.00328418846026199
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37027,-0.0287511298732304,0.00977867614654784,-0.0479173351204642,-0.00958492462599664,0.00328612062168717
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37362,0.0138710628341204,0.00471864014938878,0.00462252814131844,0.0231195975269225,0.00329185154657193
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,40197,-0.0117397178784057,0.00399869393336504,-0.0195771579878012,-0.00390227776901025,0.00333075241929583
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37515,-0.00981838875927741,0.00335169464377698,-0.0163877102610803,-0.00324906725747453,0.00340225695168194
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37696,0.0145158044433622,0.00495680998738233,0.0048004568680928,0.0242311520186315,0.00341229336922565
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37515,-0.0196258297439571,0.00670365903797081,-0.0327650014583799,-0.0064866580295343,0.00342146116805601
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,40095,-0.0073493108388326,0.00251254865900711,-0.0122739062104865,-0.00242471546717868,0.00344904104864732
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40095,0.00636299257948816,0.00217568025330855,0.00209865928300339,0.0106273258759729,0.00345395219908502
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39691,-0.0125980025918711,0.00430936625622316,-0.0210443604540685,-0.00415164472967366,0.0034674043160899
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39815,-0.00953680738538238,0.00326250648298642,-0.0159313200920358,-0.003142294678729,0.00347011076321573
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,40038,-0.0128380420187944,0.00440407782948358,-0.0214700345645822,-0.00420604947300662,0.00356154638943946
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37515,-0.0198781884584872,0.00684296281520851,-0.0332903955762959,-0.00646598134067849,0.00367975284114445
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,37430,-0.0133121843313351,0.00459465762031859,-0.0223177132671596,-0.00430665539551069,0.00376997365372284
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",40248,-0.0192678902765746,0.00666855527323692,-0.032338258612119,-0.00619752194103025,0.00386545734864975
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,37515,-0.0142889283315512,0.00494529538378291,-0.0239817072837657,-0.00459614937933669,0.00386614652464047
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,37362,-0.020943364978042,0.00725452608250692,-0.0351622360997555,-0.0067244938563284,0.00389656679737713
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37343,0.0150378603131017,0.00520940826622317,0.00482742011130423,0.0252483005148991,0.00389984868442781
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,40062,-0.0206106989879628,0.00714255142038429,-0.034610099771916,-0.00661129820400955,0.00391176936260202
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37784,0.00686011679266671,0.00238059784988952,0.00219414500688326,0.0115260885784502,0.00396194911775419
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40126,-0.0149174472103268,0.0051907447150193,-0.0250913068517647,-0.00474358756888902,0.00406040256270131
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,40126,-0.017524135711455,0.00609799592457316,-0.0294762077236184,-0.00557206369929158,0.00406170880335146
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40126,0.00909154880540346,0.00316591614487301,0.00288635316145236,0.0152967444493546,0.00408822790662566
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,40194,-0.0159729997114084,0.00558771611244062,-0.026924923291792,-0.00502107613102475,0.00426084538584717
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37362,0.00523005580396724,0.00182954809853022,0.00164414153084801,0.00881597007708647,0.00426115759798484
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40070,-0.0177576668521066,0.00623578769259951,-0.0299798107296016,-0.00553552297461154,0.00440935688308619
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40100,-0.00843965436136169,0.00296793848702579,-0.0142568137959322,-0.00262249492679113,0.00446636549862366
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,37808,0.00846566462837515,0.00298137780357116,0.00262216413337567,0.0143091651233746,0.00452505247270426
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39700,0.0137408711756287,0.00484164120366227,0.00425125441645063,0.0232304879348067,0.0045448496365575
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCT,Secretin,37376,-0.0117953913353281,0.00416038787485431,-0.0199497515700425,-0.00364103110061364,0.00458729376159524
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,40233,-0.0076124598453466,0.00268818314294605,-0.0128812988055209,-0.00234362088517235,0.00463419895233863
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,40233,-0.032771926316173,0.0115879174577822,-0.0554842445334261,-0.01005960809892,0.00468824333677393
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40065,-0.0187080425139602,0.00662084232656803,-0.0316848934740336,-0.0057311915538869,0.00472478113318038
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40297,0.00794063486180416,0.00281088097525041,0.00243130815031336,0.013449961573295,0.00473451588722244
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37515,0.01294356478279,0.00459483260052015,0.00393769288577054,0.0219494366798095,0.00485498443405061
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,37343,0.00708415730097798,0.00251656899126431,0.00215168207809993,0.012016632523856,0.00488502665162404
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,39698,-0.017259026906791,0.00613202073700359,-0.029277787551318,-0.00524026626226395,0.00489045045350442
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,39727,-0.014280179933805,0.00507566218689366,-0.0242284778201166,-0.00433188204749345,0.00490738619521956
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37282,-0.0156387649782605,0.0055658081962258,-0.0265477490428631,-0.00472978091365793,0.00496485168534809
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37349,0.0102574658164537,0.00365600252331596,0.00309170087075442,0.017423230762153,0.005029031332476
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39775,-0.0130805179932898,0.00467400082120762,-0.0222415596028567,-0.00391947638372287,0.00513935745526773
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37470,-0.00568662622926837,0.00203301445366374,-0.00967133455844929,-0.00170191790008744,0.00516328407928962
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37515,-0.022059578638494,0.00789433773280505,-0.0375324805947919,-0.0065866766821961,0.00520792133983741
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,39991,-0.0330703257464608,0.0118659170004945,-0.05632752306743,-0.00981312842549163,0.00532628247696059
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37362,-0.0119519762699303,0.00429175681837011,-0.0203638196339357,-0.00354013290592487,0.00536275180974754
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39727,0.0164365541266222,0.00590320583764418,0.00486627068483964,0.0280068375684048,0.005370214421891
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39746,0.0081665318823482,0.00293514177526741,0.00241365400282409,0.0139194097618723,0.00540363349965976
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,37343,0.0247610707430717,0.008914305344727,0.00728903226740674,0.0422331092187366,0.0054827952239289
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,37696,-0.0113878110565634,0.00410075722782619,-0.0194252952231028,-0.00335032689002411,0.00549399486180307
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,40248,0.0112573657335746,0.00405737726444169,0.00330490629526889,0.0192098251718803,0.00553443383028046
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37282,-0.010381055004656,0.00374566650155305,-0.0177225613476999,-0.00303954866161199,0.00558817853537616
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,37403,-0.0131143683749106,0.00473245363176797,-0.0223899774931758,-0.00383875925664537,0.00559372949354251
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,40297,0.00660824227454679,0.00238502361951567,0.00193359598029608,0.0112828885687975,0.00559969772262914
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37430,-0.0228619399343826,0.00825394256117107,-0.0390396673542779,-0.00668421251448725,0.00561668785187254
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37696,-0.0217557135041101,0.00787135352811179,-0.0371835664192092,-0.006327860589011,0.00571921891779733
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37791,-0.00870112541894277,0.00315140300611993,-0.0148778753109378,-0.00252437552694771,0.00576977336528913
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37737,0.0150850837385237,0.00547735525825466,0.00434946743234453,0.0258207000447028,0.0058937120072814
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,37515,0.0104674694547254,0.00380364129442779,0.00301233251764691,0.0179226063918039,0.0059321424997457
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,37791,0.00568706806420933,0.00207237028048615,0.00162522231445648,0.00974891381396219,0.00607334660101498
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37756,0.00870248321221772,0.00317393958013948,0.00248156163514433,0.0149234047892911,0.00611748860697361
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36990,0.0120907487263327,0.00441576067614512,0.00343585780108831,0.0207456396515772,0.00618844250864246
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,37470,0.00697094562728055,0.00255037032133523,0.0019722197974635,0.0119696714570976,0.00627864977439756
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,39815,-0.0173144137436363,0.00634078061405873,-0.0297423437471914,-0.00488648374008116,0.00632828179539666
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37282,0.00854874062894234,0.0031315021696425,0.00241099637644303,0.0146864848814416,0.0063436721922276
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,39810,-0.0116311107772292,0.00427090998898961,-0.0200020943556488,-0.00326012719880958,0.00646998642966886
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C2,Complement C2,40133,-0.0058527402131534,0.00216244189291261,-0.0100911263232621,-0.00161435410304468,0.00680615209407604
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,37376,-0.0147701419218407,0.00546545888902278,-0.0254824413443253,-0.004057842499356,0.00689199557933996
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,37362,0.00897332322196426,0.00332632819775184,0.00245371995437065,0.0154929264895579,0.00699181325043937
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,37777,-0.00357494138580647,0.00132575672939721,-0.006173424575425,-0.000976458196187929,0.0070154368872661
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37343,0.00833119824055577,0.00309358456207398,0.00226777249889078,0.0143946239822208,0.00708918089730895
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37756,0.0102702819143941,0.00381998909492635,0.00278310328833843,0.0177574605404497,0.00718496391344846
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37343,0.0150458867816901,0.0055963671946562,0.00407700708016399,0.0260147664832163,0.00718640282070596
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,37282,0.0152556785534313,0.00567938224079859,0.00412408936146606,0.0263872677453965,0.007237345802954
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39727,-0.0112607055242017,0.00419823920682798,-0.0194892543695845,-0.00303215667881885,0.0073208574127552
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37782,0.0347829363498568,0.0130234501433408,0.00925697406890883,0.0603088986308047,0.00757642101357938
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39810,-0.00984358627994532,0.0036912836253858,-0.0170785021857015,-0.00260867037418915,0.00766777912358316
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,37282,-0.00882933342946304,0.00331512993586226,-0.0153269881037531,-0.00233167875517301,0.00774647459731578
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40065,-0.00495113284166143,0.00186008026133936,-0.00859689015388658,-0.00130537552943627,0.0077807206358662
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,37430,0.00430063942186812,0.00161715996765959,0.00113100588525534,0.00747027295848091,0.00783812331503902
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,39810,-0.0107694559135313,0.00405732053940154,-0.0187218041707583,-0.00281710765630423,0.00795486427366324
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37376,-0.0129189326268154,0.00487456990783541,-0.0224730896461728,-0.00336477560745796,0.008052512266516
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,40205,0.0101330932232254,0.00382547107662296,0.00263516991304443,0.0176310165334064,0.00808470831009532
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,37403,-0.0148980728896718,0.0056357198764945,-0.025944083847601,-0.00385206193174254,0.00821505509234552
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,37376,-0.00747341087118455,0.00282791178661758,-0.013016117972955,-0.0019307037694141,0.00823394357901756
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,40100,0.0156693848236558,0.00593728859443762,0.00403229917855802,0.0273064704687535,0.00831969847630585
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,39991,-0.00826825092505972,0.00313445248436833,-0.0144117777944216,-0.0021247240556978,0.00835138046627668
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37737,-0.0567208139006667,0.0215370467405752,-0.0989334255121941,-0.0145082022891392,0.00845730303252191
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37674,-0.00987629546900322,0.00375149519234642,-0.0172292260460022,-0.00252336489200424,0.00848253048565018
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,37737,0.00930711660357239,0.00354179241428052,0.00236520347158257,0.0162490297355622,0.008603819764883
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,37622,-0.0105460182963578,0.00401599542545272,-0.0184173693302451,-0.00267466726247049,0.00864938378073739
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,37441,0.00757514266109286,0.00288579339799948,0.00191898760101388,0.0132312977211718,0.00867561820417906
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,37403,0.00647827966462964,0.00246860120714501,0.00163982129862541,0.0113167380306339,0.00869364422750987
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,37362,0.00875152071891735,0.00334877322695323,0.00218792519408903,0.0153151162437457,0.00897630859606964
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,37282,-0.00847354733676726,0.0032435287976302,-0.0148308637801224,-0.00211623089341208,0.00900013893202269
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,40274,-0.0208592704574596,0.00798503265176218,-0.0365099344549134,-0.00520860646000569,0.00900212783571578
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,37430,-0.0219432347521407,0.00841000258016341,-0.038426839809261,-0.0054596296950204,0.00908628379242872
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37362,-0.0107365827038287,0.0041185894905976,-0.0188090181054,-0.00266414730225736,0.00914819806253997
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37515,-0.0101675953792707,0.00390745317754981,-0.0178262036072683,-0.00250898715127309,0.00927586174510045
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39727,-0.0096439319915152,0.00370682056818273,-0.0169093003051534,-0.00237856367787704,0.00928599719414513
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,39746,0.0198460842376165,0.00762865370141209,0.0048939229828488,0.0347982454923842,0.00929014430253943
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37775,-0.00570499492666233,0.00219896379207707,-0.0100149639591334,-0.00139502589419127,0.00948595281913965
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37697,-0.0143318779551735,0.00553949905306892,-0.0251892960991886,-0.00347445981115844,0.00968605821680482
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,37737,-0.0165769592665009,0.00641672485820455,-0.0291537399885818,-0.00400017854442,0.0097937992173563
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37343,0.0117486762721168,0.00454804213688984,0.00283451368381268,0.0206628388604209,0.00979868031441905
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,37470,-0.0197796038153535,0.00768108692588179,-0.0348345341900818,-0.00472467344062519,0.010031908336811
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37362,-0.010624362179325,0.00413496817264762,-0.0187288997977143,-0.00251982456093564,0.0101987804403612
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,37403,-0.0101019312518961,0.00393307143144749,-0.0178107512575332,-0.00239311124625903,0.0102262942729184
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37696,-0.0119582421224123,0.0046667962586646,-0.0211051627893949,-0.00281132145542966,0.010405830459408
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40126,-0.0147396394872499,0.00576357007799331,-0.0260362368401168,-0.00344304213438304,0.0105557180936713
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,40174,0.00674587644996357,0.00264265018186952,0.00156628209349931,0.0119254708064278,0.0106987096813773
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERVV_1,,37362,0.0111332671316676,0.00437222891046813,0.00256369846715009,0.0197028357961851,0.010896809764321
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37737,-0.00667714355664371,0.00262750759371637,-0.0118270584403278,-0.00152722867295962,0.0110570830768699
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,37470,0.0207022969495269,0.00815390680916261,0.00472063960356816,0.0366839542954856,0.0111303642930307
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37143,-0.0113163064219841,0.00446211244680774,-0.0200620468177273,-0.00257056602624093,0.0112217681799291
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39746,-0.0106889792096111,0.00422909931511829,-0.0189780138672429,-0.00239994455197925,0.0114983066945879
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,37697,0.0132965244641306,0.00527381112343671,0.00295985466219465,0.0236331942660666,0.0117059644737558
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,37362,0.0122240348829379,0.00484872959230658,0.00272052488201704,0.0217275448838588,0.0117114699261305
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,40121,-0.00579857897824886,0.00230244749366275,-0.0103113760658278,-0.00128578189066987,0.0117974281635576
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37791,0.00505837599133339,0.00201514950561031,0.00110868296033718,0.0090080690223296,0.0120789073049986
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,40065,0.00730336064491198,0.00291341957570433,0.00159305827653148,0.0130136630132925,0.012193035465181
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,37343,0.00766987834998756,0.00306528521892347,0.00166191932089757,0.0136778373790776,0.0123555959163299
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40126,0.00715630056640739,0.00286432449013969,0.00154222456573359,0.0127703765670812,0.0124848043323938
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,39815,0.00668652362996351,0.00267751523693124,0.00143859376557827,0.0119344534943487,0.0125251481710417
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,37791,0.0112770490943838,0.00452067150779517,0.00241653293910522,0.0201375652496623,0.0126236354104031
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,40248,0.0136463702104786,0.00547273535497625,0.00291980891472514,0.0243729315062321,0.0126585273817952
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39312,-0.00856967806352234,0.00344018283486057,-0.0153124364198491,-0.00182691970719563,0.0127473355381348
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37343,0.00929787247467275,0.00373664839789819,0.00197404161479231,0.0166217033345532,0.0128483569469375
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39991,-0.01080142813407,0.00435189445932121,-0.0193311412743396,-0.00227171499380042,0.0130749924603764
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37756,-0.0128310210778059,0.00517818587018869,-0.0229802653833757,-0.00268177677223608,0.0132281747775635
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37258,-0.0199791174048384,0.00807739118873262,-0.0358108041347544,-0.0041474306749225,0.0133939897269335
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40174,-0.00739556251917598,0.00299247143039757,-0.0132608065227552,-0.00153031851559675,0.0134694286254089
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,37343,0.0204038291771169,0.00829851246008978,0.00413874475534094,0.0366689135988929,0.0139558621777768
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37282,-0.0171362036741028,0.0070096876595584,-0.0308751914868373,-0.00339721586136834,0.0145128058931101
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,37403,0.00579037211790524,0.00237095408769314,0.00114330210602668,0.0104374421297838,0.014610857432655
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39727,-0.00606033822021048,0.00248721788925849,-0.0109352852831571,-0.00118539115726383,0.0148376903921682
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,37372,-0.00941249473670766,0.00386437412727902,-0.0169866680261745,-0.00183832144724078,0.0148760204598489
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40194,0.00741878340353622,0.00304625121935234,0.00144813101360563,0.0133894357934668,0.0148871261846931
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40261,-0.0111855475790872,0.00459395297064374,-0.0201896954015489,-0.0021813997566255,0.0149092967529863
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,40117,-0.0086939131906835,0.00357069222173031,-0.0156924699452749,-0.00169535643609208,0.0149112041127906
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37791,0.00649668577987067,0.00266928227806159,0.00126489251486996,0.0117284790448714,0.0149513993741444
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39810,-0.0137672162758063,0.00565763098435886,-0.0248561730051497,-0.00267825954646296,0.014969555436601
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,37697,-0.00874893583629329,0.00360287480091658,-0.0158105704460898,-0.00168730122649679,0.0151821437073011
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37756,-0.0168852681573912,0.00696801576800872,-0.0305425790626883,-0.00322795725209409,0.0153954448041768
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37376,0.0153529337308702,0.00634404996352928,0.00291859580235287,0.0277872716593876,0.0155319684454553
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37470,0.00841648506246999,0.00347804008288565,0.00159952650001411,0.0152334436249259,0.0155386762175703
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37362,0.0071697798963425,0.00296756654521471,0.00135334946772167,0.0129862103249633,0.0157038277382127
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37282,0.00660156651433625,0.00273371467003643,0.00124348576106485,0.0119596472676076,0.0157547051122467
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40065,-0.0123928795626069,0.00515190821933986,-0.022490619672513,-0.00229513945270079,0.016162213451935
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,40100,-0.0121899814760442,0.00507317900937574,-0.0221334123344206,-0.00224655061766771,0.0162803634790877
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37515,0.0159911728016007,0.00668232216217469,0.00289382136373827,0.029088524239463,0.0167227111784887
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37362,0.0152307780843612,0.00637281262124642,0.00274006534671824,0.0277214908220042,0.016864383565649
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,39746,-0.0131856697134806,0.00552209333212718,-0.0240089726444498,-0.00236236678251129,0.0169614997486464
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,37376,-0.00975076819375005,0.00408569619113162,-0.017758732728368,-0.00174280365913207,0.0170210282412964
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37706,-0.0123382977061678,0.00517428679305672,-0.022479899820559,-0.00219669559177661,0.0171144325077495
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_DRA,,40047,0.00775478036406001,0.00325275023924653,0.00137938989513682,0.0141301708329832,0.017134287765434
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37696,-0.00912899333941678,0.00383012828800014,-0.0166360447838971,-0.0016219418949365,0.0171643208584721
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37470,-0.00857161258888491,0.00359793925165118,-0.0156235735221212,-0.00151965165564859,0.017216004112658
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39596,0.0186374627669295,0.00783382322610775,0.00328316924375828,0.0339917562901006,0.0173672004485987
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37515,-0.0127128996158182,0.00534437497636026,-0.0231878745694844,-0.00223792466215215,0.017386024081464
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,37730,-0.00676852099922701,0.00284702881263171,-0.0123486974719852,-0.00118834452646885,0.0174493357557556
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37430,0.00806219159166022,0.0033947184353613,0.00140854345835208,0.0147158397249684,0.0175671053654998
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,37343,0.0170318855961677,0.00717327281781162,0.0029722708732569,0.0310915003190784,0.017594265220145
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39727,-0.00984166355742842,0.0041484098465881,-0.0179725468567411,-0.00171078025811575,0.0176855360370756
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37697,-0.00609739847326258,0.00257213106963989,-0.0111387753697568,-0.0010560215767684,0.0177752547185194
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37343,0.0123552580901141,0.00522507056758869,0.0021141197776403,0.0225963964025879,0.0180637604748194
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40065,-0.00795584386580178,0.00336620611333927,-0.0145536078479468,-0.0013580798836568,0.0181180814117818
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37376,0.0104890205010518,0.00444076632692708,0.00178511850027474,0.0191929225018289,0.0181921509601285
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,37808,0.00481307917555695,0.0020392537300325,0.00081614186469325,0.00881001648642065,0.0182785942549517
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,37343,0.00956638502445331,0.00405577548976831,0.00161706506450742,0.0175157049843992,0.0183535786873303
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,37343,0.00935105792492354,0.00397303706896477,0.00156390526975258,0.0171382105800945,0.0186060515275871
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37403,-0.00950485977688224,0.00403899167128269,-0.0174212834525963,-0.00158843610116816,0.0186237118889911
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39700,-0.0147891301458418,0.0062855271844817,-0.0271087634274259,-0.00246949686425763,0.0186409668968969
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37791,0.00548581026307135,0.00233504603219882,0.000909120039961658,0.010062500486181,0.0188213741980952
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39815,0.00816484285571158,0.00347571924813868,0.00135243312935978,0.0149772525820634,0.0188309995933094
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37515,-0.00951871754403497,0.00405580446543997,-0.0174680942962973,-0.00156934079177263,0.0189433069701486
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,40177,-0.0238611144873515,0.0101764637571714,-0.0438069834514074,-0.00391524552329549,0.0190529583719192
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,39810,0.0272199110093101,0.011611393903597,0.00446157895825992,0.0499782430603603,0.0190784967318896
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,39901,-0.0161799667200429,0.00690730514932846,-0.0297182848127267,-0.00264164862735915,0.0191705994526401
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39904,0.0062583876332486,0.00267308093317997,0.00101914900421585,0.0114976262622814,0.019231222858249
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37756,-0.0191619270859115,0.00819027482808199,-0.0352148657489522,-0.00310898842287077,0.0193193656792869
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,40126,0.0166390073099951,0.0071136613331201,0.00269623109707966,0.0305817835229104,0.0193468120691433
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,39727,0.00748771410612683,0.00321091647329788,0.00119431781846298,0.0137811103937907,0.0197159650000391
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,37784,0.00776163314457459,0.00332876083882294,0.00123726190048163,0.0142860043886676,0.0197319059482954
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40071,-0.0186618147747569,0.00800385862114826,-0.0343493776722075,-0.00297425187730629,0.0197342748370785
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39810,-0.012308662126555,0.00528998153346336,-0.0226770259321431,-0.00194029832096677,0.0199895233565721
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,37784,-0.0118058419944059,0.00507507961569198,-0.0217529980411621,-0.00185868594764958,0.0200207819805718
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,39815,-0.0238277508774573,0.0102595997195219,-0.0439365663277203,-0.00371893542719435,0.0202199152855103
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,37515,0.00724948026548607,0.00313033321559866,0.0011140271629127,0.0133849333680594,0.0205801536411722
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,37697,-0.0110198323888274,0.00476362103959426,-0.0203565296264322,-0.00168313515122267,0.0207196836368227
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40065,0.00499429384458571,0.0021612411257014,0.000758261238210957,0.00923032645096046,0.0208543663645705
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40065,-0.0114509119979452,0.00495749435971373,-0.0211676009429841,-0.00173422305290628,0.0209111857086848
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37362,-0.011608547796779,0.00502983051714596,-0.0214670156103851,-0.00175007998317296,0.0210181961082324
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40065,-0.00441200648693212,0.00191311843036623,-0.00816171861044993,-0.000662294363414315,0.0211132878173126
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,37343,0.0110427238299199,0.0047952385500841,0.00164405627175504,0.0204413913880847,0.0213030271457093
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,37808,-0.00412888801070485,0.00179313794457606,-0.00764343838207392,-0.000614337639335779,0.0213163877580085
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,40105,0.012419182146488,0.0054060638003952,0.00182329709771343,0.0230150671952626,0.0216165678781484
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39815,-0.00727785962381672,0.00316919352361253,-0.0134894789300973,-0.00106624031753616,0.0216641854644819
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,39675,-0.0236330616350195,0.0103120677478665,-0.0438447144208379,-0.00342140884920111,0.02193153045248
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37782,0.0129615254381757,0.00565578039989734,0.00187619585437688,0.0240468550219745,0.0219367064680131
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40121,-0.0604288042634519,0.0264192800604903,-0.112210593182013,-0.00864701534489078,0.0221916180259538
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37697,-0.00986351013846265,0.00432972736773872,-0.0183497757792305,-0.00137724449769475,0.022737050712555
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,37403,0.0091898647332694,0.00403811362117596,0.00127516203576452,0.0171045674307743,0.022875340660389
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,40148,0.0116143210755792,0.00511044358791197,0.00159785164327178,0.0216307905078867,0.0230598962821437
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37576,0.00166582291786357,0.000733273122309616,0.000228607598136722,0.00310303823759042,0.0231169282125422
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,39810,-0.0153273428350088,0.00675786252518243,-0.0285727533843664,-0.00208193228565129,0.023338426550318
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,37376,-0.0144103507491726,0.00635715692275558,-0.0268703783177735,-0.00195032318057164,0.0234194032455713
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,37282,0.00767193107848984,0.00338762809421893,0.00103218001382073,0.0143116821431589,0.0235482542808037
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39815,-0.0130081612037793,0.00575635780561164,-0.0242906225027781,-0.00172569990478048,0.0238482171877783
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,37343,0.0074108717529077,0.00328544766718586,0.000971394325223409,0.013850349180592,0.0241082656109744
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39995,-0.0118717118383181,0.00526470696404771,-0.0221905374878516,-0.00155288618878461,0.0241495966420152
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,37782,0.00455036537045082,0.00201803961436123,0.000595007726302804,0.00850572301459884,0.0241592532581578
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,40100,0.00709287386599822,0.00315269580664091,0.000913590084982026,0.0132721576470144,0.0244767143805274
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37697,-0.00829027380269954,0.00368609050252722,-0.0155150111876529,-0.00106553641774619,0.0245244348602586
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37343,0.00690247869713409,0.0030724247081013,0.000880526269255539,0.0129244311250126,0.024683095495221
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,37343,0.0152831194888171,0.00681355681469099,0.00192854813202276,0.0286376908456114,0.0249107843508122
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,39575,-0.00715735563907839,0.00319392633018024,-0.0134174512462317,-0.000897260031925117,0.0250452595453111
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37376,0.0159300670198737,0.00711563527844931,0.00198342187411303,0.0298767121656343,0.025189701114613
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37430,-0.00854512617482456,0.00381811773990158,-0.0160286369450317,-0.00106161540461747,0.025234896928575
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37430,-0.00736557276883367,0.00330301085065992,-0.0138394740361271,-0.00089167150154022,0.0257673216705134
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39691,-0.00948049635976691,0.00425249127442299,-0.017815379257636,-0.00114561346189785,0.0258019390452094
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37782,0.00517586670590108,0.00233329096963814,0.000602616405410324,0.00974911700639184,0.0265532921886012
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,37343,-0.0078308079020569,0.00353388916766192,-0.0147572306706743,-0.000904385133439533,0.0267145319206875
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,39991,0.00865774064292843,0.00390858267630336,0.00099691859737384,0.016318562688483,0.0267704723468932
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,40160,0.0165096726839928,0.00746959629353415,0.00186926394866592,0.0311500814193198,0.0271022010264785
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',37362,-0.00863871017950146,0.00390843088941499,-0.0162992347227548,-0.00097818563624809,0.0271035008950254
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,40035,-0.00686305982907271,0.00311076638218257,-0.0129601619381505,-0.000765957719994884,0.0273825759032519
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,40283,-0.00671390072442266,0.00304588492299368,-0.0126838351734903,-0.000743966275355054,0.0275208974741973
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40100,0.0090772365307546,0.00412006357123278,0.00100191193113835,0.0171525611303708,0.0275966705467559
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,40118,0.0365554251891487,0.0166362252340297,0.00394842373045048,0.0691624266478469,0.0280108360678174
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,40100,-0.0124672781025946,0.00567520014176884,-0.0235906703804615,-0.00134388582472762,0.0280493634618452
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37515,-0.0106047956365651,0.00483954805930967,-0.0200903098328121,-0.00111928144031819,0.0284492718485031
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39810,-0.010440949759231,0.0047666627877404,-0.0197836088232022,-0.00109829069525983,0.0285094360975445
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37430,-0.0128249518256542,0.0058623945918151,-0.0243152452256118,-0.0013346584256966,0.0287118338470397
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,37697,-0.015404095811713,0.00704345750502139,-0.0292092725215549,-0.00159891910187106,0.0287593898198394
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37756,0.010561450432667,0.00483224413232168,0.00109025193331647,0.0200326489320175,0.0288607770112816
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39727,0.00660274321069814,0.00302263731326855,0.000678374076691788,0.0125271123447045,0.0289457283665019
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37362,0.0096747641211905,0.00443348973648592,0.000985124237678089,0.0183644040047029,0.0291126923048447
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40248,0.00742160595006747,0.00341209984552461,0.000733890252839242,0.0141093216472957,0.02963855694573
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40083,0.00478016442446401,0.00219823500113832,0.000471623822232901,0.00908870502669512,0.0296790565898556
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,37362,0.00936599362456761,0.00430904259669483,0.000920270135045741,0.0178117171140895,0.0297557678192742
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39727,-0.0103236398413595,0.00474976634005853,-0.0196331818678742,-0.00101409781484474,0.0297576561569729
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,37282,0.00703401416700097,0.00324558220857401,0.000672673038195921,0.013395355295806,0.0302335191431109
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,37737,0.0105111067992827,0.00485076423819129,0.00100360889242775,0.0200186047061376,0.0302604175173536
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,40119,0.00764453625518991,0.00354794260606554,0.000690568747301445,0.0145985037630784,0.0312052718913743
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,37403,0.00810418885540349,0.00376759639928581,0.000719699912803302,0.0154886777980037,0.0314927769497966
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37756,-0.00599422185698173,0.00279181847487314,-0.0114661860677331,-0.000522257646230383,0.0318059503964861
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,40248,-0.00394150312875012,0.00183951414629396,-0.00754695085548628,-0.000336055402013971,0.0321534722598892
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40100,0.0116429542916036,0.00545823103371799,0.000944821465516336,0.0223410871176909,0.032932012246965
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40186,-0.00504556266095739,0.00237103374247002,-0.00969278879619863,-0.000398336525716147,0.0333524827926093
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37777,0.00357252122847025,0.00167940598061877,0.000280885506457466,0.00686415695048303,0.0334173901051351
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37737,-0.00878798421799524,0.00413500764369956,-0.0168925991996464,-0.000683369236344116,0.0335829645265546
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37737,0.00766964849117707,0.00360928213761245,0.000595455501456664,0.0147438414808975,0.0336067768036256
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37403,-0.00737681286887524,0.00348637324439959,-0.0142101044278984,-0.000543521309852041,0.0343724491640085
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37282,0.00579000803101553,0.0027401865782002,0.000419242337743125,0.0111607737242879,0.0346202210763911
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37515,-0.0114002421890258,0.00540174287147117,-0.0219876582171093,-0.000812826160942311,0.0348364368276386
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39746,-0.0100432780909994,0.00476024932830322,-0.0193733667744737,-0.000713189407525072,0.0348899034892266
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,40168,0.00765266027255509,0.00363707562805997,0.000523992041557548,0.0147813285035526,0.0353882195123746
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,37343,0.0095381516442712,0.0045376467517669,0.000644364010808082,0.0184319392777343,0.0355722748195851
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39940,0.00503947496615347,0.00239777571818599,0.000339834558508927,0.00973911537379801,0.0355931231522007
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,37343,0.0103895122540314,0.00494380764930698,0.000699649261389679,0.020079375246673,0.0356146735672242
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,37282,-0.0098224599422883,0.00467730492380696,-0.0189899775929499,-0.000654942291626652,0.0357460662955609
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37784,-0.00630922311498112,0.00300576539733895,-0.0122005232937655,-0.000417922936196768,0.035832093031242
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,40248,-0.00858230554882757,0.00409092285000571,-0.0166005143348388,-0.00056409676281639,0.0359307225283736
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37362,0.0048702945002266,0.00232357843873415,0.000316080760307663,0.00942450824014553,0.0360987815509159
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37697,-0.00998481146642341,0.00477641446575429,-0.0193465838193018,-0.000623039113545013,0.0365972418551576
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,40126,-0.0223069378295204,0.0106917949135176,-0.0432628558600149,-0.00135101979902599,0.0369621107445174
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,39946,0.0130546186585575,0.00626315226489478,0.000778840219363745,0.0253303970977513,0.0371444308208586
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40123,-0.0109402680165144,0.00525304664811476,-0.0212362394468193,-0.000644296586209459,0.0372991339248771
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,37282,0.011280410160099,0.00542024150462733,0.000656736811029405,0.0219040835091685,0.0374387029939782
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,37403,0.00317648493271256,0.00152632401151266,0.000184889870147757,0.00616807999527737,0.0374412330271745
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37696,-0.00957916660378863,0.00461199849321766,-0.0186186836504953,-0.000539649557082007,0.0378198737727812
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39810,0.00818529839573956,0.00394149410305738,0.000459969953747099,0.015910626837732,0.0378458999306077
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37705,-0.00770681540739328,0.00371120053661795,-0.0149807684591645,-0.000432862355622093,0.03785432122255
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,40065,0.0142073867071636,0.00686156631520459,0.000758716729362579,0.0276560566849646,0.0384149406181196
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37362,0.00922012409385131,0.00445449635247403,0.000489311243002213,0.0179509369447004,0.0384865545332722
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,37343,-0.0162395121440608,0.00788026751461031,-0.031684836472697,-0.00079418781542457,0.0393438733646818
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39991,-0.00474753661819094,0.00230386274801498,-0.0092631076043003,-0.000231965632081584,0.03934965683355
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,40126,-0.00449379848372569,0.00218423617917486,-0.00877490139490841,-0.000212695572542975,0.039666428049822
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,40223,0.0055423282652912,0.00270160768808513,0.000247177196644344,0.0108374793339381,0.0402354758118899
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37756,-0.00735032690276448,0.0035839383566313,-0.0143748460817618,-0.000325807723767137,0.0402954767463131
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,37697,-0.00758649782587468,0.00371252337884552,-0.0148630436484119,-0.000309952003337461,0.0410238750521458
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_E,,40100,-0.00530974736752424,0.00259910787675272,-0.0104039988059596,-0.000215495929088919,0.0410779187974526
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39991,-0.00895901672103371,0.00438568978782874,-0.017554968705178,-0.000363064736889379,0.041090667654162
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,37737,0.00676158102740751,0.00331956535125869,0.000255232938940479,0.0132679291158745,0.0416811044664328
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37784,0.0192627460809036,0.00947948247640435,0.00068296042715103,0.0378425317346561,0.0421687670693365
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37282,0.0106540562844145,0.00524485124131328,0.000374147851440484,0.0209339647173886,0.0422414700064039
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37403,0.00540810550542831,0.00266299202622633,0.000188641134024713,0.0106275698768319,0.0422918124888633
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37784,-0.00461117226644437,0.00227224720514693,-0.00906477678853235,-0.000157567744356397,0.042443043401859
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37737,0.00651958472314241,0.00321443676387147,0.000219288665954337,0.0128198807803305,0.0425577180607717
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40095,0.0217541125875611,0.0107378917866025,0.000707844685820181,0.0428003804893021,0.0427898951270042
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37343,0.0130437895323327,0.00643922315558822,0.000422912147379833,0.0256646669172857,0.0428184018451758
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,39978,-0.00821314833379138,0.00406390113650447,-0.0161783945613401,-0.000247902106242622,0.0432967882148424
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37362,-0.0154255314060713,0.00764952021978518,-0.0304185910368502,-0.000432471775292317,0.0437646446848578
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37737,-0.00400702556366441,0.00198785341505993,-0.00790321825718187,-0.000110832870146937,0.0438456902810559
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37697,-0.00733800581509643,0.00364066341431393,-0.0144737061071517,-0.000202305523041135,0.0438652939154674
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,37515,-0.00806243765194779,0.00400565390219291,-0.0159135193002459,-0.000211356003649688,0.0441598987691293
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37515,0.0117512661972014,0.005841549877929,0.000301828436460542,0.0232007039579422,0.0442753115166199
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,40258,0.00541838204607727,0.00269508523192226,0.000136014991509629,0.0107007491006449,0.0443986558421638
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37282,0.00478298305491112,0.00238201280665411,0.000114237953869061,0.00945172815595317,0.0446686170688367
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,37515,0.00720333037015878,0.003589264312149,0.000168372318346735,0.0142382884219708,0.0447798149032803
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37362,0.00901396724415406,0.00449312877107891,0.000207434852839392,0.0178204996354687,0.0448592403743194
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37376,0.00941808725334906,0.00470045193598268,0.000205201458823003,0.0186309730478751,0.0451277912381881
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,40100,0.0072726749279449,0.00363229761110833,0.000153371610172574,0.0143919782457172,0.0452778272402964
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,39941,0.00608809645554698,0.00304362226629651,0.000122596813605821,0.0120535960974881,0.0454874736770982
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,37154,0.00700718919412864,0.00350480818079764,0.000137765159765264,0.013876613228492,0.045596359924109
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37376,0.0143438754738694,0.00718068389132888,0.000269735046864849,0.0284180159008741,0.045784876087347
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39892,0.0314200605124323,0.0157803126624906,0.000490647693950741,0.0623494733309139,0.0464883234923155
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37282,0.0114660946849846,0.0057728478555602,0.000151312888086603,0.0227808764818826,0.0470311277968389
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,37782,0.00458489794528231,0.002309481170411,5.83148512767456e-05,0.00911148103928787,0.0471371013696853
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,39815,0.0260900049241664,0.0131492479658914,0.000317478911019256,0.0518625309373135,0.0472575249019276
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39727,-0.00987385707352441,0.00499277665968853,-0.0196596993265139,-8.80148205348943e-05,0.0479885851531087
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,37362,0.010053603565869,0.00509907162982974,5.9423171402704e-05,0.0200477839603353,0.0486704672486311
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40095,-0.00646562219412304,0.00327960590728702,-0.0128936497724056,-3.75946158404942e-05,0.04868851911735
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39792,-0.00753530016707699,0.00382271471341499,-0.0150278210053704,-4.27793287836199e-05,0.0487199990067896
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39946,0.00726611030021007,0.00368646332492276,4.06421833614567e-05,0.0144915784170587,0.0487388191941633
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37756,-0.00665038477708382,0.00337989056660913,-0.0132749702876377,-2.57992665299274e-05,0.0491310013951066
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,40126,0.00617536214842832,0.00314558184298331,1.00217361810248e-05,0.0123407025606756,0.0496422239964815
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,37443,-0.0249610627080757,0.0127629377877434,-0.0499764207720528,5.42953559014916e-05,0.0505165029709151
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37376,0.00797650173703138,0.00408206470822447,-2.43450910885849e-05,0.0159773485651513,0.0507184874029283
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40126,0.00777449316001172,0.00398017526071542,-2.66503509905062e-05,0.0155756366710139,0.0508013237676125
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37697,0.0100373188139501,0.00515012590750948,-5.69279647684769e-05,0.0201315655926687,0.051322921085418
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39746,-0.00714113762040065,0.00366520048807195,-0.0143249305770217,4.26553362203735e-05,0.0513899193285012
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37343,0.0102451205735349,0.0052654379158159,-7.51377414642488e-05,0.0205653788885341,0.0517088846148836
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,39810,0.00898157962160412,0.00462153014072038,-7.66194542078172e-05,0.0180397786974161,0.0519835329096657
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37737,0.00465384061983521,0.00239992084340334,-5.00042332353279e-05,0.00935768547290575,0.052502491624298
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40261,-0.00664523181149259,0.00342697225468093,-0.0133620974306672,7.16338076820235e-05,0.0525072918153559
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,37362,0.00741053996694835,0.00382834610281205,-9.30183945632669e-05,0.01491409832846,0.0529259272121907
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,40274,-0.010594689139773,0.00548922646194874,-0.0213535730051925,0.000164194725646574,0.0536138099153389
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37403,0.010208115839254,0.00529615423857994,-0.000172346468362694,0.0205885781468707,0.0539443987183712
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,37362,0.00633066469458304,0.00329993629067808,-0.000137210435146006,0.0127985398243121,0.0550797716769682
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,37362,0.0069815262488539,0.00364449421483552,-0.000161682412223716,0.0141247349099315,0.0554334415591107
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,37782,0.00820144230105294,0.004284260412341,-0.000195708107135421,0.0165985927092413,0.0556007585449024
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37782,-0.0044471930251974,0.00232832731243304,-0.00901071455756616,0.000116328507171362,0.0561497929422708
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,39622,0.011426938646235,0.00599663767315098,-0.000326471193140941,0.0231803484856109,0.0567265093672576
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,39810,0.0184962848841186,0.00971888449552284,-0.000552728727106183,0.0375452984953433,0.0570424749952554
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37808,-0.00555679373520004,0.00293045402450041,-0.0113004836232208,0.000186896152820764,0.057952150164501
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,39727,0.00899191528639898,0.00474375704784803,-0.000305848527383164,0.0182896791001811,0.0580415966289387
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37403,-0.00671211710054355,0.00354179569167297,-0.0136540366562226,0.000229802455135465,0.0580991558332855
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,37403,0.00575795302081282,0.00304140673253636,-0.000203204174958451,0.0117191102165841,0.0583552187620532
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,37362,0.00938346258137383,0.00495685139947465,-0.000331966161596494,0.0190988913243441,0.0583763803162922
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40126,-0.00832435003409036,0.00440590239813985,-0.0169599187344445,0.000311218666263744,0.0588616128655768
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37362,-0.00836229996735859,0.00442976533641856,-0.017044640026739,0.000320040092021795,0.0590816107104039
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,40233,-0.00603445611639821,0.00319779679285817,-0.0123021378304002,0.00023322559760381,0.0591696806585112
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,40297,-0.0083731625638452,0.00443762760514094,-0.0170709126699214,0.000324587542231046,0.0591980136592177
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37697,-0.00934151050093161,0.00495403455614229,-0.0190514182309705,0.000368397229107269,0.0593657624701209
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,40213,-0.00471812430138078,0.0025055343138071,-0.00962897155644269,0.000192722953681126,0.0597077778305444
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37376,-0.0176983886422984,0.00940105183769291,-0.0361244502441765,0.00072767295957972,0.0597774952762381
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37343,0.00973351298361509,0.00517314396313169,-0.000405849184123024,0.0198728751513532,0.0599200753502244
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37697,-0.00769847046143934,0.00409409035984449,-0.0157228875667345,0.000325946643855862,0.0600774063885241
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,37403,0.00589092394508589,0.00314137167278669,-0.000266164533576018,0.0120480124237478,0.0607779001299397
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,40248,0.00531278559650369,0.00283656960229027,-0.000246890823985248,0.0108724620169926,0.0610921590070884
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,37362,0.00786327552053878,0.00420252093095746,-0.000373665504137847,0.0161002165452154,0.0613558475409776
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39746,-0.00773941501409756,0.00414229799993651,-0.0158583190939731,0.000379489065778004,0.0617272761793854
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,37430,-0.00497522724309069,0.00266839053085711,-0.0102052726835706,0.00025481819738924,0.0622733899831982
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37362,0.0120410313412084,0.00647326308872281,-0.000646564312688299,0.0247286269951051,0.0628915983333238
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,37756,-0.00615085726856744,0.00330904629743514,-0.0126365880115403,0.000334873474405431,0.0630774723267003
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,40095,-0.00561135623808014,0.00302133455268834,-0.0115331719613493,0.000310459485189005,0.0632951922289977
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37784,-0.00460075834257793,0.00247811263413905,-0.00945785910549047,0.000256342420334619,0.0633961934575311
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,39936,-0.0118027508935309,0.00635754742270856,-0.0242635438420397,0.000658042054977831,0.0634021075768672
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40075,0.00676782404120785,0.00364834751509239,-0.000382937088373238,0.0139185851707889,0.0636095952657741
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,37403,-0.0067045780606532,0.00363703893078811,-0.0138331743649979,0.000424018243691495,0.0652910368980863
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,37403,0.0172361655928955,0.00935832249736072,-0.00110614650193146,0.0355784776877226,0.0655271477598179
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37696,-0.0131466973327429,0.00713996843582971,-0.0271410354669692,0.000847640801483298,0.0656025540055571
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,37343,-0.00756702838670033,0.00411301671823683,-0.0156285411544445,0.00049448438104386,0.0658241463855258
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFP,Properdin,37808,-0.00362025840069863,0.00197079630393863,-0.00748301915641833,0.000242502355021075,0.0662391743008199
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37376,0.0109510327682287,0.00596962555042686,-0.000749433310607932,0.0226514988470654,0.0666088769581305
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40121,0.0043875918429442,0.00239861752178046,-0.000313698499745503,0.0090888821856339,0.0673861073390231
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39727,0.00582098157828733,0.00318542340047004,-0.000422448286633956,0.0120644114432086,0.0676620330931158
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,37791,-0.0149248968969843,0.00816797046347615,-0.0309341190053975,0.00108432521142898,0.0676850197002597
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,37697,-0.00828086233607396,0.00453768618379878,-0.0171747272563196,0.000613002584171657,0.0680373427044764
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,37376,0.00577094871768927,0.0031708786734974,-0.000443973482365624,0.0119858709177442,0.0687845494961296
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,39727,0.00617587039971809,0.00340323610448709,-0.000494472365076611,0.0128462131645128,0.0695888248365161
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39746,0.00886490940557214,0.00489572904550853,-0.000730719523624574,0.0184605383347688,0.0702001840504725
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,37362,-0.0060965670996121,0.00336734894056414,-0.0126965710231178,0.000503436823893602,0.0702423578326676
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,37343,0.0155496188288138,0.00861979098904176,-0.00134517150970803,0.0324444091673357,0.0712634462429301
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39531,-0.00501911358767851,0.00278239028714307,-0.0104725985504789,0.000434371375121903,0.0712692021992646
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,37696,-0.00910214762452468,0.00505058198448348,-0.0190012883141123,0.000796993065062947,0.0715370226205373
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,37784,-0.00493217394408704,0.00273799989766811,-0.0102986537435165,0.000434305855342459,0.0716658399083819
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37782,0.00772030513787873,0.00428838112942326,-0.000684921875790866,0.0161255321515483,0.0718383604629042
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37515,-0.00870660957291487,0.00484108520491027,-0.018195136574539,0.000781917428709259,0.0721235730808182
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,40233,0.00420180758009478,0.00234013870042839,-0.000384864272744864,0.00878847943293443,0.0725871744201697
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39746,-0.00761945214816706,0.00429071244983993,-0.0160292485498533,0.000790344253519194,0.0757855755572725
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37282,0.00796719256601166,0.00448694009667271,-0.000827210023466852,0.0167615951554902,0.075815888180792
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37282,0.00756591428735113,0.00426132910649127,-0.000786290761371763,0.015918119336074,0.0758419897536894
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40100,-0.00752353749485819,0.00423913744385198,-0.0158322468848081,0.000785171895091687,0.0759536119530044
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37376,0.00580480765686434,0.00327615430381762,-0.000616454778618188,0.0122260700923469,0.076445366814985
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40074,-0.013946380094928,0.00788025893596318,-0.0293916876094158,0.00149892741955983,0.0767821276719522
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,37470,0.00610917845758673,0.00345652021773974,-0.000665601169183164,0.0128839580843566,0.0771786526355043
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37697,-0.00968268937566373,0.00547893958759316,-0.0204214109673463,0.00105603221601887,0.0772083726876393
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37362,0.00653433541146875,0.00369808764843186,-0.000713916379457685,0.0137825872023952,0.0772602509565384
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39991,0.00966029555705082,0.0054771464254568,-0.00107491143684451,0.0203955025509462,0.0777943866491364
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37403,0.0068102678562279,0.00386123193117198,-0.000757746728869173,0.014378282441325,0.0777967791005197
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37697,-0.00598539849352001,0.00339412939880068,-0.0126378921151693,0.000667095128129318,0.0778466335154835
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,37756,0.00339448917130351,0.00192589935730264,-0.000380273569009662,0.00716925191161669,0.0779997899602224
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37403,-0.00481751557099217,0.00275072507655586,-0.0102089367210417,0.000573905579057322,0.0799072322615326
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37791,0.00847173487333715,0.00484713266127546,-0.00102864514276274,0.017972114889437,0.080524660676586
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,39954,0.00737988917432242,0.00423131420356233,-0.000913486664659741,0.0156732650133046,0.0811592464427182
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,37282,0.00722044162565376,0.00414464930416574,-0.000903071010511084,0.0153439542618186,0.0815128811539227
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,37455,0.00582774515069957,0.00335255956874233,-0.000743271604035403,0.0123987619054345,0.0821821180509613
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39746,-0.00533441330199271,0.00306947776768843,-0.011350589726662,0.000681763122676608,0.0822504070526287
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,37376,-0.0103097159455129,0.00593252927716325,-0.0219374733287529,0.00131804143772703,0.0822649309686652
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,40100,-0.0155937846301375,0.0089759891099727,-0.033186723285684,0.00199915402540898,0.0823578630642975
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40251,0.00707540152242894,0.00408050069589717,-0.000922379841529506,0.0150731828863874,0.0829457080087815
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,37403,0.00880364096442576,0.00508379293987808,-0.00116059319773527,0.0187678751265868,0.0833495157491293
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,37282,0.00726671851661759,0.00420422225382796,-0.000973557100885205,0.0155069941341204,0.0839345959183515
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37362,-0.00560621771451315,0.00324471895284872,-0.0119658668620966,0.000753431433070337,0.0840484269802202
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,39727,-0.00819687197153827,0.00475489066351111,-0.01751645767202,0.00112271372894351,0.0847493226142111
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,39727,0.00512629889063606,0.00297675513073261,-0.000708141165599842,0.010960738946872,0.0850698916441232
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,40100,0.0106548836772781,0.00619581074074162,-0.00148890537457543,0.0227986727291317,0.0855082898936237
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37343,0.00467860801564978,0.002721242261974,-0.000655026817819261,0.0100122428491188,0.0855853578152835
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40186,-0.00399728390052191,0.00232875509960634,-0.00856164389575034,0.000567076094706522,0.0860921533350953
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37403,0.00784458789135524,0.00457387778074971,-0.00112021255891418,0.0168093883416247,0.0863536166113658
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,40233,0.00433131004049467,0.00252588753050995,-0.000619429519304839,0.00928204960029418,0.0864074812925656
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37343,-0.00723555050143082,0.00422391283120445,-0.0155144196505916,0.00104331864772991,0.086737115605843
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39746,0.00582653764159878,0.00340142976447639,-0.000840264696774939,0.0124933399799725,0.0867388405255
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37403,-0.00953741547250556,0.00558715730001117,-0.0204882437805275,0.00141341283551633,0.0878414333804094
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,40065,-0.0288709863817056,0.0169350856466308,-0.062063754249102,0.00432178148569085,0.0882510490313382
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,37515,0.00664194273461638,0.00389833397706815,-0.0009987918604372,0.01428267732967,0.0884440969502347
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,37282,0.00399184653933503,0.0023435687213754,-0.000601548154560747,0.00858524123323081,0.0885324929906473
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37343,0.00758962557063885,0.00447804673858431,-0.00118734603698641,0.0163665971782641,0.0901276905017299
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,37403,0.0090091774925497,0.00531677141840719,-0.0014116944875284,0.0194300494726278,0.0901976278752707
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,40186,-0.00500728814917991,0.00295777344850759,-0.0108045241082548,0.000789947809894953,0.0904895708439571
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,40202,0.00743799300429505,0.00439780212882588,-0.00118169916820367,0.0160576851767938,0.0907997266319513
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,37282,0.00703693029572338,0.00416122235004259,-0.0011190655103601,0.0151929261018069,0.0908471704977877
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39815,-0.00580783754987749,0.00343942092146511,-0.0125491025559491,0.000933427456194132,0.0913146554098831
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37362,0.0091730058435472,0.00543691671714445,-0.00148335092205593,0.0198293626091503,0.0915947178586242
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40284,0.00839869454659558,0.00497849478035783,-0.00135915522290576,0.0181565443160969,0.0916240620423271
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37756,-0.0110332750239771,0.00654059505155078,-0.0238528413250166,0.00178629127706246,0.091647636565012
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37362,-0.00628981946482974,0.00373367505580252,-0.0136078225742027,0.0010281836445432,0.0920862990541897
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39841,-0.00518136299025598,0.00308123822942667,-0.0112205899199323,0.000857863939420298,0.0926696947063163
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,37282,0.00643095357350754,0.00383119410965431,-0.0010781868814149,0.01394009402843,0.0932589026105671
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37739,0.00335290881745787,0.00199962949878118,-0.00056636500015324,0.00727218263506898,0.0936119621193777
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37470,-0.00809034654073426,0.00483564675947346,-0.0175682141893022,0.00138752110783373,0.0943387236723711
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37515,-0.0107363510152748,0.00642712871996931,-0.0233335233064146,0.00186082127586508,0.0948495883640363
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40202,0.00342202688009815,0.00205077963902777,-0.000597501212396283,0.00744155497259259,0.0952072746862392
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37376,0.00626394996638487,0.00375650429801666,-0.00109879845772779,0.0136266983904975,0.0954403601986401
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,37430,0.00936268748901271,0.00569123863894739,-0.00179214024332417,0.0205175152213496,0.0999722921950424
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BSND,Barttin,37282,0.00507641664172349,0.00308646007611055,-0.000973045107453195,0.0111258783909002,0.100048453402422
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37403,-0.00523022809266786,0.00318072190106524,-0.0114644430187557,0.00100398683342001,0.100127676116195
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37376,0.00754842660970037,0.00459280257947822,-0.00145346644607694,0.0165503196654777,0.100296847452483
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37376,-0.00801193936690743,0.00488910826401728,-0.0175945915643813,0.00157071283056644,0.101293376396544
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37784,0.00502402069427496,0.00307039178612642,-0.000993947206532824,0.0110419885950827,0.101804602542674
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,37282,0.00626523551785806,0.00383585314098086,-0.00125303663846443,0.0137835076741805,0.102422969244922
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,40065,-0.00415791025320759,0.00254615021151382,-0.00914836466777467,0.000832544161359495,0.102485282332252
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,40248,-0.00568233762815225,0.00348391170879578,-0.012510804577392,0.00114612932108749,0.102905553739619
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39746,-0.00756173024561087,0.00464754245838752,-0.0166709134640504,0.00154745297282867,0.103749533729371
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,39727,-0.0120634101779954,0.00744738851971473,-0.0266602916766362,0.00253347132064552,0.105292131160684
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,39375,-0.00409089152229225,0.00252555413273969,-0.00904097762246205,0.000859194577877554,0.105296466670585
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37343,0.0115332233442653,0.00712040329035348,-0.00242276710482755,0.0254892137933581,0.105311957257656
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,37696,-0.016563297512915,0.0102294373091674,-0.0366129946388831,0.00348639961305301,0.105432408886599
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37696,-0.0148569193885362,0.00919195739393174,-0.0328731558806424,0.00315931710357001,0.106054256461934
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,37282,0.00465498574784298,0.00288026150016539,-0.000990326792481176,0.0103002982881671,0.106082635832149
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40213,-0.00964763128135848,0.00597153895686893,-0.0213518476368216,0.00205658507410462,0.106200370392666
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40143,-0.00482376849783058,0.0029880003631755,-0.0106802492096546,0.00103271221399339,0.106465100060599
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40065,0.0031879949882564,0.00198627971931964,-0.000705113261610091,0.00708110323812288,0.10851225266655
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,37808,-0.00212855020406573,0.00132996415309177,-0.00473527994412561,0.000478179535994144,0.109520929322362
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39991,-0.0150930529831991,0.0094308040437249,-0.0335774289088999,0.00339132294250169,0.109530340529859
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,37343,0.0131973025859752,0.0082467163467758,-0.00296626145370541,0.0293608666256557,0.109554335738139
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,39815,0.00678959818585106,0.00425351719017563,-0.00154729550689317,0.0151264918785953,0.110457682047671
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37343,0.00920813154624252,0.00576996932964021,-0.0021010083398523,0.0205172714323373,0.110541923527955
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37430,-0.00893493914980121,0.00559961431762915,-0.0199101832123543,0.00204030491275191,0.110594714887
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,37756,-0.0118512154206445,0.00744727325427593,-0.0264478709990253,0.00274544015773635,0.111554675753791
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37791,0.0197186068118323,0.0124541252745294,-0.0046914787262454,0.04412869234991,0.113376988090285
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37697,0.00551638546183614,0.00348553324137825,-0.00131525969126523,0.0123480306149375,0.113524725813978
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40099,-0.00640825738339362,0.00405165440645937,-0.014349500020054,0.00153298525326676,0.113752061712303
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,37343,0.00518839412571261,0.0032990304609258,-0.00127770557770196,0.0116544938291272,0.115812214842347
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,40178,0.0047483031562524,0.00301974938996928,-0.00117040564808739,0.0106670119605922,0.115874154368064
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,39998,0.00978287300193325,0.00624341422537968,-0.00245421887981092,0.0220199648836774,0.117155902751774
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39815,0.00773960432481128,0.00494466237463726,-0.00195193392947775,0.0174311425791003,0.117546247178023
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,37756,-0.00424678789034076,0.00271885680526822,-0.00957574722866647,0.00108217144798496,0.118317530898518
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37430,-0.00331659309937158,0.00212497816757631,-0.00748155030782115,0.000848364109077988,0.118603419295659
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40297,0.00413693174550773,0.00265099486076445,-0.00105901818159058,0.00933288167260605,0.118656907782419
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37430,0.0036798561492319,0.00236254485305974,-0.000950731762765197,0.008310444061229,0.119356871393039
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37697,0.00575268391786003,0.00371090249429893,-0.00152068497096587,0.0130260528066859,0.121114640087052
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37756,0.00597470714870775,0.00385461627604876,-0.00158034075234781,0.0135297550497633,0.121162069295746
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,37376,0.00833714589644175,0.00538074258162553,-0.00220910956354429,0.0188834013564278,0.121300107841848
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39746,-0.0061783753618661,0.00398991729462349,-0.0139986132593281,0.00164186253559595,0.12152335035021
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,39815,0.00714052427226412,0.00462507759200016,-0.00192462780805618,0.0162056763525844,0.122640125816288
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37737,-0.00788744612046858,0.00510972721959569,-0.0179025114708761,0.00212761922993897,0.122705706582315
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,37282,0.00585619987901758,0.00379420309443886,-0.00158043818608259,0.0132928379441177,0.122743921623222
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,40010,0.00708635954028871,0.00459404876375392,-0.00191797603666897,0.0160906951172464,0.122970397875057
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,39691,-0.00472150664208071,0.00306287906521055,-0.0107247496098934,0.00128173632573197,0.123209668783156
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,39727,-0.00611047172918292,0.00399280986421662,-0.0139363790630475,0.00171543560468166,0.125946169598612
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C5,Complement C5,37808,-0.00211118594534633,0.00138202854291534,-0.00481996188946039,0.000597589998767739,0.12663571621738
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37343,0.0090188637216007,0.00590644229170584,-0.00255776317014275,0.0205954906133442,0.126797066764636
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37791,0.0055114520192086,0.00363253738513664,-0.0016083212556592,0.0126312252940764,0.12922833956666
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,37362,-0.00854110164886208,0.00565292968859666,-0.0196208438385115,0.00253864054078737,0.130834340735853
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,37362,0.00641680530297966,0.00425238902972908,-0.00191787719528933,0.0147514878012486,0.131326243705954
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39746,0.0041169795543074,0.00272867107860888,-0.00123121575976601,0.0094651748683808,0.131374245707672
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,37362,0.00561052285029569,0.00372406817111784,-0.00168865076509528,0.0129096964656867,0.131948583916317
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39746,0.00651218015008653,0.00432996934991104,-0.00197455977573911,0.0149989200759122,0.132607590700508
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39746,0.0067553857472365,0.00449430289408286,-0.00205344792516591,0.0155642194196389,0.132833959684531
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,37470,-0.00573359170951502,0.00382635861935136,-0.0132332546034437,0.00176607118441364,0.134041663706794
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,37282,0.00650334538489965,0.00434482687566625,-0.00201251529140619,0.0150192060612055,0.134469394733399
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37282,0.0129219002883869,0.00865361332408289,-0.0040391818268156,0.0298829824035893,0.135399608319762
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37403,0.00553084379945255,0.0037086475401467,-0.00173810537923498,0.0127997929781401,0.135897359371093
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,37362,0.00704156377459262,0.00473352436663338,-0.0022361439840088,0.016319271533194,0.136882345780077
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39727,-0.00406575586163263,0.00273462535098058,-0.00942562154955456,0.00129410982628931,0.137096504071946
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,37756,0.00588941539346484,0.0039622527095,-0.00187659991715516,0.0136554307040848,0.137202185958972
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,37791,0.00583143779928535,0.00394188406828967,-0.00189465497456241,0.0135575305731331,0.139069624443478
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,40174,0.00407050914043774,0.00275846111961151,-0.00133607465400083,0.00947709293487631,0.140059265258135
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39746,0.00441388427440615,0.00299473970253177,-0.00145580554255612,0.0102835740913684,0.140534725975781
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40143,0.00353932866006396,0.00240252594308896,-0.00116962218839039,0.00824827950851831,0.140725315364565
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37362,0.00588446395688302,0.00399990119487603,-0.001955342385074,0.01372427029884,0.141274299146417
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39815,-0.0039390265564582,0.00268285680917588,-0.00919742590244293,0.00131937278952654,0.142064690078176
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37362,-0.00508668640104961,0.00346503485407409,-0.0118781547150348,0.0017047819129356,0.142127390867451
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,40186,-0.00893951024657139,0.00610879109050233,-0.020912740783956,0.00303372029081317,0.143382171318607
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37362,-0.00494849188715071,0.00338851001107419,-0.0115899715088561,0.00169298773455471,0.144211651363818
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,39991,0.00466011302957694,0.00319159093899409,-0.00159540521085147,0.0109156312700054,0.144276687689281
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39942,0.00571393186180904,0.00391875259791261,-0.00196682323009967,0.0133946869537177,0.144833346911985
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ELN,Elastin,37784,-0.00461029565397513,0.00316674997554861,-0.0108171256060504,0.00159653429810015,0.1454591475653
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37282,0.0117333142714942,0.00807717371069171,-0.00409794620146152,0.02756457474445,0.14634514023305
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39815,0.00545484738966934,0.00378038280748249,-0.00195470291299633,0.012864397692335,0.149059116492556
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37362,0.00415829095446273,0.00288878005040601,-0.00150371794433306,0.00982029985325852,0.150043733771564
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40065,0.00501531021671013,0.00348537067935564,-0.00181601631482692,0.0118466367482472,0.150181802960497
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,37282,0.00680831188761822,0.00473955899563437,-0.00248122374382514,0.0160978475190616,0.150888375336671
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40248,0.00459106004173605,0.00319716190743589,-0.00167537729683829,0.0108574973803104,0.151027880628644
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAT,Catalase,37587,-0.00702746232757765,0.00490833781102414,-0.016647804437185,0.00259287978202966,0.152242110966986
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FST,Follistatin,40160,0.00670039452297476,0.00468118024496767,-0.00247471875716187,0.0158755078031114,0.152350609964894
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37737,-0.00484808964413912,0.00338812466486984,-0.011488813987284,0.00179263469900576,0.152480531762956
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40097,-0.00406837871384793,0.00284673823422227,-0.00964798565292358,0.00151122822522771,0.152984849297544
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37737,-0.00365650082247557,0.0025590836306301,-0.00867230473851057,0.00135930309355944,0.153076009640659
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37282,-0.00377508005394653,0.00264427293340096,-0.00895785500341241,0.00140769489551936,0.153418727148633
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37430,0.00549754138963715,0.00385860865603104,-0.00206533157618368,0.013060414355458,0.15425437254405
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37362,0.00466065052074629,0.00327523832978676,-0.00175881660563575,0.0110801176471283,0.154761524369662
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37403,-0.0101188652508114,0.007123050871038,-0.0240800449580459,0.00384231445642304,0.155462902977083
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,37343,-0.0082968851233371,0.00585072167315482,-0.0197642996027206,0.00317052935604636,0.156186905236468
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37403,0.00620495804604948,0.00437577327424101,-0.0023715575714629,0.0147814736635619,0.156207382631677
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37675,-0.0111657343194306,0.00788894969004759,-0.0266280757119239,0.00429660707306269,0.156985389395816
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,39991,0.00673038468518504,0.00475780208978552,-0.00259490741079457,0.0160556767811646,0.157205978394413
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39810,0.00717722749296757,0.0050758217580811,-0.00277138315287139,0.0171258381388065,0.157381274555187
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,37362,0.00442542705927134,0.00313067439797334,-0.0017106947607564,0.0105615488792991,0.157512339031784
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,37376,0.00844873235781798,0.00600006429715204,-0.00331139366460001,0.020208858380236,0.159123450910822
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,37403,-0.00533615112761188,0.00379610496055099,-0.0127765168502918,0.00210421459506806,0.159839846547883
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37403,-0.00413035362307512,0.00293935561100894,-0.00989149062065263,0.0016307833745024,0.159988721098759
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39727,-0.0087856311211038,0.00626342923286103,-0.0210619524175114,0.00349069017530383,0.16073050215752
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,40233,0.00369658711656907,0.00263980893325525,-0.00147743839261122,0.00887061262574937,0.16143605523361
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37282,-0.00638686939472695,0.00456735788792728,-0.0153388908550644,0.00256515206561051,0.162025293056422
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40100,0.00422210522846657,0.00303280132079656,-0.00172218536029469,0.0101663958172278,0.163897675485229
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37282,-0.00839459877447481,0.00604050151918842,-0.0202339817520841,0.00344478420313449,0.164638384209954
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37697,0.00559930743909066,0.004034409331551,-0.00230813485074929,0.0135067497289306,0.165194563055904
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,40237,0.00271152023884319,0.001954282032999,-0.00111887254583484,0.00654191302352122,0.165316123374304
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37362,0.00679901657865343,0.00490689024399188,-0.00281848829957065,0.0164165214568775,0.165891180194405
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,37376,-0.00965598300982199,0.00697505083398513,-0.0233270826444328,0.00401511662478886,0.166272080212175
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,37258,0.00508480256007677,0.00368205826330771,-0.00213203163600634,0.0123016367561599,0.167313071373244
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37515,-0.0114657994288314,0.00831441958175631,-0.0277620618090738,0.00483046295141098,0.167910398156926
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,37362,0.00396220463369798,0.00287328783168121,-0.00166943951639719,0.00959384878379315,0.167925005686104
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40194,-0.00912648802966896,0.00662503167727198,-0.022111550117122,0.00385857405778412,0.168353660906699
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37696,0.00267161888198327,0.00194191610189696,-0.00113453667773478,0.00647777444170132,0.168917876834738
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37737,-0.00672568985456483,0.00491097619697434,-0.0163512032006345,0.00289982349150488,0.170859317060873
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37362,0.00647706855401087,0.00473369155465073,-0.00280096689310457,0.0157551040011263,0.171244752408917
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,37697,-0.00611784137692616,0.00447569578231815,-0.0148902051102697,0.00265452235641741,0.171678954088757
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,39638,0.00861268117741754,0.00632228177920901,-0.00377899110983212,0.0210043534646672,0.173131579574279
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39815,-0.00754485940983088,0.00555554031203089,-0.0184337184214114,0.00334399960174968,0.1744587457115
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,37362,-0.00470378694369029,0.00346561684221134,-0.0114963959544245,0.00208882206704394,0.174718322074747
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,37756,0.00313026025577528,0.00230796305023611,-0.0013933473226875,0.00765386783423806,0.175030890180621
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,37343,0.00564243157165663,0.00416331920735223,-0.00251767407475374,0.013802537218067,0.175354534134877
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,40095,0.00236970113214109,0.00175142123506773,-0.00106308448859165,0.00580248675287384,0.176070039761427
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37343,0.00665748190411335,0.0049213287641612,-0.00298832247364261,0.0163032862818693,0.176149209468868
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37376,0.00516812273868284,0.00384024128570925,-0.00235875018130729,0.012694995658673,0.17839684769371
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,37737,-0.0047054678420329,0.00349906167659846,-0.0115636287281659,0.00215269304410009,0.178719278039331
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,37430,-0.00353488136601049,0.0026303564104408,-0.00869037993047446,0.00162061719845348,0.179010934387825
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,39648,0.0084254138843353,0.00634351627424045,-0.00400787801317599,0.0208587057818466,0.184134305217381
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,37376,0.00326641834732392,0.00245979328897364,-0.00155477649906441,0.00808761319371226,0.184226693347253
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37362,0.0116001321935146,0.0087535961459511,-0.00555691625254955,0.0287571806395788,0.18513333152565
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,37697,0.00422236194851034,0.00320559183830084,-0.00206059805455931,0.01050532195158,0.187798940400362
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,37327,-0.0113882621893687,0.00864804279314718,-0.0283384260639371,0.00556190168519979,0.18790897300214
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37403,-0.00343992114079562,0.00261592915362695,-0.00856714228190446,0.00168730000031321,0.188536486598089
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,37282,-0.00851627714328878,0.00647863363269352,-0.0212143990633681,0.00418184477679051,0.188695618115146
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,37677,0.00603613167646007,0.00462166531909805,-0.00302233234897211,0.0150945957018922,0.191557851902527
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,37343,0.00409430225995437,0.00313614651596787,-0.00205254491134266,0.0102411494312514,0.191739112018562
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37791,0.00325960834301156,0.00250127874103,-0.00164289798940724,0.00816211467543036,0.192536913770798
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37697,-0.00764153612885471,0.00586470125861318,-0.0191363505957365,0.00385327833802711,0.192607286721811
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40297,0.00824767034889505,0.00633531217775908,-0.00416954151951275,0.0206648822173029,0.192984208185753
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,37737,-0.00807483719590799,0.00620983204507215,-0.0202461080042494,0.00409643361243343,0.193510100410466
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,37282,0.00363324609473239,0.00280922023702634,-0.00187282556983925,0.00913931775930402,0.195920568369273
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,37343,0.00565419071645503,0.0043843098539161,-0.00293905659722052,0.0142474380301306,0.197198076037932
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37697,-0.00597628477019064,0.00464551551873182,-0.015081495186905,0.00312892564652372,0.198303938756985
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39815,-0.0056541873780911,0.00441062457947989,-0.0142990115538717,0.0029906367976895,0.199880549839279
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37362,0.0033259606832954,0.00259503884017181,-0.00176031544344134,0.00841223681003214,0.199984526921132
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,39438,-0.00260899297101701,0.00203623091266903,-0.00660000555984831,0.00138201961781429,0.200113259282351
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37756,-0.00909054312361756,0.00709654365713122,-0.0229997686915948,0.00481868244435963,0.20022239481033
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37376,0.00426582289283932,0.00334311288806937,-0.00228667836777664,0.0108183241534553,0.201977303238788
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39810,-0.00403712068903092,0.0031673246079952,-0.0102450769207015,0.00217083554263968,0.202464691814935
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37403,0.00485019802424114,0.0038102166889017,-0.00261782668600618,0.0123182227344885,0.203060246895432
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37362,-0.00541890728898675,0.00426139330409621,-0.0137712381650153,0.00293342358704181,0.203528210598035
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,37282,0.00933110559787235,0.00733810803185014,-0.00505158614455393,0.0237137973402986,0.203539904915813
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,39746,0.0164105698862414,0.0129436607700667,-0.00895900522308941,0.0417801449955722,0.204872215038418
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40274,0.0039898976168806,0.00314941097491829,-0.00218294789395924,0.0101627431277204,0.205220046559472
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37282,0.00471209049268115,0.00372221822451945,-0.00258345722737698,0.0120076382127393,0.205558939856981
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37376,0.0044759606811454,0.00355497162898465,-0.00249178371166451,0.0114437050739553,0.208027530075433
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,39727,-0.0059626353786511,0.00474418006065892,-0.0152612282975426,0.00333595754024037,0.208833841955099
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,40095,-0.00750779401682023,0.00597702143895112,-0.0192227560371644,0.00420716800352397,0.209094994707625
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39727,0.00769670579634997,0.00613075302111775,-0.00431957012504083,0.0197129817177408,0.209343416117028
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37282,0.00380520875895136,0.0030429230164836,-0.00215892035335649,0.00976933787125921,0.211135738658039
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,37376,0.00526992743313862,0.00422778471694203,-0.00301653061206776,0.013556385478345,0.212604020522414
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37430,-0.00875902275777986,0.00704520228661909,-0.0225676192395533,0.00504957372399356,0.213794259379762
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40174,0.00304307248498814,0.00245537095681524,-0.00176945459036973,0.00785559956034601,0.215233129591233
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,37376,-0.00392196931387243,0.00316602294376082,-0.0101273742836436,0.00228343565589878,0.215453761379414
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,40032,-0.00606291899964045,0.0049047784974575,-0.0156762848546571,0.00355044685537625,0.216430763302437
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,37470,0.00574309475636749,0.00466293833395388,-0.00339626437818211,0.0148824538909171,0.218103163897884
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,37697,0.00307736460754328,0.00250171207994848,-0.00182599106915575,0.0079807202842423,0.218680223779259
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37282,0.00548122941419562,0.0044651506461057,-0.00327046585217155,0.0142329246805628,0.2196356250862
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37282,0.00625443642998887,0.00510187972742781,-0.00374524783576964,0.0162541206957474,0.220255705975231
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37362,-0.00435680699052894,0.00355608354880982,-0.0113267307461962,0.00261311676513831,0.220533515597659
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39727,-0.00426512536013196,0.00348215170685229,-0.0110901427055624,0.00255989198529854,0.220649348436566
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37756,-0.00481297456369251,0.00393270220024147,-0.0125210708761658,0.00289512174878077,0.221036538470935
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,40297,-0.00357196861176086,0.00292096364895192,-0.00929705736370662,0.00215312014018491,0.221395722248413
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37430,0.00497501188292365,0.00408420640642088,-0.00303003267366127,0.0129800564395086,0.223204391474711
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37362,-0.00441338401044377,0.00362617785683803,-0.0115206926098463,0.00269392458895876,0.223592306423377
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37430,0.00638678525257143,0.0052520254516105,-0.00390718463258514,0.016680755137728,0.223983663545419
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37282,0.00942070576770843,0.00774879361171874,-0.00576692971126029,0.0246083412466772,0.224097133921963
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,40072,-0.0029749566642576,0.00244832573296217,-0.00777367510086346,0.00182376177234826,0.224346932777681
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,37737,0.0104164117013676,0.00857281551676073,-0.0063863067114834,0.0272191301142187,0.224368072725197
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37343,0.00347774044739899,0.00286392557252624,-0.00213555367475244,0.00909103456955041,0.224645350357157
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,37282,-0.0059704960737429,0.00491992943669296,-0.0156135577696611,0.0036725656221753,0.224948495979991
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,39727,-0.00428152186351433,0.00353746319964198,-0.0112149497348126,0.00265190600778396,0.226168413249543
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40095,-0.00375895155379305,0.0031062448932657,-0.00984719154459381,0.00232928843700772,0.226248358155596
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,40027,-0.00323469544869144,0.00268096350047374,-0.00848938390961996,0.00201999301223709,0.227626845271058
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37403,0.00595567528320008,0.00493700131624045,-0.0037208472966312,0.0156321978630314,0.227710555058236
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37343,0.00464643504496229,0.00386055157537365,-0.00292024604277006,0.0122131161326946,0.228778824676632
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,37403,-0.00560785570064777,0.00465996785283895,-0.0147413926922121,0.00352568129091656,0.228839382340905
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37403,0.00323507056608335,0.00269074161336927,-0.00203878299612042,0.00850892412828711,0.229270460977791
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37696,-0.0042580861157211,0.00355367790081552,-0.0112232948013195,0.00270712256987732,0.230853021827383
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,40233,-0.00279769173940721,0.00235216213463322,-0.00740792952328833,0.00181254604447391,0.234295163395967
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40121,0.00317420092113068,0.00267141780601595,-0.00206177797866059,0.00841017982092194,0.2347693473239
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,37515,-0.0079040191413276,0.00666001820400274,-0.020957654821173,0.00514961653851778,0.235333460178813
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37376,0.00345788838798628,0.00291375730054279,-0.00225307592107758,0.00916885269705015,0.235349832520028
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37791,-0.00495208485298533,0.00417295428675195,-0.0131310752550192,0.0032269055490485,0.235363327333237
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37403,-0.00396806850860974,0.00334568585331014,-0.0105256127810976,0.00258947576387814,0.235634014615919
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,40100,-0.0035926151986779,0.00303212886888083,-0.00953558778168433,0.00235035738432853,0.236095105030372
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37343,0.00808614596175659,0.00684800340949341,-0.00533594072085051,0.0215082326443637,0.237702604178597
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37515,-0.00734490782158535,0.00623348235272724,-0.0195625332329307,0.00487271758976004,0.238698774998415
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37737,-0.00631624740788688,0.00536176419522095,-0.0168253052305199,0.00419281041474619,0.238811076110576
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,40095,-0.00496264596095302,0.00421400450289873,-0.0132220947866345,0.0032968028647285,0.238951854330319
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,37343,0.00797035898339307,0.00677180463061096,-0.00530237809260442,0.0212430960593905,0.23922048328372
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37515,0.0043171701606554,0.00366937483384426,-0.00287480451367934,0.0115091448349902,0.239400173077179
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,37362,0.00699097705881578,0.00594994786100308,-0.00467092074875026,0.0186528748663818,0.240030619602736
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39810,0.00348537051542157,0.0029721780582645,-0.00234009847877685,0.00931083950961999,0.240948180651548
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37282,-0.00939414464002968,0.00808038034681629,-0.0252316901197896,0.00644340083973025,0.245018757200435
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,37376,-0.00509898649067729,0.0043985302366768,-0.0137201057545638,0.00352213277320923,0.246376610791275
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40233,0.00492393488592646,0.00425359700400433,-0.00341311524192201,0.0132609850137749,0.247047613297358
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,40040,0.00348223082164136,0.00301267110949928,-0.00242260455297723,0.00938706619625995,0.247755490817487
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,37403,0.00277898279663606,0.00240489707540277,-0.00193461547115337,0.00749258106442549,0.247885910086928
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37403,-0.00972646740556145,0.00845852112416896,-0.0263051688089326,0.00685223399780971,0.250205613943545
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37403,0.00962013830721094,0.00836964736624963,-0.00678437053063833,0.0260246471450602,0.250409074120173
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,37696,-0.00365266572500154,0.00317898170295713,-0.00988346986279751,0.00257813841279443,0.250574688103542
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,40262,0.00632588781679216,0.00550961735278222,-0.00447296219466099,0.0171247378282453,0.250922470803327
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40100,0.00568937363480593,0.0049744929660745,-0.00406063257870009,0.0154393798483119,0.252761730512904
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,40095,0.00522538766680862,0.00457518254531789,-0.00374197012201444,0.0141927454556317,0.253423425071257
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39727,-0.00678446271369414,0.00594752638047118,-0.0184416144194177,0.00487268899202936,0.254004315823657
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37430,-0.00707872473150454,0.0062079272273479,-0.0192462620971064,0.00508881263409736,0.25419409993777
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37282,0.00428693434831418,0.00376525179353338,-0.00309295916701123,0.0116668278636396,0.254911385006892
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37343,0.00624115408643642,0.0054858628879949,-0.00451113717403358,0.0169934453469064,0.255275455395229
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,37282,0.00431660719649381,0.00379466249452825,-0.00312093129278155,0.0117541456857692,0.255330902873138
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37515,-0.00736794899256062,0.0064863469432231,-0.0200811890012779,0.00534529101615665,0.256012320658762
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37808,-0.00181730102975479,0.00160727157539824,-0.00496755331753534,0.00133295125802577,0.258212409252011
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37697,0.00437116585603966,0.00386622503966643,-0.00320663522170655,0.0119489669337859,0.258242671572686
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37430,0.00841944402515411,0.00746048002497283,-0.00620309682379264,0.0230419848741009,0.259113140067765
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,37515,0.003628162146498,0.00322294539037125,-0.00268881081862965,0.00994513511162565,0.260301050381511
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,37403,0.00707965303836761,0.00629575421822846,-0.00526002522936017,0.0194193313060954,0.260816597766793
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37515,0.00709115372899756,0.00631117313031158,-0.00527874560641313,0.0194610530644083,0.261208810937927
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,39800,-0.00433413279659839,0.00385807282160133,-0.011895955526937,0.00322768993374021,0.261288105279822
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39746,0.00503861628227932,0.00449282759778766,-0.00376732580938448,0.0138445583739431,0.262101208910759
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,39810,-0.00617353819552711,0.00551637448444372,-0.0169856321850368,0.00463855579398258,0.26310233903093
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39815,0.00601781792555727,0.00538065459117808,-0.00452826507315175,0.0165639009242663,0.263406237382193
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,37716,-0.00320801019667453,0.0028726595309365,-0.00883842287731006,0.002422402483961,0.264126275476297
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,37808,0.00276775462873274,0.00248494579626727,-0.00210273913195112,0.00763824838941659,0.265381241603203
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37480,-0.00663944106021477,0.00596310789544938,-0.0183271325352956,0.005048250414866,0.265548813704612
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37362,0.00605146374608523,0.00544605516952418,-0.00462280438618216,0.0167257318783526,0.266518196510829
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37716,-0.00387597451877615,0.00348892323398151,-0.0107142640573799,0.0029623150198276,0.266615530344618
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37376,-0.0029668556494106,0.00267347522186328,-0.00820686708426264,0.00227315578544144,0.267132815929124
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,39815,-0.00894803690555791,0.00812356857047637,-0.0248702313036916,0.00697415749257578,0.27070031675121
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37362,0.00376582076217016,0.0034348218874431,-0.00296643013721832,0.0104980716615586,0.272939236666829
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37403,-0.00290945257831118,0.00265415766640021,-0.0081116016044556,0.00229269644783324,0.2730174213495
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,39770,-0.00617431268129339,0.00564295600163922,-0.0172345064445063,0.00488588108191949,0.273900777382661
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40181,-0.00313316258965025,0.0028699660937063,-0.00875829613331459,0.00249197095401409,0.274978550226858
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40065,-0.00259500094362533,0.00238238792538534,-0.00726448127738059,0.00207447939012994,0.276063262182804
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,37403,0.00382237013426656,0.00351346478045749,-0.00306402083543013,0.0107087611039632,0.276650478986915
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37515,-0.00441600407792383,0.00407228646013601,-0.0123976855397904,0.00356567738394276,0.278205685840176
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,40248,-0.0027839479366783,0.00257614445925879,-0.00783319107682552,0.00226529520346892,0.279862866036399
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37403,0.00448758252073214,0.00415709676584368,-0.00366032714032147,0.0126354921817858,0.280385365526521
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37305,0.00336545688804615,0.00312257238149166,-0.0027547849796775,0.00948569875576979,0.281150626437415
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,40186,0.00418794045821098,0.00390549281753631,-0.00346682546416019,0.0118427063805821,0.283592497426325
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37756,-0.00268582687633205,0.00250562264669699,-0.00759684726385815,0.00222519351119405,0.283775437316577
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,37282,0.00909760661919027,0.00855105507760381,-0.0076624613329132,0.0258576745712937,0.287386655039383
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,39815,-0.00309540904836081,0.0029354981829824,-0.00884898548700631,0.00265816739028469,0.291682145533939
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39746,-0.00510559124815414,0.00484212759846911,-0.0145961613411536,0.00438497884484531,0.2917115730722
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37343,0.00675954542866109,0.00641504978850351,-0.00581395215680578,0.019333043014128,0.292039505034434
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37362,-0.00462156284129876,0.00438975303197654,-0.0132254787839728,0.00398235310137526,0.292449147764602
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37403,0.00345788084618229,0.00328464075234458,-0.00298001502841307,0.00989577672077766,0.292478675207208
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,37362,0.00478917003220413,0.00455041471390362,-0.00412964280704697,0.0137079828714552,0.292604163803846
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37737,-0.00615777806488074,0.00585327146917775,-0.0176301901444691,0.00531463401470766,0.292807986718249
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,37362,0.00429659134302066,0.00408658652763001,-0.00371311825113416,0.0123063009371755,0.293099732668137
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37756,-0.00310852395325951,0.0029593671014081,-0.00890888347201939,0.00269183556550037,0.293552587524223
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,40186,0.00723834857757932,0.00690348181557652,-0.00629247578095065,0.0207691729361093,0.294421212906231
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37343,0.00864295896178916,0.00825152649496583,-0.00753003296834388,0.0248159508919222,0.294917444014386
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,39746,-0.00293763109798737,0.00280542837594197,-0.00843627071483362,0.00256100851885889,0.295058986232198
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37362,0.00371187959258551,0.00354857812082634,-0.00324333352423412,0.0106670927094051,0.295571915110083
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37362,0.00595348205902733,0.00569249525986088,-0.0052038086503,0.0171107727683547,0.295651017558535
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37282,0.00240908330256166,0.00230375359515813,-0.00210627374394828,0.0069244403490716,0.295709607262902
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37697,-0.0064080706679498,0.00615876353147835,-0.0184792471896474,0.00566310585374775,0.298135914110305
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37697,-0.00416299348240879,0.00400137595190736,-0.0120056903481472,0.00367970338332964,0.298177509405496
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,37343,0.00689210286527319,0.00662923843186936,-0.00610120446119075,0.0198854101917371,0.298520976346001
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37403,0.00582273462705033,0.00563628522095974,-0.00522438440603075,0.0168698536601314,0.301585662017916
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,39700,0.00335124772689162,0.00324469245449107,-0.00300834948391086,0.00971084493769411,0.301695223844604
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37696,0.00405456218143333,0.00392672455184258,-0.00364181794017813,0.0117509423030448,0.301830679870779
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,40233,-0.00499188028780905,0.00483919930071017,-0.014476710917201,0.00449295034158289,0.302298370780292
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,37403,0.00508426230015441,0.00492875063689745,-0.00457608894816459,0.0147446135484734,0.302301325665848
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,39746,0.00861035832951965,0.00846356406550449,-0.00797822723886915,0.0251989438979085,0.309005780878327
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,37376,0.00560463973844108,0.00552175032733278,-0.00521799090313117,0.0164272703800133,0.310119376492391
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,39669,0.00388092350322275,0.0038598217373574,-0.00368432710199775,0.0114461741084432,0.314688004723428
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37403,-0.00794912683522314,0.00792951915574167,-0.0234909843804768,0.00759273071003054,0.316134052881955
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37696,-0.00246146035720997,0.00246079148613712,-0.00728461167003873,0.00236169095561878,0.317197259793255
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,40150,0.00274080851593329,0.00274407746064911,-0.00263758330693896,0.00811920033880554,0.317902753007387
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40135,0.00513886579442688,0.00514620767570555,-0.00494770124995599,0.0152254328388097,0.318016826155898
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,39781,-0.00652476153564628,0.00655113386453671,-0.0193649839101382,0.00631546083884568,0.319278311288155
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,37620,-0.00262788573810729,0.00263889483381502,-0.00780011961238473,0.00254434813617015,0.319351952925956
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40054,-0.0161504900200473,0.0162237312825131,-0.0479490033337731,0.0156480232936784,0.319515608446057
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,37258,-0.00316019569889214,0.0031891145843022,-0.00941086028412445,0.00309046888634016,0.321737507339917
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40256,-0.00470888205111961,0.00475706150264906,-0.0140327225963118,0.00461495849407254,0.322251834639693
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37362,-0.00589687414741318,0.00597661228334418,-0.0176110342227678,0.00581728592794142,0.323828667429719
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,39810,-0.0105474178228113,0.0106996499389056,-0.0315187317030663,0.0104238960574438,0.324260423268563
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40297,0.00542233377037349,0.00550135909410526,-0.00536033005407281,0.0162049975948198,0.32432715479727
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37362,0.00339866607379279,0.00345102720775607,-0.00336534725340911,0.0101626794009947,0.32472732652218
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,40033,-0.00355826094532457,0.00361937032107158,-0.0106522267746249,0.00353570488397573,0.325565605817873
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37756,0.0023915722666519,0.00243321784667913,-0.0023775347128392,0.007160679246143,0.32568212846546
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,37376,0.00515653036190594,0.00525397214834701,-0.0051412550488542,0.0154543157726661,0.326387431765518
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,39815,0.00341138436393741,0.00350063418893234,-0.00344985864636999,0.0102726273742448,0.329821365161093
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37756,0.00206045101003748,0.00213434446814703,-0.0021228641475307,0.00624376616760566,0.334372637929535
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37376,0.00438004225861151,0.00454280835376266,-0.0045238621147633,0.0132839466319863,0.334978441328387
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40186,0.00228468989968569,0.00237998009589859,-0.00238007108827555,0.00694945088764694,0.337089208434835
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37403,-0.00526026009082165,0.0054816206233862,-0.0160042365126586,0.0054837163310153,0.337265579549112
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37362,0.00543937291040033,0.00567638179220559,-0.00568633540232262,0.0165650812231233,0.337956425576254
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,37362,0.0056882866653476,0.00594234028832643,-0.00595870029977221,0.0173352736304674,0.33846058812429
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,37343,0.0043010513853994,0.00449741608560989,-0.00451388414239599,0.0131159869131948,0.338919264860331
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39746,-0.0104619038683909,0.0109405193119286,-0.031905321719771,0.0109815139829892,0.338959568865752
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,37362,-0.00409196937031474,0.00428403838036246,-0.0124886845958252,0.00430474585519569,0.339511456387032
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,39815,0.00413642091527707,0.0043506568211121,-0.00439086645410265,0.0126637082846568,0.341742295022933
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,37430,-0.00452423241301816,0.00476047102588795,-0.0138547556237585,0.00480629079772224,0.341939465364609
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39810,-0.00232618874447389,0.00245211039475485,-0.00713232511819339,0.00247994762924562,0.342814778184567
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37515,0.00265045867355557,0.00280345185956656,-0.00284430697119489,0.00814522431830604,0.344458484069682
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39815,0.00249806176593183,0.00264333986791438,-0.00268288437518035,0.007679007907044,0.344653345083413
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,37343,-0.00982916509588067,0.010419283992754,-0.0302509617216785,0.0105926315299172,0.345513034677607
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,37403,0.00367568234045377,0.00390171989302661,-0.00397168864987839,0.0113230533307859,0.346175807250242
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40066,0.00189485777701317,0.00201226488339608,-0.00204918139444315,0.00583889694846948,0.346384254143489
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,37403,-0.00254129047774142,0.00269986903233456,-0.00783303378111716,0.00275045282563432,0.346586961770531
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37403,-0.00410717602209859,0.0043725443238059,-0.0126773628967582,0.00446301085256098,0.347588957663843
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,37791,0.00397901517697938,0.00424648077124055,-0.0043440871346521,0.0123021174886109,0.348767927912986
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37696,-0.00456868251725096,0.00488641087987137,-0.0141460478417988,0.00500868280729692,0.349817122132851
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39727,0.00431311536042546,0.00463212033991999,-0.00476584050581773,0.0133920712266686,0.351800016113851
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37362,0.00319896214644082,0.00343994617457148,-0.00354333235571928,0.00994125664860092,0.352416739056977
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37737,0.00277980835772287,0.0029908553402474,-0.00308226810916203,0.00864188482460778,0.352680111688056
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39746,-0.00672641250127927,0.0072453358062431,-0.0209272706815157,0.0074744456789572,0.353226024692889
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37362,0.00511706500602712,0.00551513517197151,-0.00569259993103704,0.0159267299430913,0.353517137200963
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,37376,-0.0044004287528515,0.00474619208670958,-0.0137029652428023,0.00490210773709928,0.353866326817124
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BSG,Basigin,40261,-0.00168977842501764,0.00182329358395154,-0.00526343384956265,0.00188387699952737,0.354058793305585
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,37403,0.00742494653945539,0.00803102011367693,-0.00831585288335139,0.0231657459622622,0.355225882060027
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,39727,-0.00365116092922555,0.00396155224164891,-0.0114158033228574,0.00411348146440632,0.356726211594543
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,37403,0.00265901499385646,0.00288918831200036,-0.00300379409766425,0.00832182408537717,0.357415974848495
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,37606,-0.00252454642500961,0.00274310192925158,-0.0079010262063427,0.00285193335632348,0.357419608185841
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39746,-0.00637030059022109,0.00693661312134097,-0.0199660623080494,0.00722546112760722,0.358445468254665
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37515,-0.00702288412377427,0.00766342162286137,-0.0220431905045826,0.00799742225703401,0.35946553161701
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,39810,-0.00245742937887742,0.00273303052679691,-0.00781416921139936,0.00289931045364453,0.368581997843859
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37362,0.00971450894305046,0.0108163013224785,-0.0114854416490073,0.0309144595351083,0.36912983049817
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37282,0.00518444337768528,0.00577723113914407,-0.0061389296550371,0.0165078164104077,0.36952639967165
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,37343,0.00528049861678157,0.00589266552986354,-0.00626912582175097,0.0168301230553141,0.370208746152435
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37376,-0.00286914674819964,0.00320994043673001,-0.00916063000419045,0.00342233650779118,0.371428551188171
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,37282,-0.00595579159553723,0.0066686532700235,-0.0190263520047833,0.00711476881370883,0.371818980166537
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,37756,0.00307169626347883,0.00344905434797633,-0.00368845025855477,0.00983184278551243,0.373164811418561
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37559,0.00357938661881952,0.00402868532276723,-0.00431683661380424,0.0114756098514433,0.374301545261368
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39746,-0.00332101424428,0.00375569989050132,-0.0106821860296626,0.00404015754110259,0.376569911392151
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,37362,-0.0038718100318061,0.00439703007071612,-0.0124899889704097,0.00474636890679749,0.378577182129199
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37362,0.00708552517003271,0.00805148374548621,-0.00869538297112027,0.0228664333111857,0.378860923708479
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39727,-0.0064511621035095,0.00733547325908975,-0.0208286896913254,0.00792636548430641,0.379172633620041
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,39746,0.00673933541984656,0.00767396036811602,-0.00830162690166083,0.021780297741354,0.379844503675968
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,37403,0.00280186140792498,0.00319117871986556,-0.00345284888301152,0.00905657169886148,0.379958902423868
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37376,0.0045208592972465,0.00515902514252792,-0.00559082998210824,0.0146325485766012,0.380882665746042
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,37430,-0.00538973814494459,0.00616045790199852,-0.0174642356328617,0.00668475934297252,0.381648614593397
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37680,0.00330847651640287,0.00378249471132568,-0.00410521311779547,0.0107221661506012,0.38176334387874
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,37362,0.00877099131668651,0.0100347910425465,-0.0108971991267047,0.0284391817600777,0.382102822565733
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,39815,-0.00389394429389858,0.0044756778053313,-0.0126662727923479,0.00487838420455077,0.38430122516559
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,40064,-0.0022118667478822,0.00256253044873651,-0.00723442642740576,0.00281069293164136,0.388064271392833
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37362,0.00406747165600205,0.00471941435030988,-0.0051825804706053,0.0133175237826094,0.388780896726361
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37714,-0.00296788007195518,0.00345337339889964,-0.00973649193379847,0.00380073178988811,0.3901272630662
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37343,0.00428830159985103,0.00499508421037277,-0.00550206345247959,0.0140786666521817,0.390629983214297
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,37376,-0.00473777389932066,0.00552360892538437,-0.015564047393074,0.0060884995944327,0.391056594441955
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,37697,-0.00287423599572514,0.00335190433963525,-0.00944396850141024,0.00369549650995995,0.391187751775731
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39727,0.00386696550082474,0.00451137777423332,-0.00497533493667257,0.0127092659383221,0.391370779111134
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40065,0.00268033250162593,0.00313031842468429,-0.00345509161075527,0.00881575661400713,0.391873120245818
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37282,0.00438197134993051,0.00512197433509176,-0.00565709834684934,0.0144210410467104,0.39227716694838
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,40100,-0.00520959776580127,0.00609935129780355,-0.0171643263094962,0.00674513077789368,0.393049776900413
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37362,0.00409406501377043,0.00479453272252375,-0.00530321912237612,0.013491349149917,0.393174680404857
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,37737,-0.00210920407101952,0.00247135535447388,-0.00695306056578832,0.00273465242374927,0.39341939464402
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37343,0.00251252633536801,0.00294601219919921,-0.00326165757506245,0.00828671024579846,0.393754604077134
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,40095,-0.00312190052218276,0.00367235709359299,-0.010319720425625,0.00407591938125949,0.395277997859788
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37515,-0.00426577141165449,0.0050233741869571,-0.0141115848180904,0.00558004199478143,0.395794207778912
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40143,0.0025552303664132,0.0030115820552887,-0.00334747046195265,0.00845793119477905,0.39619044721836
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,39815,-0.00314728498676092,0.00372293393362608,-0.010444235496668,0.0041496655231462,0.397913207650579
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,39815,-0.00335020295502137,0.00400253157697932,-0.0111951648459008,0.00449475893585811,0.402593787755486
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,39815,-0.00390389551054833,0.00469144379201187,-0.0130991253428916,0.00529133432179494,0.405347976351827
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,40065,-0.00317719563840042,0.00383695330357941,-0.0106976241134161,0.00434323283661523,0.407653888232696
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,37403,0.00784682906652546,0.00949322466164833,-0.0107598912703053,0.0264535494033562,0.408495197139846
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37515,0.00570090434889758,0.00690775246562635,-0.00783829048373007,0.0192400991815252,0.409221601580211
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,40197,0.00295858676188938,0.00360074844003681,-0.00409888018058276,0.0100160537043615,0.411283536306301
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,37403,0.0025711143294755,0.00313557507721945,-0.00357461282187462,0.00871684148082563,0.412241603294195
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,37362,0.00628964790306343,0.0076723023273754,-0.00874806465859236,0.0213273604647192,0.412353108977436
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37282,0.00416538103054835,0.0051158490440577,-0.00586168309580475,0.0141924451569015,0.415539144287769
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,37791,0.00665433141064715,0.00821879062987481,-0.00945449822390748,0.0227631610452018,0.41815667377524
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,40095,-0.00408411993394787,0.00504799667242501,-0.0139781934119009,0.00580995354400516,0.41849433611446
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37343,0.00539295897840912,0.0066755529533996,-0.0076911248102541,0.0184770427670723,0.419182053511127
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,37282,0.00855176973853243,0.0106027452981999,-0.0122296110459393,0.0293331505230042,0.419933917633218
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40100,-0.00540265581909281,0.00669912771982647,-0.0185329461499527,0.00772763451176706,0.419983270488024
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,37282,0.00536422415197548,0.00669078325889929,-0.00774971103546714,0.0184781593394181,0.422722061727524
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,37403,0.00158706108860796,0.00198053954432792,-0.00229479641827476,0.00546891859549067,0.422956691863612
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37696,0.00355211423061963,0.00443441788408708,-0.00513934482219105,0.0122435732834303,0.423127020014684
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,37696,0.0187843591340655,0.023474100667675,-0.0272248781745774,0.0647935964427084,0.423599812176778
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37515,0.0029958091884743,0.00374614528619228,-0.00434663557246257,0.0103382539494112,0.423896574966228
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37515,-0.00393414908514049,0.00493803752389689,-0.0136127026319784,0.00574440446169742,0.425638046751574
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39967,-0.00284930104186063,0.00357731267204301,-0.00986083387906493,0.00416223179534368,0.425758291749309
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39746,-0.00334097343265745,0.00421538830565753,-0.0116031345117462,0.0049211876464313,0.428043020242105
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,37282,0.0051411776556078,0.00650829889343319,-0.00761508817552126,0.0178974434867369,0.429576329445484
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39746,0.00899475142234516,0.0114469823971236,-0.0134413340760171,0.0314308369207074,0.432011548437914
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39974,-0.00286051392193642,0.00364307300655314,-0.0100009370147806,0.00427990917090773,0.43235264479332
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,37791,0.00316601914146293,0.00403358034273208,-0.00473979833029196,0.0110718366132178,0.432517139134967
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,39955,-0.00243060225015722,0.00309824572016352,-0.00850316386167773,0.00364195936136329,0.43275337668165
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,40186,-0.00440227105351713,0.00563025238015111,-0.0154375657186133,0.00663302361157905,0.434287541277105
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,37756,-0.0021406529607166,0.00274522214191211,-0.00752128835886434,0.00323998243743114,0.435537760614452
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37260,0.00342617837920742,0.0044222870318387,-0.00524150420319643,0.0120938609616113,0.438500164583345
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,39727,0.00338659374484631,0.00438126089880231,-0.00520067761680621,0.0119738651064988,0.439550676522227
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,40174,-0.00402066026217229,0.00522652209470693,-0.0142646435677979,0.00622332304345329,0.441738511393365
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,37756,0.00260763636495078,0.00339704553672155,-0.00405057288702344,0.00926584561692501,0.442727252365295
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37470,-0.00177445604017541,0.002315087982851,-0.00631202848656336,0.00276311640621254,0.44340788254201
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37737,-0.00319193483759758,0.00416577903882943,-0.0113568617537033,0.0049729920785081,0.44355450806027
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,37515,0.00400324866994217,0.00522578588951979,-0.00623929167351663,0.014245789013401,0.443656364566832
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37696,0.00568732286465669,0.0074323674316747,-0.00888011730142572,0.0202547630307391,0.444160062514733
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,36008,-0.00717165862589927,0.00945320650477467,-0.0256999433752576,0.0113566261234591,0.448078470357672
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37808,-0.00184602501523648,0.00243382480057171,-0.00661632162435702,0.00292427159388407,0.448172742846834
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,37403,0.0039913189640823,0.00527236487085018,-0.00634251618278404,0.0143251541109486,0.449047867235069
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37376,0.00247052189533562,0.00327685321416249,-0.00395211040442287,0.00889315419509411,0.450904266657857
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37343,0.00440549611249001,0.00585803566904933,-0.00707625379884667,0.0158872460238267,0.452038787788859
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,37445,-0.00563713815841742,0.00752626797787671,-0.0203886233950558,0.00911434707822094,0.453873691973597
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,40100,-0.00599255770164155,0.00800547150556967,-0.0216832818525581,0.009698166449275,0.454135058881437
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37470,0.00169268259769904,0.00226275456253579,-0.00274231634487112,0.0061276815402692,0.45443576989948
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,37376,0.00157893697262954,0.00211286364428118,-0.00256227577016157,0.00572014971542065,0.454897810024836
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,37376,0.00254828933358714,0.0034109659007507,-0.00413720383188423,0.00923378249905851,0.455024451866644
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,37376,-0.00351406361917991,0.00471806372401733,-0.0127614685182539,0.00573334127989407,0.456399801659084
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37470,0.00255455220153998,0.00343285378213319,-0.00417384121144106,0.00928294561452103,0.456800211414943
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37697,-0.00571738002171128,0.00769958784706794,-0.0208085722019644,0.00937381215854188,0.457763321476497
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37282,0.00245272050158781,0.00331168302264087,-0.00403817822278829,0.00894361922596391,0.458933435155922
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37376,-0.00489193621155177,0.00660533253493682,-0.0178383879800279,0.0080545155569244,0.458946989233906
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,39746,0.00711916589487648,0.00971086509857755,-0.0119141296983355,0.0261524614880885,0.46350046862319
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39978,-0.00621825852040893,0.00848894130778166,-0.022856583483661,0.0104200664428431,0.463866665326835
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37282,0.00369661591577073,0.00505933801324692,-0.00621968659019323,0.0136129184217347,0.465005025488844
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37697,-0.00624132220198536,0.00858208995536178,-0.0230622185144945,0.0105795741105237,0.467085869490543
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,37403,0.00184367622924818,0.00254385540984076,-0.00314228037403971,0.00682963283253606,0.468614402628753
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,37343,0.0033165936015487,0.00459264071833432,-0.00568498220638656,0.012318169409484,0.470212935794822
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37362,0.00277139296326543,0.00384523724447385,-0.00476527203590333,0.0103080579624342,0.471086280503435
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,40274,0.00172525627218128,0.00240259453858938,-0.00298382902345391,0.00643434156781647,0.472718259430405
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,37331,0.00572411503881016,0.00797597128408647,-0.00990878867799933,0.0213570187556197,0.472973822936369
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,37696,-0.00224008172200889,0.0031447929979667,-0.00840387599802363,0.00392371255400584,0.476282581229107
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37493,-0.00358147900145568,0.00504980076564794,-0.0134790885021256,0.00631613049921428,0.478193356751026
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39955,0.00198496503771533,0.00281393973020002,-0.00353035683347671,0.00750028690890736,0.480569299899266
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,39810,-0.00210804595810701,0.00299468173862761,-0.00797762216581713,0.00376153024960312,0.481487114502723
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40248,0.00160327775486058,0.00228493099713559,-0.00287518699952517,0.00608174250924632,0.482892533197995
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39810,-0.00383108570784137,0.00551769148080692,-0.0146457610102229,0.00698358959454019,0.487487263163165
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39746,0.00224144086486202,0.0032317889179567,-0.0040928654143331,0.00857574714405715,0.487968458265643
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37784,0.00311745057354623,0.00450567181615914,-0.00571366618612569,0.0119485673332181,0.489015490990487
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37515,-0.00425662145012321,0.00617495054447583,-0.0163595245172958,0.00784628161704941,0.490623507246537
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,37376,0.00245511394256473,0.00356254168298274,-0.00452746775608144,0.00943769564121089,0.490743308728834
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37258,0.00320600363388463,0.00466926061527415,-0.00594574717205269,0.012357754439822,0.492335206116229
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,37343,0.00291455570981986,0.00424995671411103,-0.00541535944983777,0.0112444708694775,0.492861156206745
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,39991,-0.00345998830732874,0.00504668723121227,-0.0133514952805048,0.00643151866584731,0.49297816635351
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37376,-0.00266444482539849,0.00390042913772513,-0.0103092859353397,0.00498039628454277,0.494545908613657
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,37376,0.00394573858264655,0.00578321822174704,-0.00738936913197764,0.0152808462972708,0.495078030340993
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,37282,-0.00385215853996831,0.00565390673915047,-0.0149338157487032,0.00722949866876662,0.495676986618406
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37343,0.00237023530390119,0.00347963425385712,-0.00444984783365876,0.00919031844146115,0.495773829542967
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37343,-0.00246889265323416,0.00363117358524273,-0.00958599288030991,0.00464820757384158,0.496569923180186
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,37737,-0.00444328479022172,0.00653705175031754,-0.0172559062208441,0.00836933664040065,0.49670136563536
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,37362,0.00382619588745731,0.00568181306182202,-0.00731015771371385,0.0149625494886285,0.50069785457717
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37376,-0.00321902686168397,0.00478303776979258,-0.0125937808904774,0.00615572716710949,0.500953679119015
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,40297,0.00433201544075554,0.00645806693273125,-0.00832579574739772,0.0169898266289088,0.502363235532066
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37362,-0.00276652106111155,0.00413903988512528,-0.0108790392359571,0.00534599711373399,0.503892280307513
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,37470,-0.00470507831786192,0.00707334377728109,-0.0185688321213328,0.00915867548560901,0.505944306717883
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37343,0.0071612752644614,0.010800569737363,-0.01400784142077,0.0283303919496928,0.507312907365638
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40297,0.00170240544365042,0.0025785644254697,-0.0033515808302702,0.00675639171757104,0.509125830127479
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37282,0.00259669115515282,0.00393736461131353,-0.00512054348302169,0.0103139257933273,0.509586714709475
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,37727,-0.00379062612894147,0.00581295118643624,-0.0151840104543565,0.00760275819647357,0.514347881009796
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39305,-0.00168567261759312,0.00258992454349261,-0.00676192472283863,0.00339057948765239,0.51514834621721
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,37696,-0.00417135784036576,0.00643339549945442,-0.0167808130192964,0.0084380973385649,0.516743120181522
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,39815,0.00372728248487547,0.00577981481076556,-0.00760115454422504,0.015055719513976,0.51901508625788
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37362,0.00568314125828924,0.00882768963034826,-0.0116191304171934,0.0229854129337718,0.519725777258791
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,37362,0.00235166768044147,0.00367532563871219,-0.00485197057143443,0.00955530593231736,0.522279607135838
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37260,0.00145691618344796,0.00228960559631852,-0.00303071078533633,0.00594454315223226,0.524580850517497
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37515,0.00207507443671265,0.0032628950256059,-0.00432019981347491,0.00847034868690021,0.524812892904317
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,39786,0.00320288940499988,0.00504523162775718,-0.00668576458540418,0.0130915433954039,0.525545533229234
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37697,-0.00309272510662941,0.00487539965410003,-0.0126485084286655,0.00646305821540665,0.525861335972282
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,37376,0.00244731694294785,0.0038614206746465,-0.00512106757935928,0.010015701465255,0.526231271226666
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37756,-0.00422160217875435,0.00666212001317854,-0.0172793574045843,0.00883615304707559,0.526305475345722
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37362,0.00236358883471147,0.00373467567659662,-0.0049563754914179,0.00968355316084084,0.526825440902674
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,37515,-0.00169155959192096,0.00268497823285211,-0.00695411692831109,0.00357099774446916,0.528699924724866
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40095,0.00275827380323593,0.00438542259593302,-0.0058371544847928,0.0113537020912647,0.529381679794808
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,37376,0.00396187512760238,0.00630562641996492,-0.00839715265552887,0.0163209029107336,0.529813335884782
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37697,-0.00284898766002819,0.00455316577969895,-0.0117731925882381,0.00607521726818175,0.531512164885714
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37282,0.00799840996835047,0.0128525988238323,-0.0171926837263609,0.0331895036630618,0.53374352084756
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37489,0.0029610106546442,0.00476178797929423,-0.00637209378477248,0.0122941150940609,0.534066183538187
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37515,-0.0031671400717633,0.00510656105006791,-0.0131759997298964,0.00684171958636981,0.535130377884852
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39727,-0.00796886836963765,0.0128712119608371,-0.0331964438128784,0.0172587070736031,0.535844309580706
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37282,0.00359739570523439,0.00581497449422458,-0.00779995430344578,0.0149947457139146,0.536162274332499
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TTN,Titin,37362,0.0036849229092394,0.00595831407471542,-0.00799337267720283,0.0153632184956816,0.536289263304289
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40226,-0.00356454873397492,0.00576593127123089,-0.0148657740255875,0.00773667655763762,0.5364467178054
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,37560,0.00348477706407642,0.00565391434900901,-0.00759689505998123,0.0145664491881341,0.537675771293478
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40229,-0.00339423113255975,0.00551906519938716,-0.0142115989233586,0.00742313665823908,0.538562868148368
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37403,-0.00356035661180409,0.00582758638782688,-0.0149824259319448,0.00786171270833659,0.541244232472248
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37430,0.0144944216325351,0.0237840062095998,-0.0321222305382804,0.0611110738033507,0.542257517192606
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37376,-0.00236964936018509,0.0038917357938218,-0.00999745151607583,0.00525815279570565,0.542606291729309
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,37357,-0.00377960465957717,0.00620879210956075,-0.0159488371943162,0.0083896278751619,0.542700611776116
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,37697,-0.00243905624985557,0.00402450691399911,-0.0103270898012938,0.00544897730158268,0.544491304637521
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39727,-0.00460294155169222,0.0076757532754677,-0.0196474179716089,0.0104415348682245,0.548733118934521
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,37447,-0.00310185389477089,0.00518460873510987,-0.0132636870155862,0.00705997922604445,0.549662750922014
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,37376,0.00379309218821702,0.0063603509005142,-0.00867319557679081,0.0162593799532249,0.550941701763228
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,37343,0.00340975266806551,0.00572980150807464,-0.00782065828776078,0.0146401636238918,0.551793164696085
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,40248,0.00319537922412974,0.00538453347872683,-0.00735830639417485,0.0137490648424343,0.55289749977384
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,40174,0.00425033485188235,0.00716982062745973,-0.00980251357793872,0.0183031832817034,0.553317449065187
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37376,0.00464426937825998,0.00783833314746534,-0.0107188635907721,0.020007402347292,0.553521319717678
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40297,-0.00122087560518747,0.00206643217563792,-0.00527108266943779,0.00282933145906285,0.554653951972137
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,37515,0.00329415631914477,0.00558762049514014,-0.00765757985132991,0.0142458924896195,0.555505618995133
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40137,-0.00143059641827563,0.00243109106487653,-0.00619553490543364,0.00333434206888237,0.556232994857022
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37784,0.00386878869852075,0.00662834855832589,-0.00912277447579801,0.0168603518728395,0.5594501480504
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,39810,-0.00146136148816674,0.0025075952446025,-0.00637624816758764,0.00345352519125416,0.560053958488169
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,37696,-0.00177087015275526,0.00305261480179265,-0.00775399516426885,0.00421225485875833,0.561846381985703
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,37362,0.00277456715609005,0.00478350990703253,-0.00660111226169371,0.0121502465738738,0.561906214805541
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,37403,0.00304625956418906,0.00525209591018241,-0.00724784841976847,0.0133403675481466,0.561919066549043
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37362,0.00353596314472892,0.00610366408110689,-0.00842721845424057,0.0154991447436984,0.562384655463808
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37362,-0.00249380052782821,0.00431063327009367,-0.0109426417372118,0.00595504068155539,0.562921159903932
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37515,-0.00345877829282122,0.00603572790062023,-0.0152888049780369,0.00837124839239443,0.566620208100994
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,37515,0.00443404871064673,0.00776377499896516,-0.010782950287325,0.0196510477086184,0.567927993351043
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,40100,0.00287511400649062,0.00503815735128986,-0.00699967440203749,0.0127499024150187,0.568233066501797
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40097,0.0024951691405141,0.00438482655055465,-0.00609909089857302,0.0110894291796012,0.569332916883637
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37403,0.00552160009718519,0.0097267010239026,-0.0135427339096639,0.0245859341040343,0.570265853005095
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37403,0.00349212652350687,0.00617559900727586,-0.00861204753075381,0.0155963005777675,0.571762757835082
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,40095,0.00223414648668051,0.00395711850902332,-0.0055218057910052,0.00999009876436622,0.572361288724275
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,37282,-0.0040327460886858,0.00715251405131903,-0.0180516736292711,0.0099861814518995,0.572885007759968
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,37791,0.00459429585666687,0.0081752239293981,-0.0114291430449534,0.0206177347582871,0.574140462300504
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37362,0.0024606614513518,0.00439301605595507,-0.00614965001832013,0.0110709729210237,0.575400275599871
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39727,-0.00245911763453683,0.00439659512690478,-0.0110764440832702,0.00615820881419655,0.575949368419573
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,39718,-0.00448670692726801,0.00802179539039401,-0.0202094258924403,0.0112360120379042,0.575955268088799
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39727,-0.0016475927638586,0.00294611959515434,-0.00742198717036111,0.0041268016426439,0.576005015234976
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37282,0.00163892144584089,0.00294962442915378,-0.00414234243530051,0.0074201853269823,0.578468494206741
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37282,-0.00413231750639229,0.00744514344143782,-0.0187247986516104,0.0104601636388258,0.578880184171413
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37362,-0.00168531153271479,0.0030388017036008,-0.00764136287177237,0.00427073980634278,0.57917967320118
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37696,0.00239677547138701,0.00433412274768895,-0.00609810511408333,0.0108916560568574,0.580271860439628
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37756,-0.00169054042262104,0.00305980450874451,-0.00768775725976027,0.00430667641451819,0.580615467368694
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37343,0.0036120286032306,0.00660262703861468,-0.00932912039245416,0.0165531775989154,0.584347454322997
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,37697,0.00199025571204636,0.00364262420251727,-0.00514928772488748,0.0091297991489802,0.584814203573432
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,37430,-0.00416850798242103,0.00767125936910675,-0.0192041763458702,0.0108671603810282,0.586868636581017
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,37282,0.00282323031449624,0.00520323404742464,-0.00737510841845606,0.0130215690474485,0.587420550602849
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,37808,-0.000926509793987714,0.00172107925691027,-0.00429982513753184,0.00244680554955641,0.590357734154774
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,40159,-0.00724900066731849,0.0134702934492568,-0.0336507758278619,0.0191527744932249,0.59048305575831
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39746,-0.00378637627278415,0.00705104729035279,-0.0176064289618756,0.0100336764163073,0.5912789644405
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37376,-0.00175816707595142,0.00331946368176306,-0.00826431589220702,0.00474798174030418,0.596360974247022
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39727,0.00182827879449597,0.00346059210375323,-0.00495448172886036,0.0086110393178523,0.597289184066605
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37403,-0.00267145910219345,0.00509215857940224,-0.0126520899178218,0.00730917171343494,0.59985487583335
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,37213,-0.00207028374702927,0.00397030640539537,-0.0098520843016042,0.00571151680754566,0.602068083183994
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39810,-0.00234559797285306,0.00450965309401895,-0.0111845180371302,0.00649332209142408,0.602981686673544
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,37403,0.00142826558321826,0.00276022237914964,-0.00398177027991503,0.00683830144635154,0.604853805746101
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37403,0.00131213056865403,0.00254799932942096,-0.00368194811701106,0.00630620925431912,0.60658624072677
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,37697,-0.00373901685419918,0.00729999529094154,-0.0180470076244446,0.0105689739160462,0.608523488166029
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37343,0.00491907386133517,0.00981192196748273,-0.014312293194931,0.0241504409176013,0.616142936512429
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39815,0.00143155997481983,0.00288127684328257,-0.00421574263801401,0.00707886258765366,0.619302535902276
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37343,-0.00296745426574355,0.00603218315104621,-0.0147905332417941,0.00885562471030702,0.622772236034239
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,37403,0.00214261742220546,0.00437227638312375,-0.00642704428871709,0.010712279133128,0.624109508776337
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,39815,0.00196946103388197,0.00402741151960412,-0.00592426554454209,0.00986318761230604,0.624838692894364
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37430,0.00179401637422531,0.00367684971015733,-0.00541260905768304,0.00900064180613367,0.625613235259756
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,37697,0.00201015348766506,0.00412370593345991,-0.00607231014191636,0.0100926171172465,0.625938424235919
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,37282,0.00198730507150442,0.00408901760798783,-0.00602716944015173,0.0100017795831606,0.626968094611416
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40095,-0.00162173864949165,0.00335324598744927,-0.00819410078489222,0.00495062348590892,0.628653494113516
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37376,-0.00238174815815577,0.00493933230535336,-0.0120628394766483,0.00729934316033681,0.629671737881146
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,37515,0.00154005885582268,0.00319848494208547,-0.00472897163066485,0.0078090893423102,0.630171832016964
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37515,-0.00202270266053807,0.00421074132503659,-0.0102757556576098,0.00623035033653365,0.630974248794143
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,37376,0.00289512712041406,0.00603996709378584,-0.00894320838340618,0.0147334626242343,0.631713207299071
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39815,0.00248696888725549,0.00518999796504948,-0.00768542712424149,0.0126593648987525,0.63181388421803
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40233,0.00192581397048423,0.00402862135363234,-0.00597028388263515,0.00982191182360361,0.632633335770604
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37369,0.00165048900931896,0.00345732252011765,-0.00512586313011163,0.00842684114874956,0.633092961621557
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,39727,0.0029478275239999,0.00619843942615228,-0.00920111375125857,0.0150967687992584,0.634383450617571
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,37403,0.00137585765240224,0.00296917947807825,-0.00444373412463113,0.00719544942943562,0.643099975822365
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36783,0.00209291150504002,0.00452609546733758,-0.00677823561094164,0.0109640586210217,0.643795535829448
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37362,0.00163008149959311,0.00352802950437238,-0.00528485632897675,0.00854501932816298,0.644062302405069
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37343,0.00207625540837425,0.00451186925900349,-0.0067670083392726,0.0109195191560211,0.645397425460954
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,37376,0.00139643791989174,0.00304851913867676,-0.00457865959191471,0.0073715354316982,0.646909202749526
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37282,0.00185189109946841,0.00405403019368202,-0.00609400808014834,0.00979779027908516,0.647820747111787
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37282,0.00169788202270542,0.00375537875960469,-0.00566266034611977,0.00905842439153062,0.651190145654954
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40065,0.00182382052457736,0.00406121447766728,-0.0061361598516505,0.00978380090080522,0.653378346339861
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,37655,0.00289656584114192,0.00646823231303171,-0.00978116949240023,0.0155743011746841,0.654294690526125
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37343,0.00222891998568886,0.00497961925970217,-0.00753113376332741,0.0119889737347051,0.654443277501358
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,40126,0.00111915184261259,0.00250314970405909,-0.00378702157734323,0.00602532526256841,0.654810879962489
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39727,0.00200423940059795,0.00448306843972439,-0.00678257474126186,0.0107910535424578,0.654831825069537
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,37258,0.00330590754680837,0.00743936945192971,-0.0112752565789739,0.0178870716725906,0.656775326658826
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37756,-0.00146636247393754,0.00332497795397779,-0.00798331926373401,0.00505059431585893,0.659209887253101
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40100,0.00338646448525521,0.0076808477436049,-0.0116679970922104,0.0184409260627208,0.659293490958168
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,37515,-0.00681414739859985,0.0155217199353783,-0.0372367184719414,0.0236084236747417,0.66066355270627
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,37403,-0.00248012476174487,0.00565072726100578,-0.0135555501933162,0.00859530066982647,0.660738681157224
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37784,0.0010725255770208,0.00244666218897113,-0.0037229323133626,0.00586798346740421,0.661130443936822
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40036,0.00132911736840802,0.00303763050831807,-0.00462463842789539,0.00728287316471144,0.661718076144791
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39815,0.00182720577062348,0.00418942235454474,-0.00638406204428421,0.0100384735855312,0.662735899088947
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,37403,-0.00148031575253249,0.00340098319493898,-0.0081462428146129,0.00518561130954792,0.663380156354792
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,37376,0.00116530276272825,0.00268986532774094,-0.00410683327964398,0.00643743880510049,0.664862367943052
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,37697,0.00423357068788924,0.00980604100775169,-0.0149862696873041,0.0234534110630826,0.665944050296986
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,39662,-0.00119186938886916,0.00276540003456902,-0.00661205345662443,0.00422831467888612,0.666479217804651
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39815,0.00146288820989531,0.0033978482453452,-0.00519689435098127,0.00812267077077189,0.666813490419648
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37362,0.0018749269311497,0.00439175665814847,-0.00673291611882129,0.0104827699811207,0.669445018991875
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39746,0.00226133674510907,0.00530503805624582,-0.00813653784513275,0.0126592113353509,0.669922859020938
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39967,-0.000927427640920776,0.00218257133179219,-0.00520526745123346,0.00335041216939191,0.670897737200755
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37430,0.00126057279629958,0.00297369395304622,-0.00456786735167101,0.00708901294427017,0.671639900919466
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39815,0.00159218297975769,0.00379315010419242,-0.00584239122445946,0.00902675718397485,0.674672380320422
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40053,-0.00103871622529334,0.00247496834945594,-0.00588965419022699,0.00381222173964031,0.674718667250479
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37282,0.00344686205995621,0.00823257356454894,-0.0126889821265597,0.0195827062464721,0.675452746749856
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37515,-0.00136193654221975,0.00325517572250223,-0.00774208095832411,0.00501820787388461,0.675668072602298
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40274,0.00220158447962892,0.00527726436871293,-0.00814185368304843,0.0125450226423063,0.676550288444279
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37343,-0.00294421705241126,0.00706561086690064,-0.0167928143515365,0.010904380246714,0.67690717328204
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37756,0.00142253502312383,0.00341500194824413,-0.00527086879543467,0.00811593884168233,0.677010888710021
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37343,-0.00213000072551377,0.00516702412726628,-0.0122573680149557,0.00799736656392814,0.680177936249946
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,37376,0.00155689629220496,0.00380640557748368,-0.00590365863966305,0.00901745122407298,0.682531706995681
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39727,0.00145240102332237,0.0035807990059708,-0.00556596502838039,0.00847076707502514,0.685036269211895
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37470,-0.0011277928381499,0.00283808684102746,-0.00669044304656373,0.00443485737026393,0.691095364235092
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37515,-0.00191507050156313,0.00482413099608893,-0.0113703672538974,0.00754022625077116,0.691390684892476
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,37784,0.00104128525064505,0.00262754317561153,-0.00410869937355355,0.00619126987484365,0.691892907695839
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,40034,0.00133369572435899,0.00336781344248873,-0.00526721862291891,0.0079346100716369,0.692101337784666
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37697,-0.00206013354681689,0.00521111951505983,-0.0122739277963342,0.00815366070270038,0.692602660348957
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37515,0.00241129954878149,0.00610759591827664,-0.00955958845104072,0.0143821875486037,0.692994441630544
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,37282,-0.00216100186237158,0.0055329453183158,-0.0130055746862705,0.00868357096152738,0.696121667710352
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37362,-0.00142692281788633,0.00365654795750806,-0.00859375681460214,0.00573991117882948,0.696367234319531
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,37499,0.00346511121227926,0.00888928337025774,-0.0139578841934259,0.0208881066179844,0.696685103492205
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,37696,0.00210998225039105,0.0054418687337686,-0.0085560804677954,0.0127760449685775,0.698221201387291
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39727,0.00195089149981592,0.00506216973152975,-0.00797096117398238,0.0118727441736142,0.699956504363554
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37362,-0.0014184822359916,0.00369660907962197,-0.00866383603205066,0.00582687156006746,0.701188416400673
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,37403,-0.00113866490738194,0.00298929428658678,-0.00699768170909202,0.00472035189432815,0.703273097310721
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,37282,0.00274313614847809,0.0073303641987668,-0.0116243776811048,0.017110649978061,0.708250152398464
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39815,-0.00222495738038134,0.00601898668229959,-0.0140221712776885,0.00957225651692584,0.711643563503004
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,37403,0.00145022291876918,0.00392464438837092,-0.00624208008243782,0.00914252591997618,0.711748427020267
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37362,0.00107721122389164,0.00292292685204057,-0.00465172540610788,0.00680614785389116,0.712477748881463
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,37282,-0.00179770328756166,0.00488645132076329,-0.0113751478762577,0.00777974130113439,0.712957249766939
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,37282,0.00226321579443064,0.00619392063502066,-0.00987686865020985,0.0144033002390711,0.714824022685136
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37784,-0.0020778795177047,0.00572312309976691,-0.0132952007932478,0.00913944175783844,0.716560280151541
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39727,-0.00194364418137273,0.00536379404238331,-0.012456680504444,0.00856939214169857,0.717085285462627
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,37513,0.00125398120173617,0.00347429642098158,-0.00555563978338772,0.00806360218686006,0.718156883322535
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,37230,-0.00114207910767651,0.0031656158554953,-0.0073466861844473,0.00506252796909428,0.718272661008471
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,39783,0.00129750464267059,0.00360541132465527,-0.00576910155365375,0.00836411083899493,0.718944068194815
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39529,0.00209682563974732,0.00589199862838871,-0.00945149167189455,0.0136451429513892,0.721937807038954
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,37430,-0.00219720181234516,0.00618047920835782,-0.0143109410607265,0.00991653743603617,0.722215798794912
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40278,0.000870325076439963,0.00245171719094867,-0.00393504061781942,0.00567569077069935,0.722604871690884
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39727,0.00156850080234889,0.00441851480512103,-0.00709178821568832,0.0102287898203861,0.722606691963699
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37696,-0.00554279189382308,0.015654831282924,-0.0362262612083541,0.0251406774207079,0.723297528330046
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37403,-0.00065651779389116,0.00185434607419716,-0.00429103609931759,0.00297800051153527,0.723312605015819
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39930,-0.00102841240758931,0.00290617218086661,-0.00672450988208786,0.00466768506690924,0.723439774831832
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,40213,-0.00165244654618575,0.00467503704716339,-0.010815519158626,0.00751062606625449,0.723747063890127
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,40106,0.00164841712079626,0.00467413203123786,-0.00751288166042994,0.0108097159020225,0.724342047983168
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37403,-0.000991681606531413,0.00284388319859908,-0.00656569267578561,0.00458232946272278,0.727315055190757
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37362,-0.00179425418109865,0.00524387831169671,-0.0120722556720242,0.00848374730982689,0.732234795941637
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,37376,-0.00269280231090674,0.00789430757861224,-0.0181656451649867,0.0127800405431733,0.733028697293199
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,37376,-0.0013232759695427,0.00388500590330128,-0.0089378875400132,0.0062913356009278,0.733401940202336
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39727,-0.00152928605552421,0.00450773573442048,-0.0103644480949884,0.00730587598393994,0.734419935461527
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40065,0.001087434255375,0.00324250532307814,-0.00526787617785815,0.00744274468860814,0.737351607330202
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40204,0.000836402604009136,0.00251189198600157,-0.00408690568855394,0.00575971089657221,0.73915597217356
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39810,-0.00188510784844454,0.00575664474587585,-0.0131681315503612,0.00939791585347212,0.743319600116716
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37756,-0.00086708293304124,0.0026571534055802,-0.00607510360797843,0.00434093774189595,0.744187210325901
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37362,0.00212000860682404,0.00651895278600916,-0.0106571388537539,0.014897156067402,0.74502973585583
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37756,0.0013288622278925,0.00408783300754347,-0.0066832904668927,0.0093410149226777,0.745127585770757
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37499,-0.00297026061277127,0.00916896551912179,-0.02094143303025,0.0150009118047074,0.745983209111539
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40054,0.000830047574073122,0.00257891458964615,-0.00422462502163333,0.00588472016977957,0.747563620353372
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,37403,0.0014212206998891,0.00444059691309475,-0.00728234924977661,0.0101247906495548,0.748934283535006
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40174,0.00106493003548544,0.00333692268880838,-0.00547543843457897,0.00760529850554986,0.7496281081964
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,37376,-0.00267258518565885,0.00838118743215222,-0.0190997125526772,0.0137545421813595,0.749823375588292
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,39746,0.00482581255175854,0.0152548424364277,-0.0250736786236397,0.0347253037271567,0.751744009515869
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37282,-0.00157534206145282,0.0049859772159708,-0.0113478574047556,0.00819717328184994,0.752042164808224
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37343,0.00243918884328525,0.0077532327554644,-0.012757147357425,0.0176355250439955,0.753068333758668
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,37282,-0.00176411558997171,0.00565443697901741,-0.0128468120688458,0.00931858088890242,0.755054833088846
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,39667,-0.00131860510268088,0.00423015130451566,-0.00960970165953158,0.00697249145416982,0.755260771440502
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,37376,0.000926910226813273,0.00301220845628207,-0.00497701834749958,0.00683083880112613,0.758302015651739
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,37362,0.00118798873934768,0.00390359492200674,-0.00646305730778554,0.00883903478648089,0.760879894865609
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37343,0.00236677748440126,0.00779491358007127,-0.0129112531325384,0.017644808101341,0.761413923795236
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37515,0.00103530547671971,0.00342451875833666,-0.00567675128962014,0.00774736224305956,0.762411841397618
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,37403,-0.00205579245815805,0.00688852186814866,-0.0155572953197294,0.0114457104034133,0.765374146446169
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39810,-0.000908442045703835,0.00305730792782166,-0.00690076558423429,0.00508388149282662,0.766365251777498
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37697,-0.0012422702441068,0.00421627196256106,-0.00950616329072648,0.00702162280251288,0.768275717295802
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,37791,-0.00152442834441162,0.00517827411230443,-0.0116738456045283,0.00862498891570507,0.768465044765687
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37282,0.00157751951440291,0.0053844458550014,-0.00897599436139983,0.0121310333902056,0.769544367807369
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40216,0.000685129569635377,0.00236027419073469,-0.00394100784420462,0.00531126698347537,0.771609363894121
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,37696,-0.00152019981375951,0.00527816758527354,-0.0118654082808956,0.00882500865337662,0.773338548613647
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40066,-0.000932524997756648,0.00324398270850631,-0.00729073110642902,0.00542568111091572,0.773761644343685
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37403,-0.00113223845825892,0.00394527730727278,-0.00886498198051357,0.00660050506399572,0.774127804784437
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37376,0.00216992535100675,0.00759820497578569,-0.0127225564015332,0.0170624071035467,0.775201378378162
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37376,-0.0018790645820049,0.00657989406228026,-0.0147756569440742,0.0110175277800644,0.775206910467895
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,40164,-0.000781925543959087,0.00275600723270177,-0.00618369972005456,0.00461984863213639,0.776631159787876
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,37403,0.000714408978485746,0.00252196878742149,-0.00422864984486037,0.00565746780183186,0.776971093269522
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37697,0.00090266640842022,0.00321908943517937,-0.00540674888453135,0.00721208170137179,0.779166978242721
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,40138,0.00167463469892003,0.00599777250787851,-0.0100809994165219,0.0134302688143619,0.780087781100677
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37430,-0.00116635630366379,0.00417991494260836,-0.00935898959117618,0.0070262769838486,0.780219888942574
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37756,-0.000907603929017945,0.00332455135396126,-0.00742372458278202,0.00560851672474613,0.784857127017136
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37737,-0.000984219207712077,0.00361437948841951,-0.00806840300501432,0.00609996458959016,0.785390552440344
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37430,-0.00119362431903929,0.00442292297835696,-0.00986255335661894,0.00747530471854036,0.787262802524376
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,37376,0.00146669297597135,0.00544008551582829,-0.00919587463505211,0.0121292605869948,0.787465809904721
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,37403,0.000718679925698951,0.00267306597817643,-0.00452052939152685,0.00595788924292475,0.788041872692411
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37737,0.00172352600280463,0.00642689781490992,-0.0108731937144188,0.0143202457200281,0.78856965767912
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,39727,-0.00125963537444845,0.0048045316909524,-0.0106765174887152,0.00815724673981827,0.793188894031114
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,39991,-0.000286676940857536,0.00110090513734781,-0.00244445101005925,0.00187109712834418,0.794557822417789
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37376,0.000983373760454026,0.00379117184311141,-0.00644732305204435,0.0084140705729524,0.79534220073166
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,39815,-0.00138602849420262,0.00537306980707615,-0.0119172453160719,0.00914518832766662,0.796442467594267
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,37515,-0.0014227048922915,0.00551732940049936,-0.0122366705172702,0.00939126073268725,0.796518132547574
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,37362,-0.00109504701174005,0.00431186242723752,-0.00954629736912559,0.00735620334564549,0.79952935293555
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37515,0.00167070150928702,0.00677883524134586,-0.0116158155637509,0.0149572185823249,0.805331204896755
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40126,-0.00109932250014697,0.00446288566906495,-0.00984657841151427,0.00764793341122034,0.805433505022371
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37343,-0.00136993845223024,0.00559504880152994,-0.0123362341032289,0.00959635719876844,0.806577754483907
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,37343,0.00129287341284267,0.005299906887618,-0.00909494408688861,0.011680690912574,0.80727910689844
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,39783,-0.00105592579275043,0.00437030385777671,-0.00962172135399277,0.00750986976849191,0.80908264690957
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,37376,0.00104855665347476,0.00442348168133306,-0.00762146744193804,0.00971858074888756,0.81262696317735
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,37737,0.000496516415784404,0.00210169287089889,-0.00362280161117742,0.00461583444274623,0.813245472388398
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37515,-0.0016645584418697,0.00706210695783537,-0.015506288079227,0.0121771711954876,0.813666985649928
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40274,0.000939220662700023,0.00398901659976611,-0.00687925187284155,0.0087576931982416,0.813861225173728
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37791,0.000530631167879435,0.00225604625305348,-0.00389121948810538,0.00495248182386425,0.814053989687789
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,39815,0.000991559461625426,0.00427094688161278,-0.00737949642633562,0.00936261534958647,0.816413848310765
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,37734,0.00048060330882052,0.00210723755656749,-0.00364958230205176,0.0046107889196928,0.819593252448184
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37343,-0.00094254408782176,0.00416311766200131,-0.00910225470534432,0.0072171665297008,0.820891255744148
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37697,-0.00158445096253373,0.00702338162990412,-0.0153502789571458,0.0121813770320783,0.821518672116867
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,40079,-0.00256973571302627,0.0115235006611262,-0.0251557970088336,0.0200163255827811,0.823538754400653
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39922,-0.00118656330629144,0.0053336735740006,-0.0116405635113326,0.00926743689874974,0.823953742157216
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,37515,-0.00110565169757321,0.00501270370187355,-0.0109305509532454,0.00871924755809894,0.825430764916653
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,39810,0.000995815665657408,0.00453354993620344,-0.00788994220930133,0.00988157354061614,0.826142986717798
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,37403,-0.000562641078914165,0.00257409385416895,-0.0056078650330853,0.00448258287525697,0.826981996113361
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37489,0.00100208530163383,0.00460052768006741,-0.0080149489512983,0.0100191195545659,0.827573047282595
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37343,-0.00118679438233416,0.00546941466041304,-0.0119068471167437,0.00953325835207541,0.828221553233609
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39815,0.00234127865447073,0.0108524480001506,-0.0189295194258244,0.0236120767347658,0.829195329384383
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,37403,-0.00123509842319376,0.00574001227773666,-0.0124855224875576,0.0100153256411701,0.82963545386584
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37282,-0.00124569719399558,0.0058131758781443,-0.0126395219151584,0.0101481275271672,0.830325429871064
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37737,-0.000503806184597085,0.00235790155630655,-0.00512529323495792,0.00411768086576375,0.830809882965066
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,37756,-0.000914642584783988,0.00429943022281259,-0.00934152582149666,0.00751224065192868,0.831536326814161
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37515,0.00121924726865514,0.00573291350950924,-0.010017263209983,0.0124557577472932,0.831583801498336
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,37430,-0.000544821786270295,0.00257996167160116,-0.00560154666260857,0.00451190309006798,0.832754523529295
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,37362,0.00140315084149068,0.00672711928799361,-0.0117820029629768,0.0145883046459582,0.834778452134344
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37376,0.00191420600385804,0.00923006723053613,-0.0161767257679928,0.0200051377757089,0.835710051504018
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40100,-0.000671250952537933,0.00326995210264235,-0.00708035707371694,0.00573785516864107,0.83735718957239
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,37343,-0.00135303404349251,0.00664818732167735,-0.0143834811939801,0.0116774131069951,0.838732419925751
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,37403,-0.000871164952281806,0.00437249650747751,-0.00944125810693773,0.00769892820237412,0.842080151736906
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,39834,0.000980836293953018,0.0049707301070272,-0.00876179471582028,0.0107234673037263,0.843577874294091
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37782,0.000451204735571912,0.00231510154836191,-0.00408639429921742,0.00498880377036125,0.845477097797176
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37515,0.000954538394163721,0.00493820084907853,-0.0087243352700302,0.0106334120583576,0.846729541909938
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37376,-0.00116694902398852,0.00609696965645807,-0.0131170095506463,0.0107831115026693,0.848216636060779
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,37470,-0.00047594985353228,0.00267329287277799,-0.00571560388417715,0.00476370417711258,0.85869527519003
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37515,0.00102461436650037,0.00578749926985956,-0.0103188842024244,0.0123681129354251,0.859480326392777
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39815,0.00104192416445692,0.00601453278282476,-0.0107465600898796,0.0128304084187934,0.862469442957328
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,39810,-0.0011301301645366,0.00655417979255839,-0.013976322557951,0.0117160622288779,0.863102607281859
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37362,0.000797111230933256,0.00462684727901379,-0.00827150943593377,0.00986573189780029,0.863220450349762
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,37470,0.000495079582389666,0.00289556250391358,-0.00518022292528095,0.00617038209006028,0.864243152265914
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37697,-0.000692834370032115,0.00408458885738272,-0.00869862853050226,0.00731295979043803,0.865310349332724
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39991,0.000617347414805187,0.00369034681214543,-0.00661573233699986,0.00785042716661024,0.867146330954609
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37376,-0.000748502844329924,0.00450971665157173,-0.00958754748141051,0.00809054179275066,0.868178762867807
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37343,-0.000752127402936802,0.00458813608749927,-0.00974487413443536,0.00824061932856176,0.869789805816157
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,39599,-0.000870825947155264,0.00533276145977618,-0.0113230384083166,0.00958138651400604,0.870286479267492
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37515,0.000667129426148804,0.00409842902527625,-0.00736579146339264,0.00870005031569025,0.870696642591013
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,37756,-0.00091560385125644,0.00574520243197575,-0.0121762006179289,0.010344992915416,0.87338103494746
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,37403,0.000674039714761415,0.00426710502207225,-0.00768948612850019,0.00903756555802302,0.874489339585389
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39746,0.000601394169427274,0.00395614006508597,-0.00715264035814123,0.00835542869699578,0.879176803496376
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,39815,0.000657669183809754,0.0044609089228363,-0.0080857123049494,0.00940105067256891,0.882795025635042
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39946,0.000393730004298259,0.00268777316293121,-0.00487430539504691,0.00566176540364343,0.883537043414835
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37282,0.000347267059023533,0.00239633336338022,-0.0043495463332017,0.00504408045124877,0.884779465530859
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39727,-0.000564901115630642,0.00390268984358509,-0.00821417320905741,0.00708437097779613,0.884912848706696
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39810,0.0010371227490253,0.00721356371360279,-0.0131014621296362,0.0151757076276868,0.885680838419353
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,40297,0.000315340891320484,0.00222208109533159,-0.00403993805552943,0.0046706198381704,0.887150993197323
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,39815,0.000689362605132372,0.00487887324292347,-0.00887322895099764,0.0102519541612624,0.887638394122691
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37756,-0.000602583935058072,0.00438392630794435,-0.009195079498629,0.00798991162851285,0.890674800425353
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39815,-0.000438935880464141,0.00321949104442159,-0.00674913832753046,0.00587126656660218,0.891556629668275
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,40055,-0.00132140123892337,0.00981082413220241,-0.0205506165380401,0.0179078140601934,0.892860221385775
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,39815,0.00104477040093354,0.00778235690737076,-0.0142086491375131,0.0162981899393802,0.893207767058214
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,37697,0.000409668366751485,0.00306359276202257,-0.00559497344681276,0.00641431018031573,0.893624796916325
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,40095,0.000570636034079435,0.00435434135664434,-0.00796387302494348,0.00910514509310235,0.895737512182192
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37403,0.00026086381922476,0.00202795120628737,-0.00371392054509849,0.00423564818354801,0.897649124946303
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,40065,-0.000337112480150853,0.00264105118192587,-0.00551357279672555,0.00483934783642384,0.898432909265816
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37376,-0.000448927053875003,0.00352058106886554,-0.00734926594885147,0.00645141184110146,0.898534749969799
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,39727,-0.000689224482116191,0.00547862174056971,-0.0114273230936328,0.0100488741294004,0.899889893781045
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37362,-0.00065305803455036,0.00520306205545328,-0.0108510596632388,0.00954494359413807,0.900118459174031
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37696,0.000298646968606505,0.0023874252195638,-0.00438070646173855,0.00497800039895156,0.900452889428992
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,39810,0.000533134839569864,0.00442242206466942,-0.0081348124071822,0.00920108208632193,0.904046926908392
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37343,0.000611325776684953,0.00511711389146086,-0.00941821745057833,0.0106408690039482,0.904907317117236
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37696,-0.000438648339371848,0.00380211723133246,-0.00789079811278347,0.00701350143403978,0.908154007141135
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37782,-0.000354348113742157,0.00316857930355649,-0.00656476354871287,0.00585606732122856,0.910958409986065
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,40095,0.000390917428090861,0.00353710991567219,-0.00654181800662663,0.00732365286280835,0.91199929490979
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37515,-0.000849321880686393,0.00770827375323867,-0.0159575384370342,0.0142588946756614,0.912265818106297
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37784,-0.00038563741642203,0.00350136323642145,-0.00724830935980806,0.006477034526964,0.912300621918125
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,37737,0.000554141799930364,0.00540225306192722,-0.010034274201447,0.0111425578013077,0.918300997163636
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,40025,0.000222595290996483,0.00218753353496866,-0.0040649704375421,0.00451016101953506,0.918951433171966
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37403,0.000281651953611222,0.00281892760161682,-0.00524344614555774,0.00580675005278019,0.920413691474471
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,37403,0.000425185102167854,0.00429193678970637,-0.00798701100565662,0.00883738120999233,0.921087383508528
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39815,-0.000538288154539217,0.00544957692142233,-0.011219458920527,0.0101428826114485,0.92131730472831
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,37515,0.00046447337616499,0.00477382314561853,-0.00889221998924732,0.0098211667415773,0.922492911741309
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,40065,-0.000165681389280417,0.00172632150990449,-0.00354927154869321,0.00321790877013238,0.92354272601023
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37282,-0.000527098324872008,0.00549888722384056,-0.0113049172835995,0.0102507206338555,0.923636872165331
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,37376,-0.00057074093887946,0.00626949582025721,-0.0128589527465836,0.0117174708688247,0.927466522527579
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,39746,-0.000325012849917524,0.00369470879864825,-0.00756664209526809,0.00691661639543304,0.929903970060148
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,37362,-0.000289011252248434,0.00330179290911114,-0.00676052535410628,0.00618250284960941,0.930250317553107
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39727,0.000233884501414048,0.00278172283116431,-0.005218292247668,0.00568606125049609,0.932994715039373
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,37756,-0.0011826035608938,0.0145267982395714,-0.0296551281104537,0.0272899209886661,0.935118384938274
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,40274,-0.000332875244499741,0.0041154368609782,-0.00839913149201701,0.00773338100301753,0.935534792771897
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37515,0.000321222116331292,0.00410127214553291,-0.00771727128891322,0.0083597155215758,0.937572675286734
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,37362,-0.000619049075496923,0.00805690315814216,-0.0164105792654556,0.0151724811144617,0.93875630167943
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37376,0.000544060729937883,0.00708587139032229,-0.0133442471950938,0.0144323686549696,0.938798905178072
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39991,-0.000236224547079299,0.00313124691864329,-0.00637346850762015,0.00590101941346155,0.939864772332146
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37515,-0.000559451791100382,0.00748101186874452,-0.0152222350538396,0.0141033314716389,0.940388589593054
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37784,-0.000199445109143262,0.0026689660925973,-0.00543061865063397,0.00503172843234745,0.940432664423027
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37430,-0.000177942234131245,0.0024131708021366,-0.00490775700631899,0.0045518725380565,0.941220048794011
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37784,0.000182394409429983,0.00249476914326917,-0.0047073531113776,0.00507214193023756,0.941719094815401
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,37362,0.000310699323146781,0.00427135730058531,-0.00806116098600043,0.00868255963229399,0.942013996537328
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37362,-0.000252703961174801,0.00347624675496546,-0.0070661476009071,0.0065607396785575,0.942050364879742
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,37403,-0.00043498001285979,0.0060571644101665,-0.0123070222567861,0.0114370622310665,0.94275224780197
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,39727,0.00028187926186481,0.00409093406512459,-0.00773635150577938,0.008300110029509,0.945067414908497
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39746,0.000554951945289848,0.00807877552629456,-0.0152794480862475,0.0163893519768272,0.945235221475646
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,40065,0.000533161863482904,0.0079399037076066,-0.015029049403426,0.0160953731303918,0.946463417020964
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37756,-0.00038313710490391,0.00625564366288337,-0.0126441986841553,0.0118779244743475,0.951163712502862
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39991,0.000123021381341199,0.002044990002952,-0.00388515902444472,0.00413120178712712,0.95203100888072
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,40174,-0.000199131134468819,0.00335302274566963,-0.00677105571598129,0.00637279344704365,0.952643393367261
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,39746,0.000283666346022005,0.00483269431063464,-0.0091884145028219,0.00975574719486591,0.95319393751615
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,39815,0.000158578282732976,0.00283406270063885,-0.00539618461051918,0.00571334117598513,0.955378860036665
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37696,-0.000130168551587585,0.0023536740739402,-0.00474336973651037,0.0044830326333352,0.95589678458049
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,37343,0.000467598371373059,0.00882234103002985,-0.0168241900474855,0.0177593867902316,0.95773143781321
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,37696,-0.000145579164856348,0.00277416960737423,-0.00558295159530983,0.00529179326559714,0.95814968101543
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,39815,-0.000250065490400028,0.00482298911747393,-0.00970312416064893,0.00920299317984888,0.958649962061511
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,39815,0.000368760878229,0.00716465331699279,-0.0136739596230769,0.0144114813795349,0.958952101573902
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,40233,0.000143679757060973,0.00307489912870655,-0.00588312253520386,0.00617048204932581,0.96273167555145
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37697,-0.00024410146176648,0.00559159041578757,-0.0112036186767101,0.0107154157531772,0.965179984869404
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37756,0.000422248884127094,0.0103053308947033,-0.0197761996694913,0.0206206974377455,0.967317373198606
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37403,-0.00034100178134403,0.00846701285455954,-0.0169363469762807,0.0162543434135927,0.967875179812803
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40248,0.000116547109110548,0.00305059916432866,-0.00586262725297363,0.00609572147119473,0.969524986892174
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37697,-0.000135677851706792,0.00398707086288808,-0.00795033674296743,0.00767898103955385,0.972854174744057
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37343,-0.000114726679773509,0.00391821132450479,-0.0077944208758029,0.00756496751625589,0.976641435425494
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,37515,-0.000107356386458836,0.00375851818467092,-0.00747405202841384,0.00725933925549617,0.97721316943906
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37282,-0.000113963280074881,0.00458884579701047,-0.0091081010422154,0.00888017448206564,0.980187082522082
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37376,-8.08027166314146e-05,0.00352494274969122,-0.00698969050602621,0.00682808507276338,0.981711945023232
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,39810,-0.000108523649821541,0.00493864465069451,-0.00978826716518278,0.0095712198655397,0.982468678585976
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,37362,-0.000136916274477158,0.00659047467641428,-0.0130542466402491,0.0127804140912948,0.983425562902784
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,37362,6.20068388689357e-05,0.00309140609617579,-0.00599714910963562,0.00612116278737349,0.983997565369276
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,37282,9.112557425655e-05,0.00523412765350991,-0.0101677646266229,0.010350015775136,0.986109891882628
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,40248,4.10865865753564e-05,0.00264958277415997,-0.00515209565077818,0.00523426882392889,0.987628044407775
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,37403,2.81207370920576e-05,0.0019424174662546,-0.00377901749676696,0.00383525897095107,0.988449504053109
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39810,-8.99047447120584e-05,0.00767410972264495,-0.0151311598010962,0.014951350311672,0.990652883302604
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37808,1.49870462018108e-05,0.00171886204169329,-0.00335398255551703,0.00338395664792065,0.993043329169964
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37362,-2.6149716940259e-05,0.00320656796355266,-0.00631102292550348,0.00625872349162296,0.993493410916353
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,37515,1.68307540910752e-05,0.00208806176394346,-0.00407577030323812,0.00410943181142027,0.993568870115513
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,37362,2.05476203925494e-05,0.00474677111083239,-0.00928312375683894,0.00932421899762404,0.996546229002866
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37696,4.07376398751441e-05,0.011638659372873,-0.022771034730956,0.0228525100107063,0.997207302582596
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,39761,-9.6774847704613e-06,0.0043258803661814,-0.008488403002486,0.00846904803294508,0.998215072425063
NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40028,3.12703374437946e-06,0.0024078356009962,-0.00471623074420816,0.00472248481169692,0.998963811649814
